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Abstract 
 
Proteins are involved in almost every biochemical process within every living organism. 
Amino acids form the building blocks required to make proteins, however, on their own they 
only constitute the primary structure. For the protein to be biologically active, the linear 
amino acid polypeptide structure needs to be folded into its tertiary structure, or native state. 
Molecular chaperones are proteins that assist in the folding or unfolding of other proteins. 
Although essential for cell survival, these chaperones do not form a part of the final structure 
of the secondary proteins and are not involved in any of its biological functions. They play an 
important role in preventing unfavourable hydrophobic interactions between unfolded 
proteins in the crowded intracellular environment. A sub class of chaperones, referred to as 
chaperonins, are 60kDa monomers that usually assemble into large tetradecameric double 
ringed structures. They work by encapsulating misfolded or unfolded protein into their cage 
like central cavity and allow it to fold without influence from the crowded intracellular 
environment. 
 
Most bacteria only have one GroEL (E. coli chaperonin) homologue; however some bacteria 
have been shown to have 2 or more copies of the groEL gene, including most Mycobacteria. 
In Mycobacterium tuberculosis there are 2 distinct groEL homologues which encode the 
chaperonins Cpn60.1 and Cpn60.2, while M. smegmatis has 3 copies of cpn60. Phylogenetic 
analysis of the Mycobacterial chaperonins has shown that the genes for the duplicated 
chaperonins diverged a long time ago, such that one of the groEL homologues in M. 
tuberculosis is more closely related to one in M. smegmatis than it is to the other one in M. 
tuberculosis. This suggested that the two chaperonins in M. tuberculosis have evolved to 
fulfil different functions within the cell. In both cases Cpn60.2 is predicted to be the main 
house-keeping chaperonin. Interestingly, while most chaperonins occur as stable complexes 
with a characteristic double ring structure of 14 subunits, the Mycobacterial chaperonins are 
very unstable and appear to form much smaller complexes. Given that the large structures 
formed by most chaperonins are considered essential to their mechanism of action, it is 
unclear why the oligomers are so much less stable in Mycobacteria. 
 
In this study I present detailed functional and oligomeric analysis of the M. tuberculosis 
chaperonins. Using various biological techniques, including complementation assays, site 
directed mutagenesis, and domain swap experiments; I have been able to demonstrate that 
both chaperonins have evolved to fulfil alternate functions within the cell. I have shown that 
while Cpn60.2 is fully functional in E. coli, Cpn60.1 is not. However, M. tuberculosis 
Cpn60.1 was able to function in M. smegmatis and complement in an assay of biofilm 
formation for the loss of its endogenous chaperonin. Domain swap experiments between 
Cpn60.2 and E. coli GroEL have provided further evidence to support the hypothesis that 
they function in a similar manner. Using analytical ultracentrifugation on purified proteins, I 
have been able to show that Cpn60.2 and its functional chimera do form larger oligomeric 
complexes in vitro under certain conditions and in the presence of ATP.  
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1.1    Protein Folding  
The genome sequence of an organism is the basic information required by an organism to 
live. This code is read, translated and acted upon by the cell to maintain itself. Proteins 
represent the final stages of information transfer from an organism‟s genome sequence. It 
takes just 20 amino acids to form all the known and unknown proteins. A single error in the 
mechanism of protein folding in an organism can have an adverse affect on its survival 
capabilities. This, along with the importance of proteins in the medical and biotechnological 
fields makes the study of protein folding vital, as the final structure of the protein determines 
its activity. Even though the mechanism of protein folding is a very active area of research, 
exactly how the linear amino acid sequences are folded into fully functional proteins is yet to 
be conclusively answered. 
 
1.1.1   A brief historical perspective of protein folding 
Proteins were first recognised in the 18
th
 century, but it wasn‟t till the 19th century that the 
term protein came into use. Even then it took almost another century before scientists started 
to study the processes involved in protein folding. In 1959, W. Kauzmann discovered that 
protein folding is mediated by hydrophobic interactions (Kauzmann, 1959). This then led to 
the idea that proteins fold in a trial and error manner. However, in 1968 Levinthal suggested 
that if proteins were folding in a „trial and error‟ method, then it would take longer than the 
age of the universe for a protein to reach its native state (Levinthal, 1968) . A thermodynamic 
hypothesis was then put forward which suggested that a protein would reach its native state 
when its Gibbs free energy was at its lowest. Anfinsen demonstrated that the free energy of a 
protein was determined by its inter-atomic interactions, which were in turn determined by the 
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specific amino acids of the protein, and thus the native state of the protein was already 
encoded in its primary sequence (Anfinsen, 1973) 
 
1.1.2   The energy landscape theory   
During the process of understanding the mechanisms involved in protein folding, various 
models were put forward. One such model which emerged from various statistical and 
experimental studies, of the intermediate steps involved in protein folding, was the energy 
landscape theory (Onuchic et al., 2000, Wolynes et al., 1995). According to this view the 
energy landscape of a folding protein can be represented by a rugged funnel that represents 
all the energy states available to the protein as it folds (Wolynes et al., 1995). The width of 
the funnel represents the entropy while the depth represents the free energy difference 
between folded and unfolded states. The unfolded state of a protein with the highest free 
energy then folds by one of many routes down the energy funnel to its native state which is 
associated with lower free energy and as such, higher stability (Onuchic et al., 2000) 
(fig.1.1). The rugged nature of the landscape is present due to the various intermediate forms 
a protein can take during its folding process. 
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Fig 1.1: The energy landscape of protein folding. This represents the energy states that 
proteins must go through to reach their native states (from high free energy to low free 
energy). Image adapted from Wolynes at al., 1995. 
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1.2    Protein aggregation 
The tertiary structure of a protein is one of the more stable states for it to be in. However, 
when proteins are synthesised within a cell, they are in their primary state with a lot of 
exposed hydrophobic residues. These hydrophobic residues can interact with each other and 
form aggregates to shield the residues from polar compounds like water, which is the main 
component of the cytoplasm.  The internal nature of a cell is a lot more complex and crowded 
than in vitro (Ellis, 1997, Ellis, 2007). This crowded nature of the cell with macromolecules, 
such as other proteins, can promote undesired misfolding to occur. This mainly occurs 
because the possibility of unfolded proteins interacting with each other to form aggregates is 
increased (Young et al., 2004, Ellis, 1997). Ultimately, these aggregates result in the loss of 
function of the proteins and can eventually lead to cell death (Ellis, 2007). 
 
Gene product translation is also an aggregation prone period for the newly translated proteins. 
The exit channel of a ribosome has been shown to be quite long, at 100 Å (Nissen et al., 
2000). However it is also very narrow, at just 15 Å (Nissen et al., 2000, Ferbitz et al., 2004). 
This allows basic helical formation within the ribosome, but does not allow the complete 
folding of a polypeptide chain into its native state. Also, to attain the native state the entire 
polypeptide sequence needs to have emerged from the ribosome (Hartl & Hayer-Hartl, 2002). 
As a result, the nascent polypeptide chain can end up being exposed for a fair length of time, 
as it can take up to a minute for synthesis to occur for larger chains. These exposed regions 
are prone to contact with other hydrophobic chains and can form aggregates.  
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To try and escape from the aggregating tendencies of the proteins, the cells make use of 
various systems for protein quality control. This quality control can occur in one of two ways; 
refolding, or degradation. This thesis will primarily be focusing on the bacterial protein 
quality control systems, but examples of eukaryotic systems will also be given where 
relevant.  
 
1.3     Protein degradation 
A very important aspect of the protein quality control process is protein degradation. In 1972, 
Alfred Goldberg first presented the evidence to show that selective degradation of proteins 
occurred in E. coli (Goldberg, 1972). Over the last few years our understanding of the 
importance and mechanisms of protein degradation has increased. It was the study of the 
ATP-dependent proteases that led to the discovery of one of the major chaperone families, 
Hsp100 (Schirmer et al., 1996). This family of chaperones have been shown to interact with 
unfolded or misfolded proteins to direct them towards degradation (ref section 1.4.3.6). 
Degradation of proteins within a cell is an important way of regulating many important 
cellular processes. Another important aspect of proteolysis is to degrade any non functional 
proteins within the cell. This prevents potentially lethal protein aggregation from occurring. 
Proteolysis has also been shown to increase in response to stresses such as heat shock 
(Morimoto et al., 1997).  
 
Cellular protein degradation is predominantly via energy dependent proteases (Gottesman, 
1996), which include the Lon protease, the ClpAP protease, and the ClpXP protease, and the 
26S proteasome (the major cytosolic protease in eukaryotes) to name a few. One of the main 
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questions that were originally put forward was how these proteases recognise appropriate 
substrates to degrade. It has been shown that there are various methods by which this is 
achieved by different proteases. The Clp (Hsp100) proteases have been shown to both 
interact directly with their substrates and to also make use of adaptor proteins which bind to 
the substrate first and then bind to the protease to present them with the substrate (Striebel et 
al., 2009b, Gottesman, 1996). The 26S proteasome on the other hand only degrades proteins 
that have been modified by ubiquitin ligases and other ubiquitin conjugating enzymes to 
include polyubiquitin chains (Pickart, 1997). This allows the proteases to interact with a 
broad range of unfolded or misfolded proteins to degrade (Inobe & Matouschek, 2008). An 
illustration showing some of the routes taken by unfolded or misfolded proteins to reach the 
proteases can be seen in figure 1.2.  
 
The structural and functional properties of these proteases share a lot of similarities with 
molecular chaperones. Using ClpA and ClpX as examples, both have been shown to have 
chaperone activities (Singh et al., 2000, Weber-Ban et al., 1999). Structurally the ClpAP and 
ClpXP proteases consist of two heptameric rings of ClpP flanked on one or both side with 
hexameric rings of ClpA or ClpX creating a barrel shaped structure (Beuron et al., 1998). 
This barrel structure contains a series of chambers connected via axial channels (figure 1.3). 
Functionally, the degradation site of substrates is present within the ClpP chamber. So the 
substrate is first recognised by either ClpA or ClpX, then it is unfolded by them in an ATP 
dependent manner. The resulting unfolded substrate is then translocated to the ClpP chamber 
where it is degraded. This mechanism is generally conserved in all three domains of life 
(figure 1.4). Further information on the Hsp100 family of chaperones can be found in section 
1.4.3.6. 
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Fig 1.2: Pathways regulating the transfer of substrate to proteases in (a) eukaryotes and 
(b) bacteria. (1) Proteasome binding to an adaptor protein that is bound to a substrate 
protein. (2) Proteasome recognising and binding to the polyubiquitin chain of the modified 
substrate. (3) Proteasome binding to exposed polypeptide sequence of the substrate. (4) 
Bacterial proteases recognise substrate via adaptor proteins. Image taken from Inobe & 
Matouschek, 2008. 
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Fig 1.3: Cryo-EM reconstructions of ClpP attached to 1 or 2 ClpA. Two side views, of a 
1:1 and a 2:1 complex are shown. Reconstructed 2:1 complex in side view (a), and axial view 
of 2:1 complex (b). Reconstructed 1:1 complex side view (c), and both axial views (d and e). 
Image taken from Effantin et al., 2010. 
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As protein folding in Mycobacterium tuberculosis is the subject of this thesis, it is interesting 
to note that in M. tuberculosis and other actinomycetes, horizontal gene transfer has resulted 
in the acquisition of the 20S proteasome. Structurally it is composed of two rings of catalytic 
β subunits sandwiched by rings of α subunits making a barrel like structure (Hu et al., 2006). 
The eukaryotic 26S proteasome consists of a 20S core flanked on one or both sides with a 
19S ATPase cap. This cap is responsible for the recognition, unfolding and translocation of 
the ubquitinated substrate into the 20S chamber for degradation. In actinomycetes however, 
this function is performed by homologous ATPases like Mpa (Mycobacterium proteasome 
ATPase) or ARC (AAA ATPase forming Ring-shaped Complex) (Pearce et al., 2008, Wolf et 
al., 1998). While the eukaryotic protease system uses ubiquitin to recognise appropriate 
substrates for degradation, in M. tuberculosis it has been shown that Mpa recognises 
substrates that have small ubiquitin like proteins attached called Pup (prokaryotic ubiquitin-
like protein) (Pearce et al., 2008, Striebel et al., 2009a, Burns et al., 2009). An interesting 
point to note here is that although a large number of proteins (58 currently identified targets, 
including Cpn60.2 and Cpn10) in M. tuberculosis have pupylation sites, not all of them 
become proteasome substrates (Festa et al., 2010). More in depth information about the 
Cpn60 family of chaperones is available in section 1.5. A cartoon representation of the 
protease degradation process can be seen in figure 1.4 below. 
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Fig 1.4: Representation of the mechanism by which protein degradation occurs in the 3 
domains of life (Striebel et al., 2009b). Protein quality control in cells makes use of both 
chaperones to fold/unfold proteins and proteases to degrade targeted unfolded proteins. 
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1.4    The molecular chaperones and cochaperones 
Molecular chaperones are proteins that assist in the folding or unfolding of other proteins (fig 
1.5) (Ellis, 1987). Although essential for cell survival, these chaperones do not form a part of 
the final structure of the secondary proteins and are not involved in any of its biological 
functions (Ellis & Hemmingsen, 1989, Ellis, 2005, Ellis, 2007, Hartl & Hayer-Hartl, 2002).   
 
Molecular chaperones are able to recognise unfolded or partially folded proteins by a variety 
of mechanisms (Summers et al., 2009, Li et al., 2009, Gur & Sauer, 2008). Some of these 
chaperones use an ATP dependant mechanism to assist in the proper folding of the nascent 
chains, while others prevent aggregation by shielding the hydrophobic surfaces of the 
polypeptide from interacting with other proteins. It has also been shown that some forms of 
chaperones, e.g. Hsp100, have the ability to unfold proteins that have been misfolded (Ben-
Zvi & Goloubinoff, 2001). In some cases the chaperones make use of another set of proteins 
referred to as the cochaperones to work cooperatively in the folding process. More detailed 
analysis of these cochaperones will be discussed in the context of their cognate chaperone.  
 
 
 
 
 
 
Chapter 1 
13 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 1.5: A general outline of the possible routes taken by nascent polypeptides (U). 
Unfolded proteins are prone to aggregation and as a result they, sometimes, require the 
assistance of molecular chaperones to reach their native state. Image adapted from Fink, 
1999. 
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1.4.1      Classes of molecular chaperones  
A range of different chaperones that function either independently or cooperatively to assist 
in the process of protein folding are present in the cytosol of prokaryotes and eukaryotes 
(table 1). The chaperones can be distinguished in various ways. One such way is based on 
their property to either be ATP dependent (e.g. Hsp60) or ATP independent (e.g. Trigger 
factor). The other method of distinguishing them depends on whether they just hold the 
proteins and prevent them from aggregating or if they actively help fold them in vivo, i.e. the 
„holder‟ or „folder‟ chaperones (Ying et al., 2005). The most useful classification used to 
consider relationships between chaperones in different organisms is based on sequence 
similarity. Based on this classification the chaperones are grouped into families as shown in 
table 1.1 below.  
 
1.4.2      Heat shock proteins (Hsp) and their regulation 
Many molecular chaperones are also heat shock proteins (Gething & Sambrook, 1992). 
Subjecting the cells to an increase in temperatures just a few degrees above normal growth 
conditions causes the expression levels of the heat shock proteins to rise (Kregel, 2002). This 
increase in expression of HSPs is required by the cell to cope with the stress factors. When 
subjected to excess heat, the proteins within the cells start to denature and the HSPs then help 
fold or re-fold these proteins, some of which are required by the cell to increase its chances of 
survival. Other known factors that can induce heat shock proteins in cells include nalidixic 
acid, cadmium chloride, 4% ethanol, and puromycin (VanBogelen et al., 1987). In E. coli it 
has also been shown that this response can also be attained by simply preventing the export of 
some periplasmic proteins (Ito et al., 1986).  
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Table 1.1: Classes of molecular chaperone families. The examples shown are but a few of the known chaperones and are by no means 
the only example. Information obtained from Pete Lund, personal communication. 
 Bacteria 
Mitochondria (m) / 
chloroplasts (c) 
Archaea 
Eukaryotic 
cytosol 
Endoplasmic 
reticulum 
Function 
Hsp100 
ClpA 
ClpB 
ClpX 
HSP78 (m) 
ClpC (c) 
ClpB (c) 
 
Absent 
HSP104; 
absent from 
cytosol of 
animals. 
 
Absent Disassembly of oligomers and aggregates. 
Hsp90 
HtpG 
 
TRAP1 (m) 
HSP90 (c) 
Absent 
HSP90 
HSP82 
HSP83 
 
GRP94 
In eukaryotes: regulation of assembly of steroid 
receptors and signal transduction proteins; protein 
folding and degradation.  
In prokaryotes the function of HtpG is less clear, 
although there is evidence that it facilitates protein 
folding in stressed E. coli. 
Hsp70 
DnaK 
Hsc66 
Grp75 (m) 
HSP70 (absent 
from many 
archaea) 
HSP70, 
HSC70, SSB, 
SSA 
BiP 
Prevention of aggregation of unfolded/newly 
translated/newly imported proteins; many other 
functions such as clathrin uncoating, regulation of 
heat shock response. 
Chaperonin/ 
Hsp60/Cpn60 
GroEL (also 
referred to as 
Cpn60) 
HSP60 (m) Rubisco sub-unit 
binding protein (c) 
Thermosome, 
TF55, CCT 
CCT (also 
called TRiC) 
Absent 
Folding of newly translated and newly imported 
proteins. A vital part of the heat shock response. 
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Hsp40 
DnaJ 
CbpA 
DjlA 
Ydj1 (m) 
Cdj1 (c) 
HSP40 (absent 
from many 
archaea) 
HSP40 
Sis1 
Zuo1 
Sec63 
Binding of unfolded proteins, stimulation of 
ATPase activity of HSP70 (HSP70 cochaperone).  
Very heterologous group as many proteins possess 
“DnaJ-domain”. 
 
sHsps (small heat 
shock proteins) 
 
IbpA 
IbpB 
 
HSP22 (m) 
HSP21(c) 
 
HSP16.5 
 
HSP26 
Alpha-
crystallin 
 
Absent 
 
Stabilisation of unfolded proteins, prevention of 
protein aggregation. 
 
Cochaperonin GroES HSP10 Absent Absent Absent Essential for function of type I chaperonins. 
Prefoldin Absent Absent 
Prefoldin 
GimC 
Prefoldin 
GimC 
Absent 
Prevents protein aggregation; functions with type 
II chaperonins but not essential. 
Trigger factor Tig Absent (m); Present (c) Absent Absent Absent 
Assists folding of nascent ribosome-bound 
polypeptide. 
Nascent 
polypeptide- 
associated 
complex 
Absent Absent MTH177 NAC Absent 
Interacts with and probably assists folding of 
nascent ribosome-bound polypeptide. 
ER chaperones Absent Absent Absent Absent 
Calnexin 
Calreticulin 
ERp53 
HSP47 
Folding of ER glycosylated proteins.  HSP47 is 
specific for collagen chains. 
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This can be achieved by using a null mutation of secB, as this prevents it from participating in 
the export of a subset of proteins into the periplasm or outer membrane results in the cell 
seeing these proteins as abnormal, which generates the signal for heat shock protein induction 
(Wild et al., 1993). Under normal conditions heat shock proteins can make up to 5% of the 
total intracellular protein mass within a cell, rising up to 15% when the cell is put under stress 
(Qamra et al., 2005). 
 
In E. coli the increase in Hsps is regulated by the ζ32 factor of RNA polymerase (Landick et 
al., 1984, Cowing et al., 1985, Diaz-Acosta et al., 2006). The ζ32 subunit of RNA polymerase 
is encoded by the rpoH gene. Under non-heat shock conditions FtsH mediated ζ32 
degradation ensures that the levels of ζ32 within the cells do not rise high enough to cause a 
heat shock response (Herman et al., 1995).  Under heat shock conditions the levels of ζ32 
start to rise as the heat destabilizes a RNA structural element that overlaps the rpoH mRNA 
translation start point (Morita et al., 1999). This causes the levels of gene expressions of the 
recognised promoters to increase as well (Diaz-Acosta et al., 2006). In a lot of cases these 
recognised promoters are linked to the heat shock proteins. The rpoH gene was first 
discovered by Tetsuo Yamamori and Takashi Yura in 1982 and was referred to as the hin 
(heat shock induction) gene (Yamamori & Yura, 1982). They showed that strains of E. coli 
that had a mutation in the rpoH gene were unable to induce expressions of the GroE protein 
while the wild type cells did. It was later shown that a null mutation in the rpoH gene made 
the strain so sensitive to heat, that it would fail to grow over 20°C (Zhou et al., 1988). This 
clearly showed the important role played by the heat shock proteins of E. coli not only in 
protecting the cell from increasing temperatures but also during normal growth at 37°C. 
Interestingly, psudo-revertants ΔrpoH cells that could grow at higher temperatures were also 
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obtained. These revertant cells were shown to be carrying a suppressor mutation, suhA, which 
would suppress all the nonsense and missense rpoH mutations. This mutation affected 
various factors within the cell, including the increase in the levels of ζ32, resulting in higher 
levels of heat shock mRNAs (Tobe et al., 1987).   
 
1.4.3    The chaperone pathways 
A general model of some of the chaperone assisted protein folding mechanisms can be seen 
in figure 1.6. It can be seen that not all forms of protein require chaperones to fold, even if 
they may require them to stop aggregation. Most small proteins can rapidly fold without any 
assistance as soon as the entire sequence has been released by the ribosome. Chaperones such 
as the TF and Hsp70 are known to work by holding the nascent polypeptide chain in a state 
which allows them to fold once they have been released from the ribosome. Other chaperones 
such as the Hsp60 family provide chambers for the nascent chain to fold in and be kept away 
from cytosolic factors such as other folding proteins. It has also been shown that chaperones 
such as the TF bind directly to the ribosome exit site and interact with the newly formed 
polypeptide chains (Hoffmann et al., 2006). Depending on the size of the polypeptide, these 
chaperones either allow folding to occur spontaneously, e.g. smaller chains, or they are then 
transferred to the next family of chaperones such as the Hsp70 family for further folding 
(Deuerling et al., 1999, Thulasiraman et al., 1999). There are however some polypeptide 
chains that are slow-folding and aggregation prone. These are folded within the cell with the 
help of the chaperonins (Hsp60 family) (Houry et al., 1999, Saibil, 2008). Irrespective of the 
routes taken the different classes of chaperones are conserved in all domains of life. The 
importance of the molecular chaperones in cell survival makes it essential to understand their 
structural, biological, and physiological functions.  
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For this review, the practical and theoretical information of the Hsp60 family of chaperones 
will be discussed in detail after some of the other chaperone families, as it is the Hsp60 
family of chaperones that is being studied in this project. 
 
 
 
 
 
Fig 1.6: A general model for chaperone assisted protein folding within a cell. This figure 
shows just some of the routes a newly translated polypeptide chain can take to reach its native 
state. Image taken from Hartl & Hayer-Hartl, 2002. 
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1.4.3.1   The ribosome associated factor (trigger factor) 
The trigger factor is a 48kDa protein encoded by the tig gene, which is highly conserved in 
the eubacteria. In 1998 it was shown to bind with the large subunit of the ribosome (Lill et 
al., 1988). It is now known to bind to the L23 and L29 proteins near the exit channel of the 
ribosome where it interacts with nascent polypeptides (Blaha et al., 2003, Kramer et al., 
2002, Lakshmipathy et al., 2007). It has also been shown to be associated with up to 90% of 
all ribosomes in the cytosol (Patzelt et al., 2002). The structure of the trigger factor can be 
seen in figure 1.7. 
 
The trigger factor functions in an ATP independent manner and recognises nascent chains 
using hydrophobic interactions. It forms complexes with chains as small as 57 residues in 
length (Hesterkamp et al., 1996). As has already been discussed, the next step in the process 
involves either allowing the protein to fold (if it is small enough to fold without further 
support) or if it is unable to do so, then it is passed on to the next set of chaperones like the 
HSP70 (DnaK) chaperone family (section 1.4.3.2). It has been shown that both TF and DnaK 
cooperate in chaperoning unfolded proteins. In E. coli this was achieved with the help of ∆tig 
mutants which resulted in DnaK transiently binding to 40% of nascent polypeptides instead 
of the usual 15% (Genevaux et al., 2004, Deuerling et al., 1999, Teter et al., 1999). It is 
important to note that this deletion showed no defects in growth or protein folding in the 
mutant cells, however, a tig dnaK double mutant or tig dnaK dnaJ triple mutant exhibited 
synthetic lethality (Deuerling et al., 1999, Teter et al., 1999). In 2004 Genevaux et al also 
showed that both DnaK and TF could be deleted and the cells would still survive, but this was 
only achieved at a low temperature (20°C), showing the importance of these chaperones 
during normal growth conditions.  However, research done on gram positive bacteria B. 
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subtilis has shown that the tig dnaK double mutant or even the tig dnaK dnaJ, triple mutant 
did not confer synthetic lethality and the cells were able to survive at temperatures up to 
49°C. This may suggest the involvement of other chaperoning mechanisms involved in B. 
subtilis which are not present in E. coli (Reyes & Yoshikawa, 2002). Interestingly, recent 
research has suggested that the trigger factor may play a bigger role in protein folding and 
stabilisation. Other than its interaction with nascent polypeptide chains, it has been shown 
that the trigger factor may play a role in binding and stabilising native-like proteins to 
facilitate their assembly into larger protein complexes like the ribosome (Martinez-Hackert & 
Hendrickson, 2009).  
 
In archaea and eukaryotes it is the nascent chain associated complex (NAC) or ribosome 
associated complex (RAC), that play a similar role, though they do not shown any signs of 
sequence homology with TF. These are the first proteins to come into contact with nascent 
polypeptide chains. NAC/RAC is a heterodimeric complex with two subunits α and β, of 
sizes 33kDa and 22kDa respectively (Wiedmann et al., 1994). It shows a similar function to 
the TF in that it also binds to nascent chains and then releases them in an ATP independent 
manner when the chain has been released from the ribosome, but its direct role in protein 
folding is still not clear. 
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Fig 1.7: Structural and functional aspects of the trigger factor. (A) The 2.7 Å crystal 
structure of a 48kDa trigger factor. This is the best characterised ribosomal-associated 
chaperone. It assist in the folding mechanism of nascent polypeptide chains that are emerging 
from the ribosomal exit tunnel. In the space filled model, blue colour represents positively 
charged residues, while red represents negatively charged residues. (B) Trigger factor bound 
to a 50S ribosomal subunit. Image taken from Ferbitz et al., 2004. 
 
 
 
(A)                                                                                             (B) 
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1.4.3.2   Hsp70 family of chaperones 
The Hsp70 family of chaperones is very large and is present in both prokaryotes and 
eukaryotes. They are a 70kDa ATP dependent chaperone family and are known to be present 
not only in the cytosol but also in organelles such as the mitochondria, chloroplast and 
endoplasmic reticulum. Most eukaryotes have been shown to contain at least a dozen or more 
different HSP70 (DnaK) chaperones.  
 
The N-terminus of Hsp70 is used to bind to and hydrolyse ATP while the C-terminal is 
responsible for peptide binding (Bukau & Horwich, 1998). A ribbon model of the structure of 
HSP70 can be seen in figure 1.8. Its cochaperones include DnaJ (HSP40) (refer to section 
1.4.3.3), which has been shown to bind to the substrate before Hsp70, and GrpE which 
functions as a nucleotide exchange factor (Hartl & Hayer-Hartl, 2002, Fink, 1999) (figure 
1.9). Together the cochaperones work by presenting the substrate to DnaK and also by 
modulating its ATPase activity. 
 
Hsp70 binds to peptides by hydrophobic side chain interactions and hydrogen bonding 
(Frydman, 2001).  Peptide binding occurs to the ATP bound state of DnaK when the “latch” 
(yellow in fig 1.9) is in an open conformation. This latch is the α helical segment of the C-
terminal domain. The N-terminus of DnaJ then binds to DnaK and accelerates ATP 
hydrolysis by DnaK (Mayer et al., 2000). This causes the latch to close and the peptide stays 
bound to the chaperone. GrpE then induces the release of ADP from the complex (Harrison et 
al., 1997). This allows ATP to bind again to DnaK and causes it to release the peptide and 
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complete the reaction cycle. Nascent polypeptide chain can undergo repetitive cycles of 
folding to reach their native state (Szabo et al., 1994).   
 
The cellular concentration of DnaK exceeds that of the ribosomes, 50µM and 30µM 
respectively (Hartl, 1996). As discussed above, deleting the TF causes nascent chain 
polypeptide interactions with DnaK to rise from roughly 15% to about 40% (Deuerling et al., 
1999). It facilitates the folding of multi-domain proteins by cycles of binding and releasing 
(Teter et al., 1999). There is however some evidence that suggests that Hsp70 may not 
interact with short lived partially folded intermediates (Strickland et al., 1997). 
 
1.4.3.3    Hsp40 family of chaperones 
The Hsp40 family of chaperones consists of over 100 members, all of which have a highly 
conserved J domain of approximately 78 residues (Fink, 1999). To date, the best studied 
member of this family is the DnaJ protein which is a known cochaperone of DnaK. It is a 
43kDa protein and is known to form a dimer in solution (Zylicz et al., 1985, Ohki et al., 
1986). It is commonly suggested that Hsp40 is vital for efficient transfer of substrates to the 
HSP70 chaperone by stimulating its ATPase activity (Minami et al., 1996) (Fig 1.9). The 
cochaperone function of DnaJ is known but there are some evidence to suggest that Hsp40 
can function as chaperones on their own by binding to some nascent polypeptide chains 
(Hendershot et al., 1996). This suggestion came about when it was shown that DnaJ binds to 
the denatured form of the protein firefly luciferase (Langer et al., 1992, Szabo et al., 1996). It 
was also shown that the Yeast homologue (Ydj1) can bind to denatured rhodanese (Cyr, 
1995). 
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Fig 1.8: The ribbon model of HSP70 (DnaK) chaperone in E. coli. Image adapted from 
Genevaux et al., 2007. 
 
 
 
Fig 1.9: General mode of action of HSP70 chaperones. DnaJ (Hsp40), GrpE, and the 
peptide substrate are represented as J, E and S respectively. Taken from Hartl & Hayer-Hartl, 
2002. 
DnaK (HSP70) 
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1.4.3.4   The small Hsps 
One of the most divergent and widespread forms of chaperones, the small Hsps (or sHsps), 
are ubiquitous and their sizes vary from 16 to 42 kDa depending on the length of their N-
terminal domain (Stromer et al., 2003, de Jong et al., 1998). However, they are also known to 
form large oligomeric structures with 9-30 subunits (Ehrnsperger et al., 2000, Narberhaus, 
2002). Structurally the stability of the small Hsp varies from one organism to another. The M. 
tuberculosis Hsp16.3 has a defined oligomeric structure (Chang et al., 1996), while the E. 
coli IbpB seems to have a variable structure (Shearstone & Baneyx, 1999). The C-termini of 
small Hsps are known to be highly conserved and are shown to be homologous to the eye 
lens small heat shock protein α-crystallin (Ingolia & Craig, 1982).  
 
Although extremely important in the maintenance of protein quality control within cells, the 
small Hsps are not as thoroughly understood as other chaperones (Nakamoto & Vigh, 2007). 
These small Hsps have been shown to function by preventing protein aggregation in an ATP 
independent manner. In vertebrates a vital role played by these chaperones is in the eye where 
they prevent cataracts by binding to denatured proteins. It has been shown that these 
chaperones are very efficient in that they can bind up to one substrate molecule per subunit 
and prevent them from aggregating (Haslbeck et al., 1999, Ehrnsperger et al., 2000, Lindner 
et al., 2001) (Fig 1.10). They do not show any signs of substrate specificity and it has been 
proposed that they form complexes with denatured proteins when the cells are under stress so 
that they may act as a reservoir for the HSP70 chaperone machinery to refold these denatured 
polypeptides (Ehrnsperger et al., 2000, Wang & Spector, 2001). 
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Fig 1.10: Mechanism of action of small Hsps. Heat stress causes native proteins (N) to 
become unstable. This mechanism highlights the ability of small Hsps to bind one unfolded 
substrate (U) per subunit and prevent aggregation (Eyles & Gierasch, 2010). 
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1.4.3.5    Hsp90 family of chaperones 
One of the more abundant ATP-dependent forms of heat shock proteins, the Hsp90 molecular 
chaperone is 90kDa in size and found in bacteria (HtpG) and all eukaryotes (Hsp90) (fig 
1.11). They have however not been found in archaea (Chen et al., 2006). They are known to 
function as dimers for substrate binding. Some organelles have their own form of the HSP90 
chaperone like Grp94 (ER form), while in E. coli the homologue is HtpG (high temperature 
protein G). As with all chaperones the Hsp90 family are also responsible in preventing 
protein aggregation, however, this is achieved by holding their substrates in a non active form 
until a signal is received to activate them. They also do not generally interact with nascent 
chains in vivo, but do so in vitro (Nathan et al., 1997). 
 
 The prokaryotic homologue HtpG has been shown to be dispensable under stress condition 
unlike its eukaryotic homologue. The deletion of HtpG only affects cell growth at much 
higher temperatures although there is evidence that suggests HtpG does assist in the folding 
of protein in stressed E. coli cells (Thomas & Baneyx, 2000). In eukaryotes, Hsp70/Hsp40 
chaperone machinery and the cochaperone Hop deliver substrates to Hsp90. This prevents the 
substrates from unfolding further or forming aggregates under stress conditions (Jakob et al., 
1995). The binding of ATP then allows the cochaperone p23 to bind to Hps90. ATP 
hydrolysis occurs due to the conformational changes in the Hsp90 dimer from p23 binding, 
resulting in the subsequent release of the substrate. Hsp90 does show signs of substrate 
specificity to signal transduction proteins (Pearl & Prodromou, 2006), such as protein 
kinases.  
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Structurally, HtpG consist of three domains and is found as a dimer when crystallised (fig 
1.11). The N-terminal domain (NTD) contains the ATP binding site (lid), the carboxy 
terminal domain (CTD) is needed for homodimerization and the middle domain (MD) links 
the NTD and CTD together (Nemoto et al., 1995). In its substrate free state, each of the 3 
domains within each chain expose hydrophobic surfaces which has been suggested to act as 
substrate binding sites (Shiau et al., 2006).   Hsp90 interacts with its substrates when they are 
at a near native state and as such is believed to be involved in making much smaller 
conformational changes to its substrate proteins than that of Hsp70 or Hsp60 (Zhao et al., 
2005, Young et al., 2001). Crystal structures of HtpG with bound nucleotide shows distinct 
conformational states and it is believed that these confirmations are a part of the reaction 
cycle (Shiau et al., 2006, Krukenberg et al., 2008, Harris et al., 2004). A simple 
representation of the reaction cycle is as follows (fig 1.12): 
- In the absence of ATP the chaperone is in an open state that has regions of 
hydrophobic residues from the MD (src loop in fig 1.11) and CTD (H21 and H21‟ in 
fig 1.11) are available for substrate interaction. 
- The next step involves the loading of an appropriate substrate into the open cleft. 
- ATP binding and hydrolysis at the active site lid then results in the binding of the 
substrate. Conformational changes then closes the cleft resulting in substrate protein 
remodelling. This change also hides the hydrophobic residues that were present on the 
surface. 
- Once ATP is hydrolysed, the resulting ADP bound HtpG then releases the substrate 
and is ready for the next cycle. 
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Fig 1.11: Structure of HtpG dimer (Prokaryotic Hsp90) (Shiau et al., 2006). Ribbon view 
of the amino-terminal domain (NTD) (blue) contains the „„active-site lid‟‟ region. The middle 
domain (MD) (green) contains the extended „„src loop‟‟ (dark green tube), and the carboxy-
terminal domain (CTD) is shown in gold. The exposed carboxy terminal helices (H21 and 
H21‟) (red boxes) are also shown. 
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Fig 1.12: Prokaryotic Hsp90 reaction cycle. In the nucleotide free state (apo) the chaperone 
is in an “open” confirmation. The binding of substrate and ATP results in conformational 
changes that result in client protein remodelling. After the hydrolysis of ATP is complete the 
substrate is then released from the chaperone (Shiau et al., 2006).  
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1.4.3.6    Hsp100 family of chaperones 
The HSP100 (or Clp in prokaryotes) family of chaperones are ATP dependent and present in 
both eukaryotes and prokaryotes (Glover & Tkach, 2001). Hsp100 family members have 
been shown to form both heptameric (ClpP) and hexameric (ClpA) structures. If you recall 
from section 1.3, under conditions of extreme stress, when there are more proteins 
aggregating than the chaperone systems can prevent, Hsp100 acts on these aggregates and 
either resolubilize them or directs them towards proteolytic degradation (Schirmer et al., 
1996). The AAA (ATPases Associated with diverse cellular Activities) members ClpA, 
ClpB, ClpC, and ClpX are the best studied Hsp100 homologues in bacteria. They are known 
to have proteolytic properties. Hsp104 and ClpB unlike other chaperones do not promote the 
folding of non native proteins and they also do not prevent aggregation. They are responsible 
in resolubilizing stress-damaged proteins from aggregates (Hung & Masison, 2006, Mogk & 
Bukau, 2004), and require other chaperones like the Hsp70 system to act along side in a 
cooperative manner to fold them into their native state (Motohashi et al., 1999, Glover & 
Lindquist, 1998). ClpA, ClpC and ClpX disaggregate proteins by degrading them along with 
the help of the protease ClpP (Maurizi & Xia, 2004, Kress et al., 2007, Martin et al., 2007). 
In effect, the Hsp100 family of chaperones functions in two different ways (fig 1.13). 
 
This family is also sometimes referred to as the AAA+ super family due to the sequence and 
structures of the HSP100 resembling those of the ATPase associated with different cellular 
activity (AAA). They are subdivided into two groups based on their structural features and 
sequence similarities: 
 
Chapter 1 
 
33 
 
 Group 1: ClpA (Hsp104), ClpB, ClpC, ClpD, ClpE have two nucleotide binding 
domains 
 Group 2: ClpX and ClpY have one nucleotide binding domain. 
Both these groups can then be further subdivided based on specific signature motifs or by the 
length of the interdomain regions separating the two nucleotide binding domains (Schirmer et 
al., 1996).  
 
Structurally, all Hsp100 chaperones contain a conserved core, referred to as the AAA 
module, which consists of two nucleotide binding subdomains (NBD) (Maurizi & Xia, 2004). 
This area is the binding site for ATP and also contains the catalytic residues for hydrolysis 
(Lupas & Martin, 2002). The N-domain of the Hsp100 chaperones is not essential for all its 
members. Hsp78, which is a homologue of ClpB, does not have an N-domain but is active as 
a chaperone (Krzewska et al., 2001).   However, it is at this domain that the adapter protein 
ClpS associates on ClpA to alter its substrate specificity (Dougan et al., 2002). It is the I-
domain that is responsible for the biological activity of the Hsp100 chaperones. Deleting this 
region causes the proteins to lose the ability to hydrolyse ATP (Mogk et al., 2003). A general 
representation of the mechanism by which some of the Hsp100 chaperones function is shown 
in figure 1.13. 
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Fig 1.13: The different routes taken by different members of the Hsp100 family in 
protein quality control. ClpB functions by disaggregating damaged proteins and allows 
them to be refolded to their native state with the help of other chaperones like Hsp70. ClpA 
has the ability to recognise specific motifs to target substrate proteins but can also target 
substrate proteins without the motifs and degrade misfolded proteins with the help of ClpP. It 
can also make use of the ClpS adaptor protein to help disaggregate substrates. ClpX can only 
recognise substrates that have an adaptor protein attached and also have specific sequence 
motifs. ClpP are peptidases that break down misfolded polypeptides and prevent further 
aggregation. Image taken from Maurizi & Xia, 2004. 
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1.5       Hsp60 family of chaperones 
The Hsp60 family of chaperones is one of the most abundant forms of ATP dependent heat 
shock proteins within a cell. The term 'chaperonin' (Cpn) was first used by Hemmingsen in 
1988 to represent this subclass of molecular chaperones (Hemmingsen et al., 1988). The 
chaperonins are a highly conserved class of chaperones and are found in all the domains of 
life. They are usually composed of two rings stacked together to form a larger oligomeric 
structure and enclose a central cavity in each ring. Each ring is made up of seven to nine 
60kDa subunits. The central cavity is used by the chaperonins to enclose unfolded proteins 
and allow them to fold secluded from the risks of unwanted interactions from other folding 
proteins in the cell. 
 
E. coli chaperonin GroEL and its cochaperonin GroES have been the most studied 
chaperones in the Hsp60 family. The details of their mechanism of action can be found in 
section 1.5.4. 
 
1.5.1       Types of chaperonins 
Chaperonins are classed into 2 sub groups based on sequence homologies (Horwich & 
Willison, 1993, Gutsche et al., 1999) (Fig 1.14): 
 
 Group 1 chaperones are members of the GroEL family and are found in eubacteria 
and eukaryotic organelles like the mitochondria. They are usually encoded by one 
gene and require the assistance of a cochaperonin like GroES. 
 Group 2 chaperones are members of the TCP-1 ring complex (TriC) family and are 
found in archaea and the eukaryotic cytosol (Gutsche et al., 1999). They are usually 
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encoded by more than one gene and do not require the assistance of any 
cochaperonins, though they may require other co-proteins to function, e.g. prefoldin.  
 
The subunits of both groups of chaperonins consist of three domains (Fig 1.15):  
 The apical domain (shown in purple): In group I chaperonins the binding sites for 
substrates and the cochaperonin GroES (cpn10) are located in the apical domain. In 
group II chaperonins the co-chaperoning function of GroES is replaced by a 25Å 
long flexible helical protrusion that extends from the tip of the apical domain and 
functions as a lid to cover the substrate when it is in the cavity (Klumpp et al., 1997). 
 
 The intermediate domain (shown in orange): This domain connects the equatorial and 
apical domains and is responsible for relaying a lot of the allosteric information to and 
from the other domains and between the rings. In group I chaperonins, this includes 
relaying the conformational changes generated by nucleotide binding from the 
equatorial to the apical domain to facilitate substrate binding and also binding of 
GroES to one end of GroEL transmits a signal to the other end that leads to GroES 
release. 
 
 The equatorial domain (shown in green): This site contains a highly conserved 
nucleotide binding region and connects the two heptameric rings to each other. It is 
also responsible for most of the inter-subunit contacts within a ring. This is important 
as it not only controls the assembly of the ring, but also the cooperativity between the 
subunits.  
 
For this review, the group 2 chaperonins will be dealt with before the group 1 chaperonins as 
it is GroEL and its homologues that are being studied in this report. 
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Fig 1.14: The structure of the 2 groups of chaperonins.  A) Group I chaperonin, GroEL 
along with its cochaperonin GroES. B) Thermosome, a Group II chaperonin. Image taken 
from Horwich et al., 2007. The Apical, intermediate and equatorial domains are coloured red, 
green and blue respectively.  
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Fig 1.15: The illustration of a GroEL subunit. The three domains along with the substrate 
binding site, the ATP binding site, and the ring-ring contacts are also shown. Image taken 
from Ranson et al., 1998. 
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1.5.2    Nomenclature 
The term chaperonin is applied to all proteins that share homology with the E. coli GroEL. 
However, different studies use different terms for the same protein and as a result the 
nomenclature for these proteins is a little complicated. While the bacterial chaperonins are 
usually referred to as GroEL (mainly E. coli) or Cpn60, the mitochondrial homologues are 
usually called Hsp60. Similarly, the proteins that function along with the chaperonins called 
cochaperonins are referred to as GroES (in E. coli), Cpn10, or Hsp10. The eukaryotic group 
II chaperonin, which was originally called TCP-1, is now either referred to as TRiC (TCP 
containing ring complex) (Frydman et al., 1992), or CCT (chaperonin containing TCP-1). 
The archaeal chaperonins are more commonly referred to as thermosomes (Trent et al., 
1991).  
 
For this thesis GroEL and GroES will be used exclusively to refer to the E. coli chaperonin 
and cochaperonin respectively. Cpn60 (Cpn60.1, Cpn60.2, or Cpn60.3 depending on the 
homologue) and Cpn10 will be used to refer to the Mycobacterial chaperonins. Thermosome 
will be used to refer to the archaeal chaperonin, and CCT will be used to refer to the 
eukaryotic chaperonin. 
 
1.5.3    Group II chaperonins 
As stated above, these chaperonins are found in the cytosol of eukaryotes and are also present 
in the archaea (Lewis et al., 1992). These chaperonins are phylogenetically distinct from one 
another. The group II chaperonin in archaea, referred to as the thermosome, are made up of 
two ringed subunits each of which consist of 8-9 further subunits (Andra et al., 1996, Knapp 
et al., 1994) (fig 1.16). In eukaryotes it is the CCT (chaperonin containing TCP-1), that is the 
group II chaperone. They are made up of 8 different structurally related subunits 
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(Rommelaere et al., 1993, Kubota et al., 1995, Kubota et al., 1994). Though the CCT and 
thermosome are both group II chaperonins, CCT is not induced by heat shock stress, whereas 
the thermosome is (Horwich et al., 2007).  
 
Group II chaperonins share a similar architecture with group I chaperonins in that the sub-
units have the same 3 domain structure. The equatorial domain contains the inter-ring and 
inter-subunit interaction sites as well as the ATP binding site, the intermediate domain that 
connects the equatorial domain to the apical domain, and the apical domain which contains 
the binding site for client proteins. The main difference between the classes however lies in 
the absence of a GroES like cochaperonin to seal of the substrate protein within the cavity of 
the chaperonin.  The group II chaperonins have instead been shown to contain a hydrophobic 
25 Å long flexible motif that extends as a helical protrusion and acts as the lid to cap the 
central cavity (Klumpp et al., 1997).  
 
1.5.3.1    Archaeal thermosome 
The architecture of group II archaeal thermosomes consists of two ringed structures stacked 
back to back (Schoehn et al., 2000) (fig 1.16). The subunits possess an apical, intermediate 
and equatorial domain and are generally present as octameric rings but have also been seen as 
nonameric rings (Ditzel et al., 1998, Trent et al., 1991). The 8-9 subunits are encoded by up 
to three different genes. The thermosome from Thermoplasma acidophilium, for which a 
crystal structure is available, consists of two stacked eight-membered rings with alternating α 
and β subunits (Ditzel et al., 1998). More recently the crystal structure of Thermococcus KS1 
was shown to share the structural features of T. acidophilium (Iizuka et al., 2005). One of the 
conformational differences between thermosomes and group I chaperonins, like GroEL, is 
Chapter 1 
 
41 
 
that while each subunit of GroEL interact with 2 subunits from the opposite ring, in 
thermosomes each subunit is aligned such that it makes contact with just one other subunit on 
the opposite ring.  
 
Thermosomes do not have any cochaperones involved in their substrate reaction cycle, unlike 
group I chaperonins. Instead, their subunits contain approximately 30 residues that form a 
parallel β sheet that acts as the lid. Substrate folding takes place within the central cavity of 
the thermosome which is approximately 74% of the volume of the cis-GroEL-GroES cavity. 
It is known that the thermosomes are ATP dependent for their folding mechanism and also 
that substrate binding most probably occurs due to hydrophobic forces (Pereira et al., 2010). 
Until recently all the crystal structures of archaeal thermosomes were of structures in the 
closed confirmation (sealed cavity). While they were informative, they did not provide much 
information about the conformational changes that occur during the reaction cycle. However 
recent structural studies of the thermosome of Methanococcus maripaludis has shed some 
light on these conformational changes by comparing the crystal structure of the closed state 
with that of the open state (Pereira et al., 2010). It has been suggested that the closing 
mechanism is distinct from that of group I chaperonins in that all three domains of each 
subunit undergo large conformational changes between the open state and closed state 
following ATP hydrolysis, while in group I chaperonins only the apical and intermediate 
domains undergo changes and the equatorial domain is primarily stationary. These large 
conformational changes between all three domains results in the closure of the lid (Zhang et 
al., 2010). 
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Fig 1.16: Octameric structure of the two thermosome rings from Thermoplasma 
acidophilum. The space-filling image on the right shows a cut-away view to show the 
properties of the cell wall in the central cavity. The blue colour represents hydrophilic 
residues and the yellow colour represents hydrophobic residues.  Image taken from Horwich 
et al., 2007. Original source of information Klumpp et al. 1997, Ditzel et al. 1998, 
Pappenberger et al. 2002. 
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The exact mechanism of the reaction cycle is still under investigation, but based on the 
reports so far it is possible to suggest that the thermosome interaction with ATP may be as 
follows: 
1. ATP binding to one ring on the thermosome results in the opening of the cavity. The 
asymmetric nature of the rings results in the ATP affinity of the second ring to drop. 
2. ATP hydrolysis on the first ring then results in large conformational changes that 
result in the substrate being released into the central cavity for the folding process 
while the lid closes the cavity. 
3. At this stage, owing to negative cooperativity, the opposite ring can bind to ATP and 
maintain asymmetry. It has also been suggested that the dissociation of the product is 
required before ATP hydrolysis can occur on the second ring. 
 
1.5.3.2     Eukaryotic CCT 
CCT is a complex ATP dependent chaperonin as it possesses eight different but homologous 
subunits in each of its two rings which are referred to as α, β, γ, δ, ε, δ, ε, and ζ (Kubota et 
al., 1995, Kubota et al., 1994). The entire structure is made up of two barrel shaped double 
ring cylinder which is approximately 160Å in height and 150Å in diameter (Llorca et al., 
1999) (Fig 1.17). Each of these eight subunits is encoded by eight specific genes. Although 
the presence of eight different subunits could result in a very large number of possible 
arrangements, the presence of preferential inter-subunit contacts ensures that the position of 
each subunit within each ring is highly specific in arrangement and is shared between all 
CCTs (Liou & Willison, 1997) (fig 1.17a). It has also been shown that these subunits are 
always in the same phase with the opposite ring (Martin-Benito et al., 2007) (fig 1.17b). The 
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main difference between the eight subunits is present in the sequence of the apical domains 
which have specific interactions with unfolded proteins (Spiess et al., 2006). Two of CCTs 
best studied specific substrates are the cytoskeletal proteins actin and tubulin. Both of these 
have been shown to interact specifically with select subunits from the CCT complex (Llorca 
et al., 1999). As is the case with the thermosomes, it is the protrusions that are present on the 
apical domain that fold to cover the openings of the chaperonin and form the dome structure. 
EM analysis of asymmetrically arranged subunits revealed that the position of the subunits 
was directing a sequential mechanism of ATP binding and hydrolysis within the ring, unlike 
GroEL (Rivenzon-Segal et al., 2005).  
 
Although the exact mechanism of substrate folding by CCT is not yet fully understood, recent 
crystal structures have provided a lot of information about the nature of the residues on and in 
the CCT complex (Cong et al., 2010). It has been shown that, like GroEL and thermosome, 
the inner surface of the closed chamber of CCT is also very hydrophilic but varies in charge 
distribution. The inner chamber of GroEL is a lot more negatively charged, while CCT has 
been shown to be predominantly positively charged. These differences in the charged 
properties of CCT have been suggested to be related to its ability to fold some substrates that 
cannot be folded by other chaperonins. These results implicate polar and electrostatic 
interactions in substrate binding; however, hydrophobic interactions have also been shown to 
occur (Rommelaere et al., 1999, Yam et al., 2008).  
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      A) 
 
 
 
Fig 1.17: Structural properties of CCT. A) End on and side view of the double ring 
structure of CCT with 8 subunits per ring. B) Diagram illustrating the arrangement of the 16 
subunits in the two rings. Taken from Cong et al., 2010. 
 
 
B) 
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1.5.3.3      Prefoldin 
It has been shown that, for some substrates, the group II chaperonins use a substrate delivery 
agent, prefoldin (also sometimes called GimC in archaea), which interacts with the substrates 
and then delivers it to the chaperonin (Geissler et al., 1998). In this regard it can be regarded 
as a cochaperonin to the group II chaperones; however, its functional role is very different to 
that of classical cochaperonins such as GroES. Prefoldin from both archaea and eukaryotes 
are jellyfish shaped structures with six subunits. In most archaea the prefoldin complex is 
composed of two different subunits encoded by two different genes pfdα and pfdβ (Geissler et 
al., 1998). At the tip of each of the subunits is a hydrophobic substrate binding site (Siegert et 
al., 2000), although the mode of substrate binding seems to slightly differ between archaeal 
and eukaryotic prefoldin (Siegert et al., 2000, Martin-Benito et al., 2002, Zako et al., 2006). 
Recent study on the prefoldin of a hyptherthermophilic archaea has suggested that it exhibits 
some refolding activity for lysozymes at lower than physiologically active temperatures 
(Zako et al., 2010).  
 
1.5.4    Group I chaperonins 
As discussed above, the group I chaperonin family is found in eubacteria and eukaryotic 
organelles like the mitochondria. The E. coli GroEL-GroES system is one of the best studied 
examples of this group. It was first discovered by Georgopoulos when he was investigating 
mutants of E. coli that were incapable of allowing the growth of bacteriophage λ 
(Georgopoulos et al., 1972, Georgopoulos et al., 1973, Georgopoulos & Hohn, 1978, Tilly et 
al., 1981). Experiments conducted with prokaryotic Rubisco and the Rubisco binding protein 
(Homologue of GroEL) showed that both the dimeric and hexadecameric forms of Rubisco 
could be synthesised in E. coli (Gatenby, 1984, Hemmingsen et al., 1988). The chaperoning 
property of GroEL then became evident when it was shown to be responsible for the proper 
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folding of Rubisco in E. coli (Goloubinoff et al., 1989). This chaperonin was also shown to 
be essential under all growth conditions (Fayet et al., 1989). 
 
1.5.4.1     GroEL and its cochaperonin GroES 
The E. coli chaperonin and cochaperonin are generally referred to as GroEL and GroES. 
GroEL is a tetradecamer that is made up of two heptameric rings of 57kDa proteins stacked 
back to back to form two 7 subunit hollow cylinders. The entire structure is approximately 
147 Å in length and 137 Å in diameter and the enclosed ring has a diameter of 47 Å (Braig et 
al., 1994). GroES is the cochaperonin of GroEL. The GroES monomer is 10kDa in size. It 
forms a heptameric dome like structure with 7 identical subunits (figure 1.18). The 
cochaperonin can bind to either side of GroEL depending on the presence of ATP/ADP. 
GroES is largely composed of β sheets that form hydrophobic mobile loops which interact 
with specific residues on the apical domain (Bukau & Horwich, 1998, Sigler et al., 1998, 
Horwich et al., 2007). This interaction between GroEL and GroES is vital for the correct 
folding of its substrate proteins. When a substrate binds to the apical domain of one of the 
rings of GroEL, GroES also bind to the same ring (mechanism is discussed in section 
1.5.4.2). The Binding of GroES to the apical domain not only displaces the bound substrate 
into the central cavity of GroEL but has also been shown to induce large conformational 
changes to GroEL as well. It has been shown that the binding of GroES to GroEL causes the 
apical domain to expand in an upward and outward motion. The results of this motion are still 
under debate. One viewpoint has shown that if a substrate is bound to more than one apical 
domain, then the expansion of the domain can subject the substrate with stretching forces that 
which could induce their unfolding (Coyle et al., 1999, Lin et al., 2008). While the other 
viewpoint has shown that the rigid body movements of the apical domain causes the 
hydrophobic residues of the apical domain to be hidden away from the substrate and as a 
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result the substrate protein is rapidly disassociated and pushed into the central cavity to fold 
(Horwich et al., 2006, Rye et al., 1997, Chaudhry et al., 2003, Xu et al., 1997). It is however 
agreed upon that GroES acts as the lid to seal off the GroEL cavity to allow a protein to fold 
without being influenced by the crowded nature of the cell. However, the mechanism 
involved in the folding of proteins within the cavity is also subjected to further debate. 
 
1.5.4.2     GroEL and GroES function 
The mechanism of action of GroEL and its cochaperonin is now understood in detail. As 
discussed above, GroES forms a homo-heptameric ring that caps one of the two GroEL rings 
forming an asymmetric complex (Horwich et al., 2007, Bochkareva et al., 1992, Burston et 
al., 1995). This binding of GroES, displaces any bound substrate into the cavity of GroEL so 
the reaction cycle can continue. There are 3 states in which GroEL and GroES can be found 
during the reaction cycle (Ranson et al., 1997): 
1- The acceptor state (open state): In this state one ring of GroEL bind to the substrate 
(client protein) while the other ring remains bound to ADP and GroES. 
2- The encapsulation state (closed state): In this state the substrate is released into the 
cavity to fold under hydrophilic conditions. This occurs when GroES and ATP bind to 
the same ring as the substrate. 
3- The ejection state (release state): In this state the folded/semi folded protein along 
with GroES is released from GroEL. This occurs when the bound ATPs are 
hydrolysed and allows another 7 ATP molecule to bind to the second ring, followed 
by substrate and GroES binding. 
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During the process of trying to understand the mechanism behind the functions of the GroEL 
chaperonins, three main models were put forward: 
1. The Anfinsen Cage model 
2. The iterative annealing model 
3. The assisted folding model 
 
The Anfinsen cage model 
According to this model, the polypeptide in the central cavity of the chaperonins follows the 
energy landscape guided by its own primary structure without any influence from other 
factors such as molecular crowding or interactions with the cavity itself (Ellis, 1994, Horwich 
et al., 2009)  
 
The iterative annealing model 
This model suggests that GroEL allows proteins to undergo repeated attempts at folding into 
their native states by unfolding the substrates that are stuck in a non-native kinetic trap. This 
had been proposed to increase the speed at which proteins can be folded to their native states 
(Todd et al., 1996).  
 
The assisted folding model 
This model suggests that GroEL, while providing a secluded environment for the protein to 
fold, also functions by accelerating the folding process of the substrates. This is achieved 
with the help of the interactions between the hydrophobic surfaces of the substrate and the 
hydrophilic surface of the GroEL internal wall. This model was proved for some polypeptides 
by Tang et al in 2006 (Radford, 2006, Tang et al., 2006). 
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Fig 1.18: The structures of GroEL and GroES. The space-filling image shows a cut-away 
view to show the properties of the cell wall in the central cavity. The blue colour represents 
hydrophilic residues and the yellow colour represents hydrophobic residues. Images taken 
from Hartl & Hayer-Hartl, 2002. 
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Irrespective of the mechanisms used by GroEL in the folding of substrate proteins, in all 
cases a central cavity is required during the reaction cycle. This cavity provides a secluded 
environment for the substrate proteins to fold in within being influenced by the crowded 
cellular environment. The mechanism of the reaction can be summarised in the following 
steps (Tyagi et al., 2009): 
1- 7 ATP molecules bind to the equatorial domain of one of the uncapped GroEL rings 
(cis ring). This results in a small degree of elevation and counter clockwise twist of 
the apical domain, in effect, mobilising it for substrate binding. The binding of ATP 
to the cis ring also results in a large drop of affinity to ATP of the trans ring (opposite 
ring) due to negative cooperativity. 
2- A substrate protein then binds to the apical domain of the same uncapped GroEL ring 
(cis ring) due to hydrophobic interactions between the rim of the central cavity and 
the polypeptide chain. This is soon followed by the binding of the cochaperonin 
GroES to same ring.  
3- GroES binding to the cis ring causes a rigid body movement in the apical domain and 
causes the chamber to expand from 85,000Å
3
 to 175,000Å
3
. This movement results in 
the hydrophobic residues of the apical domains to move away from the cavity. As a 
result, the bound protein is displaced into the cavity and is encapsulated by GroES. 
4- The next step involves the folding of the protein within the chamber and the 
hydrolysis of ATP to ADP in approximately 8-10 seconds. This hydrolysis causes the 
affinity of the cis ring of GroEL for GroES to drop. This hydrolysis also increases the 
affinity of the trans ring for ATP. 
5- The binding of ATP molecules to the opposite ring causes the folded/semi folded 
protein and GroES to dissociate from the cis ring (Keskin et al., 2002) (Fig 1.19). 
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6- If the released peptide is not in its native state it may interact with the same or another 
GroEL complex or even to a different chaperone system to fold. 
 
This cycle can continue more than once to completely fold the polypeptide chain into its 
native form. By using this method, GroEL and the cochaperone GroES allow partially folded 
polypeptides to fold in a secluded environment free from the crowded internal environment 
of the cell. This would suggest that GroEL functions primarily as an Anfinsen cage (Horwich 
et al., 2009, Apetri & Horwich, 2008, Horst et al., 2007). However, since GroEL is also 
involved in assisting misfolded proteins to reach their native state (Chakraborty et al., 2010, 
Lin et al., 2008, Gupta et al., 2010), it would suggest that GroEL is not just a passive 
Anfinsen cage but also helps unfold misfolded proteins before they can be folded back into 
its native state (Tehver & Thirumalai, 2008, Thirumalai & Lorimer, 2001).  These studies 
along with others also favour the assisted folding model (Tang et al., 2006, Radford, 2006, 
Marchenkov & Semisotnov, 2009). It could be argued that each of the models is substrate 
dependent, and that GroEL makes use of all three models depending on the substrate it needs 
to fold (Jewett & Shea, 2010). However, it is agreed upon that the folding of substrate 
proteins occurs in a central cavity that excludes the substrate from the crowded cellular 
environment.  
 
 
 
 
 
 
 
 
Chapter 1 
 
53 
 
 
 
 
 
 
 
 
 
Fig 1.19: The protein folding mechanism of the GroEL-GroES complex (Horwich & 
Fenton, 2009). ATP binds to the apical domain of one of the rings of GroEL (a). It is then 
followed by substrate (green) and GroES (blue) (b). The substrate is then displaced by the 
binding of cochaperonin GroES and can fold within the central cavity without being 
influenced by other proteins (c). ATP hydrolysis at the original ring (d) allows ATP and 
substrate binding to occur on the 2
nd
 ring (e).  
 
 
 
 
 
Chapter 1 
 
54 
 
1.5.4.3   GroEL substrates (client proteins) 
GroEL allows the folding of a wide range of substrates in E. coli. It is the only chaperone 
system that is vital for cell survival under all growth conditions (Fayet et al., 1989, Horwich 
et al., 1993). Recent research conducted on E. coli has shed some light over the substrates 
that require the use of GroEL to fold and others that interact with it, but do not depend on it 
to reach their folded forms. It was shown using a combination of biochemical analysis and 
quantitative proteomics that around 250 proteins interact with GroEL, but only about 85 of 
those proteins were completely dependent on GroEL, and only 13 substrates out of those 
were vital for cell survival (Kerner et al., 2005). This is still under active research and may 
not be accurate. The sizes of these substrates also vary greatly. Although the GroEL cavity 
can encapsulate substrates that are 60 kDa in size, larger proteins have also been shown to 
make use of the chaperonin folding mechanism by cycling on and off the GroEL ring in trans 
with GroES (Chaudhuri et al., 2001). Experimental data has also shown that the loss of 
GroEL function in E. coli results in the accumulation of newly translated proteins (e.g. MetE) 
that were not present in the cell while GroEL was functional (discussed in further detail in 
section 3.1). It has also however been suggested that GroEL is responsible for the proper 
folding of a majority of the newly translated polypeptide and not just the limited number as 
suggested earlier (Chapman et al., 2006). This suggestion came about when it was observed 
that in a temperature sensitive E. coli strain which affected the chaperonin GroEL, a 
biochemically isolated inclusion body of the bacterial cytoplasm contained a vast number of 
newly synthesised proteins (Chapman et al., 2006).  
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1.5.5      The chaperonins of Mycobacteria 
This thesis primarily focuses on the chaperonins of Mycobacterium tuberculosis with some 
work also being done on the chaperonins of Mycobacterium smegmatis. As such, this section 
highlights some of the reasons why the chaperonins of Mycobacteria are so interesting. 
Whenever possible, examples from both Mycobacterium tuberculosis and Mycobacterium 
smegmatis have been used. This section also briefly looks into the pathogenic properties of 
Mycobacterium tuberculosis. 
 
1.5.5.1     Multiple chaperonins of Mycobacteria 
As discussed above, most bacteria only have one copy of the GroEL homologue; however it 
was shown using genome sequence analysis on 669 bacterial genomes that nearly 30% have 2 
or more copies of the groEL gene (Lund, 2009). One of these bacteria is Mycobacterium 
tuberculosis, which is a major human pathogen. In 1987 Young et al., showed the presence of 
a 65kDa antigenic protein which was initially referred to as “common antigen” (Young, 
1987). This protein was later identified as Cpn60.2 along with the discovery of a second 
homologous gene which was termed cpn60.1 (encoding chaperonin 60.1) (fig 1.20) (Kong et 
al., 1993). M. smegmatis on the other hand has 3 copies of Cpn60 (figure 1.20). In both cases 
the cochaperonin cpn10 gene is always in the same operon as cpn60.1, while 
cpn60.2/cpn60.3 are present elsewhere in the genome. Even in Actinobacteria that only carry 
one cpn60 gene the cpn10 gene is always found separate in the genome (Maiwald et al., 
2003).  
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Recent work has suggested that M. tuberculosis chaperonins exist in lower oligomeric forms, 
and have weak ATPase activity along with partial activity with regards to substrate folding 
(Qamra et al., 2004). Since the oligomeric state of a chaperonin in vital for its function, it is 
still unclear as to why they would exist as lower oligomers. Why these bacterial cells have 
evolved to contain two or more different forms of Cpn60 is also not fully understood, 
especially since GroEL can bind to a large variety of proteins without showing any signs of 
substrate specificity. One explanation could be that each copy is specialised for specific 
functions, especially those involved in cell survival in stressful environments. It was shown 
that the GroEL chaperonin could be forced to evolve to be more substrate optimised and be 
able to fold those substrates better than the WT chaperonin (Wang et al., 2002). This 
optimisation however, came with the loss of the chaperonins ability to fully support cell 
growth. So specialised mycobacterial chaperonins could have arisen due to natural evolution 
of duplicated genetic copies, resulting in homologues that would be specialised in the folding 
of a different set of substrates. What is an interesting point to note is that in knock out 
experiments done to try and understand the function of these chaperonins, it was only 
possible to generate cpn60.1 knockouts, as deleting either cpn60.2 or cpn10 resulted in cell 
death (Hu et al., 2008). This experiment has posed further questions with regards to cpn10 
and cpn60.1 being in the same operon since it would be logical to assume that the operon 
would consist of the house-keeping chaperonin and its cochaperone. Phylogenetic analysis 
has shown that the two Cpn60 proteins which are found in all Mycobacteria fall into two 
distinct phylogenetic groups, showing that the gene duplication which produced them was 
very ancient (Rao & Lund, 2010). Such is the difference, that Cpn60.1 from one 
Mycobacterial species is more similar to the Cpn60.1 from another Mycobacterial species, 
than it is to Cpn60.2 from own species (fig 1.20c). As discussed, this raises the possibility of 
the multiple Mycobacterial chaperonins being specialised for specific functions. Other 
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experiments have shown that both chaperonins as well as the cochaperonin are very potent 
immunomodulatory response factors (Henderson et al., 2006). 
 
Mycobacterium smegmatis is known to possess three copies of the GroEL homologue. 
Cpn60.1, referred to as GroEL1 in M. Smegmatis (Ojha et al., 2005), has been shown to be 
required by the cells to synthesise mycolates during biofilm formation. The mycolates are 
long-chain fatty acids which are components of the mycobacterial cell wall. The loss of 
Cpn60.1 in M. smegmatis results in the cells losing the ability to form mature biofilms during 
growth, while the remaining growth pattern and the cell number remains unaffected (Ojha et 
al., 2005). This seems to be related to loss of the ability of the cells to synthesise certain 
mycolic acids by the type II fatty acid synthase. It has been shown that Cpn60.1 interacts and 
associates with KasA, which is a key component of the FASII complex, and as such is 
directly responsible for the chaperoning of the FASII complex. It is still, however, unknown 
what parts of Cpn60.1 are responsible in this mechanism. 
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Fig 1.20: The Cpn60 homologues in M. tuberculosis (A) and M. Smegmatis (B). 
Mycobacterium tuberculosis has 2 Cpn60 homologues while Mycobacterium smegmatis has 
3. In each case, the cochaperonin Cpn10 is in the same operon with Cpn60.1. (C) 
Phylogenetic distribution between Cpn60.1, Cpn60.2, and Cpn60.3 from various 
Mycobacteria (taken from  Rao & Lund, 2010). 
cpn10 cpn60.1 
      cpn60.2 
cpn60.2 
cpn60.3 
cpn1
0 
cpn60.1 
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(C) 
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1.5.5.2 Pathogenic properties of Mycobacterium tuberculosis and the role of its 
chaperonins/cochaperonins as immunomodulatory response factors  
 
Mycobacterium tuberculosis is a major human pathogen. It is spread through the air in 
droplets caused by coughing or sneezing by infected individuals. According to the world 
health organisation, approximately a third of the world population carries M. tuberculosis, 
with 10 million people being infected each year. Although only 5-10% of the newly infected 
individual will develop the disease, M. tuberculosis still causes approximately 1.5 million 
deaths a year. During its life cycle, the M. tuberculosis bacterium causes the formation of a 
cellular structure called the granuloma. This granuloma acts as a nest for the bacteria and is 
vital for the further spreading of the organism and in the causation of the disease. Research 
has shown that chaperonins of Mycobacterium tuberculosis are involved in more than just 
protein folding. Both the Cpn60s and the Cpn10 of M. tuberculosis are very potent 
immunomodulatory response factors and behave as antigens and cytokines (Qamra et al., 
2005). Immune responses caused by Cpn10 include T-cell proliferation as well as the 
production of antibodies (Young & Garbe, 1991). It has been shown that Cpn60.2 is present 
on the bacterial cell surface to facilitate efficient bacterial association with macrophages 
(Hickey et al., 2009), and the Cpn60 proteins have been shown to be an immunodominant 
target for T-cell response in both humans and mice (Young, 1990). Cpn60.2 is one of the 
more potent immunogen in M. tuberculosis. During antibiotic treatment of TB, the 
concentration of antibodies specific to Cpn60.2 rises and persists in the cell for almost 18 
months after the treatment (Sethna et al., 1998). Cpn60.2 has also been used as a part of a 
DNA vaccine against M. tuberculosis (Lowrie, 2006). It may also play a role in 
autoimmunity, as there is an increased presence of Cpn60.2 specific antibodies for 
autoimmune diseases such as systemic sclerosis and rheumatoid arthritis (van Eden et al., 
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1998). Cpn60.1 however has been shown to be a more potent cytokine than its homologue 
Cpn60.2 (Lewthwaite et al., 2001). All the chaperonins of M. tuberculosis can also function 
as intracellular signals for a range of cells, such as myeloid cells (Maguire et al., 2002). 
Research conducted in 1998 put forward the idea that the molecular chaperones behaved like 
virulence promoting factors as well as chaperoning the folding of proteins (Lewthwaite et al., 
1998).  
 
Recent work has confirmed that the cpn60.1 gene of M. tuberculosis is in fact not required by 
the cell for its survival at all even though it is in the same operon with cpn10, but rather it is 
in fact a virulence promoting factor. While cpn60.2 and cpn10 deletion resulted in cell death, 
the deletion of cpn60.1 had no affect on the growth of the cells. It was only possible to delete 
the chromosomal cpn60.2 and cpn10 genes in the presence of a plasmid with the cloned 
chaperonin genes present. Various experiments including growing the cells under stressful 
conditions and growth in macrophages also showed that in all cases the deletion of cpn60.1 
had little to no affect on the cells survival capabilities (Hu et al., 2008). One of the main 
phenotype of cpn60.1 deletion was observed when M. tuberculosis strains lacking the 
cpn60.1 gene was intravenously injected into immunocompetent mice. The results showed 
that while there was an initial difference in cell growth between the mutatnt and the wild 
type, with the mutant having fewer CFU at various weekly intervals, by 12 weeks there is 
was no significant difference between the two. It was however noticed that the mutant cells 
had lost the function to produce granulomatous inflammation in these mice and as such failed 
to cause classic tuberculosis (Hu et al., 2008). This may in part explain the mechanisms by 
which M. tuberculosis causes TB and also makes the study of these chaperones a vital task.  
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1.5.5.3      Structural features of Mycobacterial chaperonins 
Another factor which makes the Mycobacterial GroEL homologues interesting is their 
structure. The general structure of the GroEL proteins consists of a large and stable complex 
with a characteristic “double ring” structure of 14 subunits. Size exclusive chromatography 
and native PAGE has shown that the M. tuberculosis chaperonin may in fact have a natural 
tendency to exist as lower oligomers (Qamra et al., 2004), and crystallise as a dimer (Qamra 
& Mande, 2004). Experiments using vectors to replace the E. coli GroEL chaperones showed 
that the complementation and expression levels of cpn60.1 are very weak, while the cpn60.2 
is better in this regard (Liu H., 2007, PhD thesis, University of Birmingham). Since GroEL 
function is dependent on its structural stability, these results suggested that the M. 
tuberculosis Cpn60.2 must be able to form higher oligomeric structures to be able to 
complement for the loss of native GroEL. Another point that supports this idea is that Cpn10 
has been shown to form heptameric structures (Roberts et al., 2003). So there is a possibility 
that the presence of Cpn10 may provide a scaffold onto which the chaperonin subunits could 
form a higher oligomeric structure in vivo. Results obtained when Cpn60.2 was subjected to 
crowding agents to mimic in vivo environment conditions did show presence of higher 
oligomeric structures; however, it also suggested that these higher structures were unstable 
(Liu H., 2007, PhD thesis, University of Birmingham). Qamra and Mande also noted that the 
purified M. tuberculosis chaperonins did not show any signs of ATPase dependent activity 
(Qamra & Mande, 2004). Again this is unusual since the hydrolysis of ATP by the 
chaperonin GroEL is vital in the substrate folding reaction cycle and it has been shown that 
both Cpn60.1 and Cpn60.2 can function as chaperonins in an ATP dependent manner (Das 
Gupta et al., 2008). Since the structure and ATP dependence of the GroEL proteins are 
essential for its mechanism of action, it is unclear why the Mycobacterial oligomers are much 
less stable and don‟t show signs of any ATPase activity in vitro.  
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1.6     Aims of the project 
The main aim of this project is to better understand the properties of the multiple chaperonins 
of Mycobacterium tuberculosis. These properties include the functional and oligomeric 
properties of Cpn60.1 and Cpn60.2 and chimeras between them and E. coli GroEL. A list of 
the topics that are addressed in this project are as follows: 
 Functional analysis of Mycobacterial chaperonins in E. coli. This was tested using 
protein expression and complementation assays. 
 Functional analysis of the cochaperonin of M. tuberculosis. Since functional 
cochaperonins are a vital part of the chaperoning cycle, the ability of Cpn10 to 
function in E. coli was tested along with the chaperonins using complementation 
assays. 
 Further characterisation of the proteins of M. tuberculosis by site directed 
mutagenesis and domain swaps experiments to see if the ability to oligomerise can be 
restored in E. coli (native gels and AUC), and the effect this has on the functional 
ability of the chaperonins (complementation assays). 
 Testing the ATPase activity of purified functional chaperonins compared with 
GroEL, as the functional cycle of GroEL is dependent on its ATPase activity. 
 Characterising the ability of M. tuberculosis Cpn60.1 to function in M. smegmatis. 
Since Cpn60.1 and Cpn60.2 in Mycobacteria may have evolved different functions, 
and the Cpn60.1 from one Mycobacteria is closely related to another Cpn60.1 from 
another Mycobacteria, the ability of Cpn60.1 from M. tuberculosis to complement for 
loss of Cpn60.1 in M. smegmatis was tested. 
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Materials and Methods: 
 
2.1 Bacterial strains 
 
For this project the following bacterial strains were primarily used: 
 
STRAIN Genotype feature Reference 
E. coli DH5α 
F- gyr A96 (Nal
r
) rec A1 relA1 
endA1 thi-1 hsdR17 (rk
-
 mk
-
) 
glnV44 deoR ∆ (lacZYA-argF) 
U169 [φ80d∆(lacZ) M15] 
Gibco- BRL 
E. coli MGM100 
MG1655 kan
r
 nptII-pBAD-
groESL 
McLennan et al., 1998 
E. coli TG1 
supE hsd∆5 thi∆(lac-proAB)           
F
-
 [traD36 proAB
+
 lac1
q
 lacZ∆ 
15] 
Gibson, 1984 
E. coli BL21 (DE3) 
F– ompT hsdSB(rB– mB–) gal 
dcm (DE3) 
Novagen 
E. coli AI90 TG1 ΔgroEL::nptII Erbse et al., 1999 
E. coli XL1-Red 
endA1 gyrA96 thi-1 hsdR17 
supE44 relA1 lac mutD5 
mutS mutT Tn10 (Tetr)a 
Agilent (formerly Stratagene) 
Mycobacterium smegmatis 
MC
2
 155 
WT Ojha et al., 2005 
 
 
 
 
 
Chapter 2 
65 
 
2.2   Plasmids 
The pTrc expression plasmids used in this project were constructed by Dr. Yanmin Hu (St 
George’s Hospital, London), and derived from the expression plasmid ptrc99A (fig 2.1).  
This plasmid has an amp
R
 selective marker, and contains a multiple cloning site downstream 
from an IPTG inducible Ptrc promoter.  
 
Plasmid Features/Genes Expressed Reference 
pTrc99A 
An expression plasmid driven by the trc promoter (-35 region of the 
trp promoter together with the -10 region of the lac promoter), 
inducible by IPTG. 
Amann et al., 
1988 
pTrc-groES-
groEL 
A derivative of the pTrc plasmid containing E.coli groEL and groES 
genes under the control of the Ptrc promoter. 
Lund, 
Unpublished 
pTrc-groES-
cpn60.1 
A derivative of the pTrc plasmid containing E.coli groES gene along 
with M. tuberculosis cpn60.1 gene under the control of the Ptrc 
promoter. 
Lund, 
Unpublished 
pTrc-groES-
cpn60.2 
A derivative of the pTrc plasmid containing E.coli groES gene along 
with M. tuberculosis cpn60.2 gene under the control of the Ptrc 
promoter. 
Lund, 
Unpublished 
pTrc-cpn10-
cpn60.1 
A derivative of the pTrc plasmid containing M. tuberculosis cpn10 
gene and the cpn60.1 gene under the control of the Ptrc promoter. 
Lund, 
Unpublished 
pTrc-cpn10-
cpn60.2 
A derivative of the pTrc plasmid containing M. tuberculosis cpn10 
gene and the cpn60.2 gene under the control of the Ptrc promoter. 
Lund, 
Unpublished 
pTrc-cpn60.2 A derivative of the pTrc plasmid expressing M. tuberculosis Cpn60.2  This study 
pBAD24 Expression plasmid driven by arabinose inducible PBAD promoter 
Guzman et al., 
1995 
pRARE Plasmid encoding tRNAs for codons that rarely occur in E. coli Novagen 
pET23a+ Expression plasmid driven by the T7 promoter Novagen 
pET-groES-
cpn60.1 
Derivative of pET23a+ expressing E. coli GroES and M. tuberculosis 
Cpn60.1 
This study 
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pET-cpn10-
cpn60.1 
Derivative of pET23a+ expressing M. tuberculosis Cpn10 and Cpn60.1 This study 
pSMGroEL1-
H12 
Expression plasmid containing M. smegmatis Cpn10 and Cpn60.1 Ojha et al., 2005 
pMs10-
mtbcpn60.1 
pSMGroEL1-H12 derivative expressing M. smegmatis Cpn10 and M. 
tuberculosis Cpn60.1 
This study 
 
 
2.2.1     Plasmid maps: 
 
Plasmid map of pTrc99a 
 
Fig 2.1:  Plasmid map of pTrc99a. Image obtained using Plasmapper (Dong et al., 2004) 
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Schematic representation of chaperonin Plasmid 
 
Only a schematic representation of pTrc-GroES-GroEL has been shown. The remaining 
chaperonin and cochaperonin are interchangeable with GroEL and GroES. All the pTrc 
chaperonin plasmids have the chaperonins cloned into the MCS of pTrc99a. The remaining 
plasmids have a schematic representation presented in their respective results sections. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 2.2: Schematic representation of pTrc-GroES-GroEL. 
 
 
 
 
pTrc-groES-groEL                                 
6.5 kb 
groES/cpn10 
groEL/cpn60.1/cpn60.2 (~1.6kb) 
Ptrc 
EcoRI 
HindIII 
Amp
R
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2.3      Primers:  Below is a list of all the main primers that were used in this project. Primers 
that were only used once to correct mutations during the various experiments (such as in 
chapter 4) have not been listed. 
 
2.3.1    Primers for sequencing  
 
Name of Primer Binding site on gene Sequence (5’ to 3’) 
Length 
(in bases) 
Ptrc seq For 
Within pTrc99a, upstream 
from both cochaperonin 
GGA TAA TGT TTT TTG CGC 18 
EL sequencing Prim1 groEL 470-488 CCG TAG GTA AAC TGA TCG C 19 
60.2 sequencing Prim1 cpn60.2 438-454 CGC AGC GAT TTC GGC GG 17 
60.1 sequencing Prim1 cpn60.1 472-489 GAC CTG GTT GGC GAA GCG 18 
60.2 For1 
126 bp upstream of cpn60.2 
(in groES) 
TCC GAA AGC GAC ATT CTG G 19 
60.2 SR Seq1 cpn60.2 331-349 AAC CCG CTC GGT CTC AAA C 19 
60.2 SR Seq2 cpn60.2 1049-1068 AGA TCG AGA ACA GCG ACT CC 20 
GroEL-SR Seq groEL 1009-1030 
GGT GAA GAA GCT GCA ATC 
CAG G 
22 
AI90 GroEL For groEL 15-41 
CGT AAA ATT CGG TAA CGA 
CGC TCG TGT 
27 
AI90 GroEL Rev groEL 597-571 
GTA GCC ACG GTC GAA CTG 
CAT ACC TTC 
27 
pET-60.1 Seq 
Within pET23a+, 245 bp 
upstream from groES, 278 
bp upstream from  cpn10 
GTC CTC AAC GAC AGG AGC 
ACG 
21 
pET-phos Rev cpn60.2 602-585 TAC CCC GAG ATG TAG CCC 18 
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2.3.2   Primers for site directed mutagenesis 
 
Name of Primer Binding site on gene Sequence (5’ to 3’) 
Length 
(in bases) 
ATG-cpn10 For 
21 bp upstream of cpn10 
to 22 bp into cpn10 
AAA TAG TGG AGG GCT CCA ATC ATG 
GCG AAG GTG AAC ATC AAG C 
43 
ATG-cpn10 Rev 
22 bp in cpn10 to 21 bp 
upstream of cpn10 
GCT TGA TGT TCA CCT TCG CCA TGA 
TTG GAG CCC TCC ACT ATT T 
43 
Mut 60.21 For cpn60.2 1332-1359 
GGA GGC CCC GCT GGG GCA GAT 
CGC CTT C 
28 
Mut 60.21 Rev cpn60.2 1359-1332 
GAA GGC GAT CTG CCC CAG CGG 
GGC CTC C 
28 
Mut 60.22 For cpn60.2 1362-1384 CTC CGG GCT GGC GCC GGG CGT GG 23 
Mut 60.22 Rev cpn60.2 1384-1362 CCA CGC CCG GCG CCA GCC CGG AG 23 
Mut 60.23 For cpn60.2 1368-1390 GCT GGA GCC GGC CGT GGT GGC CG 23 
Mut 60.23 Rev cpn60.2 1390-1368 CGG CCA CCA CGG CCG GCT CCA GC 23 
Mut 60.24 For cpn60.2 1371-1393 GGA GCC GGG CGC GGT GGC CGA GA 23 
Mut 60.24 Rev cpn60.2 1393-1371 TCT CGG CCA CCG CGC CCG GCT CC 23 
Mut EL.1 For groEL 1342-1367 
GAA GCT CCG CTG GAA CAG ATC 
GTA TT 
26 
Mut EL.1 Rev groEL 1367-1342 
AAT ACG ATC TGT TCC AGC GGA 
GCT TC 
26 
Mut EL.2 For groEL 1371-1393 CTG CGG CGA AGC ACC GTC TGT TG 23 
Mut EL.2 Rev groEL 1393-1371 CAA CAG ACG GTG CTT CGC CGC AG 23 
Mut EL.3 For groEL 1375-1401 
GGC GAA GAA CCG GCT GTT GTT 
GCT AAC 
27 
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Mut EL.3 Rev groEL 1401-1375 
GTT AGC AAC AAC AGC CGG TTC 
TTC GCC 
27 
Mut EL.4 For groEL 1378-1404 
GAA GAA CCG TCT GCT GTT GCT 
AAC ACC 
27 
Mut EL.4 Rev groEL 1404-1378 
GGT GTT AGC AAC AGC AGA CGG 
TTC TTC 
27 
 
Highlighted regions represent specific changes to the original sequences that were used for 
site directed mutagenesis. 
 
2.3.3    Primers for domain swaps 
 
 
Name of Primer Binding site on gene Sequence (5’ to 3’) 
Length 
(in bases) 
60.1 flanking fwd 1  cpn60.1 1-25 
ATG AGC AAG CTG ATC GAA TAC 
GAC G 
25 
2F-60.1-60.2 cpn60.1 427-447 
ACC AAG GAG CAG ATC GCG CAG 
GTG GCG ACG GTG 
33 
3F-60.1-60.2 cpn60.1 1207-1227 
CGC AAT GCC AAG GCC GCG GTC 
GAG GAG GGC ATC 
33 
4R-60.1-60.2 cpn60.1 429-409 
TGC GGT GGC CGC GAT GCC GGT 
CTT GCC GGA CAC 
33 
5R-60.1-60.2 cpn60.1 1209-1189 
CTC CTC GAC GGC GGC CTT GGC 
GGC CGC GAC CGC 
33 
60.1 flanking rev 6 cpn60.1 1620-1600 TCA GTG CGC GTG CCC GTG GTG 21 
60.2 flanking fwd 7 cpn60.2 1-25 
ATG GCC AAG ACA ATT GCG TAC 
GAC G 
25 
8F-60.2-60.1 cpn60.2 427-447 
GGC AAG ACC GGC ATC GCG GCC 
ACC GCA GCG ATT 
33 
9F-60.2-60.1 cpn60.2 1207-1227 
GCG GCC GCC AAG GCC GCC GTC 
GAG GAG GGC ATC 
33 
10R-60.2-60.1 cpn60.2 429-409 
CGC CAC CTG CGC AAT CTG CTC CTT 
GGT CTC GAC 
33 
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11R-60.2-60.1 cpn60.2 1209-1189 
CTC CTC GAC CGC GGC CTT GGC ATT 
GCG AAC CGC 
33 
60.2 flanking rev 12 cpn60.2 1623-1599 
TCA GAA ATC CAT GCC ACC CAT 
GTC G 
25 
EL flanking fwd 13 groEL 1-25 
ATG GCA GCT AAA GAC GTA AAA 
TTC G 
25 
14F-EL-60.1 groEL 430-450 
GGC AAG ACC GGC ATT GCT CAG 
GTT GGT ACC ATC 
33 
15F-EL-60.1 groEL 1213-1233 
GCG GCC GCC AAG GCT GCG GTA 
GAA GAA GGC GTG 
33 
16R-EL-60.1 groEL 432-412 
CGC CAC CTG CGC AAT CGC TTT 
AGA GTC AGA GCA 
33 
17R-EL-60.1 groEL 1215-1195 
CTC CTC GAC CGC AGC ACG GGT 
CGC GTG CAG GGC 
33 
EL flanking rev 18 groEL 1647-1623 
TTA CAT CAT GCC GCC CAT GCC ACC 
C 
25 
19F-60.1-EL cpn60.1 427-447 
GAC TCT AAA GCG ATT GCG CAG 
GTG GCG ACG GTG 
33 
20F-60.1-EL cpn60.1 1207-1227 
CAC GCG ACC CGT GCC GCG GTC 
GAG GAG GGC ATC 
33 
21R-60.1-EL cpn60.1 429-409 
ACC AAC CTG AGC GAT GCC GGT 
CTT GCC GGA CAC 
33 
22R-60.1-EL cpn60.1 1209-1189 
TTC TTC TAC CGC AGC CTT GGC GGC 
CGC GAC CGC 
33 
23F-60.2-EL cpn60.2 427-447 
GAC TCT AAA GCG ATT GCG GCC 
ACC GCA GCG ATT 
33 
24F-60.2-EL cpn60.2 1207-1227 
CAC GCG ACC CGT GCC GCC GTC 
GAG GAG GGC ATC 
33 
25R-60.2-EL cpn60.2 429-409 
ACC AAC CTG AGC AAT CTG CTC CTT 
GGT CTC GAC 
33 
26R-60.2-EL cpn60.2 1209-1189 
TTC TTC TAC CGC GGC CTT GGC ATT 
GCG AAC CGC 
33 
27F-EL-60.2 groEL 430-450 
ACC AAG GAG CAG ATT GCT CAG 
GTT GGT  ACC ATC 
33 
28F-EL-60.2 groEL 1213-1233 
CGC ATT GCC AAG GCT GCG GTA 
GAA GAA GGC GTG 
33 
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29R-EL-60.2 groEL 432-412 
TGC GGT GGC CGC AAT CGC TTT 
AGA GTC AGA GCA 
33 
30R-EL-60.2 groEL 1215-1195 
CTC CTC GAC GGC GGC ACG GGT 
CGC GTG CAG GGC 
33 
31F-60.2-EL pre cpn60.2 571-591 
CTG GAC GTG GTT ATG CGG TTC 
GAC AAG GGC TAC 
33 
32F-60.2-EL pre cpn60.2 1126-1146 
CTG GCA GGC GGC GTG ATC AAG 
GCC GGT GCC GCC 
33 
33R-60.2-EL pre cpn60.2 573-553 
GAA CTG CAT ACC CAT ACC CTC 
GGT GAG CTC GAG 
33 
34R-60.2-EL pre cpn60.2 1128-1108 
TTT GAT AAC TGC CAC CGC GAC 
ACC ACC GGC CAG 
33 
35F-EL-60.2 pre groEL 571-591 
CTC ACC GAG GGT GAA GGT ATG 
CAG TTA GAC CGT 
33 
36F-EL-60.2 pre groEL 1126-1146 
GGT GGT GTC GCG GTT GCA GTT ATC 
AAA GTG GGT 
33 
37R-EL-60.2 pre groEL 573-553 
CTT GTC GAA CCG TTC AAC CAC GTC 
CAG TTC GTC 
33 
38R-EL-60.2 pre groEL 1128-1108 
ACC GGC CTT GAT AAC GCC GCC 
TGC CAG TTT CGC 
33 
39F-EL-60.1 pre groEL 571-591 
TTC ACC GAG GGT GAA GGT ATG 
CAG TTC GAC CGT 
33 
40F-EL-60.1 pre groEL 1126-1146 
GGC GGG GTT GCT GTT GCA GTT ATC 
AAA GTG GGT 
33 
41R-EL-60.1 pre groEL 573-553 
CTT GTC GAA GCC TTC AAC CAC GTC 
CAG TTC GTC 
33 
42R-EL-60.1 pre groEL 1128-1108 
ACC CAC CTT GAT AAC GCC GCC 
TGC CAG TTT CGC 
33 
43F-60.1-EL pre cpn60.1 571-591 
CTG GAC GTG GTT ATC GGC TTC GAC 
AAG GGC TTC 
33 
44F-60.1-EL pre cpn60.1 1126-1146 
CTG GCA GGC GGC GTC ATC AAG 
GTG GGT GCC GCC 
33 
45R-60.1-EL pre cpn60.1 573-553 
GAA CTG CAT ACC GAT ACC CTC 
GGT GAA CTC CAA 
33 
46R-60.1-EL pre cpn60.1 1128-1108 
TTT GAT AAC TGC GAC AGC AAC 
CCC GCC GGC CAG 
33 
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47F-60.2-60.1 pre cpn60.2 571-591 
TTC ACC GAG GGT ATG CGG TTC 
GAC AAG GGC TAC 
33 
48F-60.2-60.1 pre cpn60.2 1126-1146 
GGC GGG GTT GCT GTG ATC AAG 
GCC GGT GCC GCC 
33 
49R-60.2-60.1 pre cpn60.2 573-553 
CTT GTC GAA GCC CAT ACC CTC GGT 
GAG CTC GAG 
33 
50R-60.2-60.1 pre cpn60.2 1128-1108 
ACC CAC CTT GAT CAC CGC GAC 
ACC ACC GGC CAG 
33 
51F-60.1-60.2 pre cpn60.1 571-591 
CTC ACC GAG GGT ATC GGC TTC 
GAC AAG GGC TTC 
33 
52F-60.1-60.2 pre cpn60.1 1126-1146 
GGT GGT GTC GCG GTC ATC AAG 
GTG GGT GCC GCC 
33 
53R-60.1-60.2 pre cpn60.1 573-553 
CTT GTC GAA CCG GAT AAC CTC 
GGT GAA CTC CAA 
33 
54R-60.1-60.2 pre cpn60.1 1128-1108 
ACC GGC CTT GAT GAC AGC AAC 
CCC GCC GGC CAG 
33 
 
 
2.4      General microbial techniques  
 
2.4.1- Media: All media was autoclaved before use. 
 
Luria-Bertani (LB): 1% (w/v) tryptone, 0.5% (w/v) yeast extract, 1% NaCl. 
 
LB agar: LB with 1.5% agar. 
 
Difco Middlebrook 7H9 broth (BD Biosciences):  4.7g was added to 900ml deionised water 
and autoclaved. 100ml Middlebrook ADC enrichment (BBL) and 0.05% Tween80 was added 
before use. 
 
Difco Middlebrook 7H10 agar (BD Bioscience): 19g was added to 900ml water and 
autoclaved. 100ml Middlebrook ADC enrichment and 0.05% Tween80was added before use. 
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Biofilm base media: 13.6g KH2PO4, 2g (NH4)2SO4 adjust the pH to 7.2 using KOH pellets 
then added 0.5mg FeSO4.7H2O, and 5g Casamino acid.  
 
Biofilm media: 94ml biofilm base media with 5ml of 40% glucose, 1ml 0.1M CaCl2, 100μl of 
1M MgSO4. 
 
2.4.2- Additives 
Additive Stock concentration Working concentration 
L-Arabinose 20% (w/v) 0.2% (w/v) 
D-Glucose 20% (w/v) 0.2% (w/v) 
Ampicillin 100mg/ml 100µg/ml 
Kanamycin 50mg/ml 50µg/ml 
Chloramphenicol 50mg/ml 50µg/ml 
Hygromycin 150mg/ml 150μg/ml 
IPTG 1 M 1 mM 
 
2.4.3- Growth conditions  
E. coli growth conditions 
E. coli was grown at 37°C, unless indicated otherwise, in Luria-Bertani (LB) media in a 
shaking incubator (180rpm). For overnight cultures, single colonies were picked from a plate 
or a loop full of frozen culture and inoculated into 5ml of LB. To subculture, 1ml of the 
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overnight culture was mixed into 49ml of LB in a 250ml conical flask. The flasks were 
shaken in the shaking incubator at 180rpm. LB agar plates were used for solid media 
experiments and were incubated at different temperatures. Incubation time varied depending 
on the strain used. In all cases appropriate amounts of additives were added depending on the 
requirement of the strains.  
 
M. smegmatis growth conditions 
M. smegmatis was grown at 37°C, unless states otherwise, in 5ml Difco Middlebrook 7H9 
broth with ADC enrichment and 0.05% Tween 80. The cultures were grown for 36 hours 
with appropriate additives and aeration at 200rpm in a shaking incubator (Infors AG CH-
4103).  Plate cultures were incubated for 48 hours at 37°C on Difco Middlebrook 7H10 
media with ADC, 0.05% Tween80 and appropriate additives. 
 
2.4.4- Glycerol stocks 
Glycerol stocks of all strains were made by mixing 875µl of fresh overnight culture with 
125µl of 80% glycerol 
 
2.4.5- Bacteriophage P1 Transduction 
Reagents required 
0.5M CaCl2.2H2O (calcium chloride) 
0.9M Na3C6H5O7 (sodium citrate) 
1M MgSO4.7H2O (magnesium sulphate) 
0.1M MgSO4/ 5 mM CaCl2 
Sloppy agar – 0.6% LBA with 2.5 mM CaCl2 
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Preparation of bacteriophage P1 lysate 
1 ml of fresh overnight (donor strain) was mixed with a pre-existing stock of bacteriophage 
P1 lysate at a range of dilutions (10
0
 – 10-5). CaCl2 was then added at a final concentration of 
2.5 mM and the solution was incubated at 37°C for 30 minutes. This was then added to 3ml 
of sloppy agar (autoclaved 0.6% agar in LB) and poured onto labelled LB plates for overnight 
incubation at 37°C. The plates were examined after the incubation period (roughly 14-16 
hours) and the plates where the plaques were about touching but where lysis had not cleared 
the whole plate was picked. The sloppy agar was scraped off into a Falcon tube. The pate was 
also washed with 2ml LB/2.5 mM CaCl2, and the washate was also added to the Falcon tube. 
The tube was then centrifuged at 10,000 rpm for 10 minutes and the supernatant was filtered 
though a 0.2 micron filter. The resultant suspension was stored at 4°C as the bacteriophage 
P1 lysate. 
 
The titre of the bacteriophage P1 lysate was checked by spotting 10-fold serial dilutions of 
the prepared lysate onto a lawn of the recipient strain. The plates were then incubated at 
37°C. The following day, the number of individually visible plaques was counted to give an 
estimate of the titre of the bacteriophage P1 lysate. Absence of plaques with certain strains 
indicates that the strain is not a recipient for the phage. 
 
Transduction of recipient strain 
The recipient strain was grown overnight in LB media with 2.5 mM CaCl2 without shaking 
and then 1ml was spun down at 13000rpm for 5 minutes. The resultant pellet was then 
resuspended in 1ml 0.1M MgSO4/ 5mM CaCl2 and incubated at 37°C for 15 minutes with 
gentle shaking. 100µl of this suspension was mixed with neat, 10x, and 100x dilutions of 
100µl bacteriophage P1 and incubated for a further 20 minutes at 37°C. To these cultures 
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200µl of 0.9M Na3C6H5O7 was added and the resultant suspension was spun at 13000rpm for 
5 minutes. The supernatant was discarded and the pellet was then resuspended in 100µl LB 
and incubated at 37°C for 1 hour. Various dilutions, including neat, were then plated out on 
selective media plates e.g. Ampicillin plates to test for Ampicillin resistant gene transfer. 
Control plates were also used and included, plates with the recipient strain on its own (not 
transduced), as well as the bacteriophage P1 lysate on its own. These plates were incubated at 
37°C for 1-2 days. The resulting colonies were screened by colony PCR. 
 
2.4.6- Plasmid purification (Mini-prep)  
Two methods of miniprep plasmid extraction were used during the project to extract plasmid 
DNA from E.coli. 
 
Alkaline lysis method 
Reagents required: 
- GTE (50 mM glucose, 25 mM TRIS pH8.0, 10 mM EDTA) – autoclaved before use 
- 1% SDS/0.2M NaOH (from stock of 10% SDS and 10M NaOH) 
- 3M Na/5M acetate 
- TE (10 mM TRIS pH8.0, 1 mM EDTA) – autoclaved before use 
- Isopropanol 
- 70% ethanol (in TE) 
- 100% ethanol 
1-5mls of overnight culture was centrifuged at 13000rpm for 2 minutes and the supernatant 
was poured off. The culture was then spun again for 20-30 seconds and the remaining LB 
was removed using a Gilson pipette. This is an important step as the left over LB can carry 
components into the prep, which can inhibit restriction enzymes and ligases. The pellet was 
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then resuspended in 200µl GTE by pipetting or vortexing. 400µl 1%SDS/0.2M NaOH was 
added to lyse the cells (tube inverted several times). 300µl of 3M Na/5m acetate was added to 
the solution which was then inverted several times until a white precipitate was formed. The 
tube was then incubated for 5 minutes at room temperature and then spun at 13000rpm for a 
further 5 minutes. The resulting supernatant, which contains the DNA plasmid, was poured 
into a clean labelled Eppendorf and 600µl isopropanol was added (and mixed very 
thoroughly). This tube was then cooled at -20°C for 30 minutes before being spun down at 
13000rpm for 10 minutes to form a pellet of nucleic acid at the bottom of the Eppendorf. The 
pellet was then washed twice with 500µl of 70% ethanol and then again with 500µl of 100% 
ethanol (ensuring the pellet was not disturbed). The pellet was then dried at 37°C for 5-10 
minutes and resuspended in 50µl TE. 
 
Kit method 
Plasmid DNA was purified from E.coli cultures using the Qiagen Qiaprep spin miniprep kit 
as per the manufacturers recommended guidelines. 5ml of overnight culture was spun down 
at 4000rpm and 4°C for 15 minutes. The pellet was resuspended in 250µl of P1 buffer 
solution and transferred to a micro centrifuge tube. The cells were then subjected to alkaline 
lysis for 5 minutes by adding 250µl of P2 solution, which degrades bacterial cell walls and 
membranes.  After this, the reaction was neutralised by the addition of 350µl of N3 buffer. 
The cell debris was then spun down by centrifugation at 13000 rpm for 5 minutes.  The 
supernatants were then added to a Qiaprep spin column and spun at 13000 rpm for 1 minute. 
This results in the plasmid DNA binding to the column.  The plasmid was then washed in 
ethanol and eluted in 50µl of MilliQ water. 
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2.4.7- Plasmid maxi prep 
This method of plasmid prep was used on large volumes of culture to extract a large amount 
of plasmid. Plasmid maxi prep was done using the GenElute plasmid maxiprep kit by Sigma-
Aldrich as per the manufacturer’s guidelines. A total of 50ml of overnight culture was 
centrifuged at 5000rpm for 10 minutes obtain the cell pellet. The pellet was resuspended in 
6ml resuspension solution provided with the kit and transferred into a Falcon tube. To this 
6ml of lysis solution was added, mixed thoroughly, and allowed to clear for 5 minutes. Once 
the solution had cleared, 8ml of neutralization solution was added and the tube was inverted 
4-6 times. This was then centrifuged at 15000g for 15 minutes. The resultant supernatant was 
then transferred to the maxi spin column in a 50ml collection tube and spun in a swing bucket 
rotor at 4000g for 2 minutes. The flow through was discarded, 15ml of washing solution was 
added to the column and the tubes were spun again at 4000g for 5 minutes. The column was 
then transferred to a clean collection tube, 5ml of elution buffer was added, and the tube was 
spun at 4000 g for a further 5 minutes. The flow through obtained via this method contained 
the plasmids from the overnight cultures and was stored at -20° C. 
 
2.4.8- Restriction digests of plasmids 
For the restriction digest of a plasmid, approximately 300ng of plasmid DNA was used. For 
all digests the restriction enzymes and buffers used were either from New England Biolabs or 
Fermentas (20,000 units/ml) and approximately 2000 units of restriction enzyme was used in 
each case for complete digestion. The following contents were used to make a total volume of 
20µl: 
 
- Milli Q water      5-15 µl 
- NEBuffer (depending on the restriction enzyme) 2 µl 
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- 10X BSA (depending on the restriction enzyme) 2 µl 
- Restriction enzyme     1 µl 
- Plasmid DNA      approximately 300ng 
The solution was then incubated at 37° C for 1-2 hours. 
 
2.4.9- Blunt ending with Klenow 
During the course of this project several ligation procedures involved the use of blunt ended 
DNA fragments. In cases where the restriction digest had not yielded a blunt ended product, 
Klenow (from Invitrogen) was used. The stock concentration of Klenow was 0.5U/µl. The 
reaction was mixed in an Eppendorf as follows: 
- 10X React 2 Buffer   3µl 
- 0.5 mM each dNTP (2 mM total) 4μl 
- DNA     0.5-1μg 
- Klenow    1μl 
- SDW     Made up to 30μl 
The Eppendorf was gently mixed with a pipette and briefly centrifuged to collect the contents 
at the bottom of the tube. The tube was then incubated at room temperature for 10-15 
minutes. The reaction was then terminated by incubation at 70°C for 10 minutes, and 
concentrated using ethanol precipitation as described below. 
 
2.4.10- Ethanol precipitation 
DNA was taken in an Eppendorf tube. 0.1 volumes of un-buffered 3M NaAc and 2.5 volumes 
of isopropanol were added. The content was gently mixed and incubated at -20°C for 20 
minutes. After incubation, the tube was centrifuged at 13,000rpm for 10 minutes and the 
supernatant was discarded. The resulting pellet was washed twice with 70% ethanol and 
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100% ethanol before being dried at 37°C for 10-15 minutes. The dry pellet was then 
resuspended in 50μl SDW. 
 
2.4.11- Ligation 
The vector backbone and the DNA insert were usually mixed in a 1:3 ratio and treated with 
1μl QuickStick DNA ligase (Bioline). The reaction included 5μl of 4X ligase buffer and was 
made up to 20μl with SDW. The mixture is incubated at 4°C overnight in a water bath. 10μl 
of the reaction is then transformed into competent E. coli cells. 
 
2.4.12- Agarose gel electrophoresis 
DNA (including plasmids, and digests) were run on 1% Agarose gel with SYBR-safe DNA 
gel stain (Invitrogen) at 5µl per 100 ml agarose. To 20µl of DNA, 5µl of loading buffer 
(0.25% bromophenol blue, 0.25% Xylene cyanol FF, 15% Ficoll type 400 [Pharmacia], made 
up using 10ml sterile water) was added, and 10-15µl was finally loaded on the gel. Bioline 
Hyperladder I was used as the marker for these gels. The gel was then run in a tank of 1X 
TAE at 90V for 1 hour (for a 10 well gel) or at 110V for 1.5 hrs (for a 24 well gel). 
 
2.4.13- PCR 
Colony PCR and gene amplification 
The PCR mix for screening and gene amplification is as follows: 
- 10 NH4 reaction buffer  5μl 
- 50 mM MgCl2    1.5μl 
- dNTPs (100 mM stock)  0.5μl 
- Primers (forward and reverse) 1-2μl 
- Taq DNA polymerase (Fermentas) 0.5μl 
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- Colony/culture   1μl  
- SDW     made up to 50μl 
The samples were PCR-amplified in a Eppendorf vapo.protect thermocycler under the 
following conditions: 
Segment Cycles Temperature Time 
1 1 94°C 4 minutes 
2 30 
94°C 45 seconds 
55°C 1 minute 
72°C 1-5 minutes 
3 1 72°C 10 minutes 
 
Alternatively, the Thermo Scientific ReadyMix master mix was also used (23μl with 0.5μl of 
each primer and 1μl culture). The cycling conditions were the same as that listed above. 
 
Site directed mutagenesis 
The QuickChange Site-Directed Mutagenesis Kit (Agilent, formerly Stratagene) was used as 
per the manufacturer’s instructions. The PCR protocol used is as follows: 
 
- 10X reaction buffer    5μl 
- DNA      50ng of dsDNA template 
- Primers     12.5pmole (for each primer) 
- dNTP mix     0.8 mM (final concentration) 
- SDW      made up to 50μl 
- PfuTurbo/PfuUltra DNA polymerase 1μl 
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The PCR cycling parameters used were as follows: 
 
Segment Cycles Temperature Time 
1 1 94°C 30 seconds 
2 30 
94°C 45 seconds 
55°C 1 minute 
72°C 1 minute/Kb 
3 1 72°C 10 minutes 
 
Following PCR, the samples were put on ice for 2 minutes to cool the reaction to ≤ 37°C. 1µl 
of Dpn I was added and the reaction was incubated at 37°C for 1 hour to allow the enzyme to 
digest the parental DNA plasmid. The digested product was then transformed into DH5α and 
plated out onto LB plates (with appropriate additives). 
 
PCR in the construction of chimeric proteins 
In chapter 4, various chimeric proteins were constructed by using a modified PCR extension 
technique. The details of the process have been outlined in the experimental design of chapter 
4. The DNA polymerase and buffers for these reactions were from Finnzymes. The lists of 
additives in the PCR mix and the cycles have been listed below: 
- 5X Phusion HF buffer 10μl 
- 10 mM dNTPs  1μl 
- Primer A   0.5 mM 
- Primer B   0.5 mM 
- Template DNA  20ng 
- DMSO    1.5μl 
- Phusion DNA Polymerase 0.5-1μl 
- SDW    Made up to 50μl 
Chapter 2 
84 
 
The PCR cycling parameters used were as follows: 
 
Segment Cycles Temperature Time 
1 1 94°C 30 seconds 
2 25 
94°C 30 seconds 
65°C 1 minute 
72°C 1 minute/Kb 
3 1 72°C 10 minutes 
 
 
2.4.14- PCR purification 
The purification of PCR products and restriction digests was carried out using the Qiagen 
QiAquick PCR Purification Kit in accordance with the manufacturer’s instructions. For the 
purification of DNA from an agarose gel slice the Qiagen QiAquick Gel Extraction kit was 
used according to the manufacturer’s instructions 
 
2.4.15- Competent cell preparation 
E. coli competent cell preparation 
Two different methods were used to prepare competent cells in this project for E. coli. Both 
methods have been detailed below. For the cells used in chapter three, method 1 was used, 
while method 2 was used for the remaining chapters. 
 
Method 1 
Solution 1 (TfbI):  30 mM CH3COOK (potassium acetate) 
    10 mM RbCl (Rubidium chloride) 
    10 mM CaCl2 (Calcium chloride) 
    50 mM MnCl2 (manganese chloride) 
    15% glycerol (v/v) 
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The solution was made up in distilled water and the pH was adjusted to 5.8 with 0.2M acetic 
acid. Solution was filter sterilised before use. 
 
Solution 2 (TfbII):  10 mM MOPS 
    75 mM CaCl2 
    10 mM RbCl 
    15% glycerol (v/v) 
 
The solution was made up in distilled water and the pH was adjusted to 6.5 with 0.1M KOH 
(potassium hydroxide). Solution was filter sterilized before use. 
 
A flask with 100ml of pre-warmed LB was inoculated with 1ml of overnight culture and 
grown in a shaking water bath at 37°C till an OD600 of 0.4 was obtained. The flask was then 
placed on ice for 5 minutes. The culture was then spun down as 50ml aliquots at 10,000 rpm 
for 10 minutes. The supernatant was discarded and the pellet was gently resuspended in 25ml 
of TfbI. This suspension was then incubated on ice for 10 minutes and then spun down at 
6000 rpm for 5 minutes. The resultant pellet was then resuspended in 2ml of TfbII and 
incubated on ice for 2 hours. Aliquots (100µl) of the solution were made and stored at -80°C. 
 
Method 2 
A flask with 100ml of pre-warmed LB was inoculated with 1ml of overnight culture and 
grown in a shaking water bath at 37°C till an OD600 of 0.4 was obtained. The culture was then 
transferred to two 50ml Falcon tubes and placed on ice for 15 minutes. The cells were then 
recovered by centrifugation at 4100rpm for 10 minutes (at 4°C). The resulting supernatant 
was disposed of and each pellet was resuspended in 30ml ice cold 0.1M CaCl2. The Falcon 
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tubes were placed on ice for a further 15 minutes before the cells were recovered again by 
centrifugation at 4100rpm for 10 minutes (at 4°C). The supernatant was discarded and the 
pellets were resuspended in 2ml ice cold 0.1M CaCl2 and 15% glycerol. 100μl aliquots of the 
solution were made and stored at -80°C. 
 
M. smegmatis competent cell preparation (electrocompetent) 
A mid-log culture of M. smegmatis was chilled on ice for 10min and the cells harvested by 
centrifuging at 5000rpm for 15min. The cell pellet was washed thrice with ice cold sterile 
10% (v/v) glycerol. For a 100ml starting volume of culture, for the first wash, 25ml of 10% 
glycerol was used, 10ml for the second wash and 5ml for the third wash. Finally the pellet 
was resuspended in 1ml ice cold 10% glycerol for use immediately or aliquoted and stored at 
-70°C. 
 
2.4.16- Transformation  
 
E. coli transformation 
To 100µl of competent cells (thawed on ice) approximately 100ng of plasmid DNA was 
added and incubated for 30 minutes on ice. The cells were then subjected to heat shock by 
placing them in a 42°C water bath for 30 seconds, followed by incubation on ice for 2 
minutes. To this, 800µl of liquid LB was added and incubated at 37°C for 1 hour. The 
resultant solution was then plated out onto LB plates at a dilution of 10
-1 
and 10
0
. The plates 
were incubated at 37°C overnight. 
 
M. smegmatis transformation (electroporation) 
1μg salt free DNA was added to 400μL of electrocompetent cells and kept on ice for 10 min. 
The cells and DNA were transferred to a 0.2cm electrode gap electroporation cuvet (pre-
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chilled on ice), placed in an electroporation chamber (Equibio, Geneflow Ltd, UK) and 
subjected to one pulse of 1.8kV. 1ml of Middlebrook 7H9 broth +ADC was added 
immediately and the culture incubated at 37°C with shaking for 3 hours. The cells were 
harvested after incubation and plated on suitable media. 
 
2.5      Complementation analysis 
 
With E. coli (spot test) 
MGM100 was transformed with the pTrc plasmids carrying the chaperonin and cochaperonin 
genes. A single colony of the transformed strain was inoculated into 5ml LB broth (with 
appropriate additives) and grown over night at 37°C. The following morning it was sub-
cultured and grown in LB + glucose for 2 hours at 37°C, and then serially diluted (in ten-fold 
steps) to spot on to square petri dishes (Sterilin). 5µl of each dilution was spotted onto the 
plates with the final dilution factor being 10
7. 
 The plates were then incubated at 37°C, 30°C, 
and 26°C.  
 
With M. smegmatis (biofilm formation) 
M. smegmatis mc
2
155 competent cells were transformed with the appropriate pMS10 
plasmids. A single colony from the resulting strain was inoculated into 3ml Difco 
Middlebrook 7H9 broth with ADC, 0.05% Tween80, and appropriate antibiotics. This was 
incubated at 37°C in a shaking incubator for 24-36 hours. 10ml of the biofilm media was 
aliquoted into a 60 mm X 15 mm Petri dish. To this media, 10μl of the culture was added and 
kept stationary at 30°C for 4-7 days. 
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2.6 Protein analysis 
 
2.6.1- Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE). 
 
Reagents required: 
 
- 1X Loading buffer (SDS-LB): 500µl of 0.05 M Tris-Cl (pH 6.8) was mixed with 2 ml 
of 2% SDS, 1 ml of 10% Glycerol and 0.05g of bromophenol blue. The solution was 
then made up to 10ml in MilliQ water and 500µl of β-Mercaptoethanol was added. 
 
- Electrophoresis buffer: A stock solution of 5X electrophoresis buffer (1L) was made 
with 15.1g of TRIS, 94g of glycine, and 5g of SDS made up to 1L in MilliQ water. 
When running the gels a solution of 1X electrophoresis buffer was used. This 
comprised 200µl 5x buffer added to 800µl MilliQ water. 
  
- Staining solution: A 1L stock of staining solution was made with 2.5g of coomassie 
brilliant blue R250, 450ml of ethanol, 450ml MilliQ, and 100ml of glacial acetic acid 
mixed thoroughly to dissolve the coomassie powder.  
 
- Destaining solutions: This comprised 300ml Methanol and 100ml glacial acetic acid 
made up to 1L in MilliQ water. 
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Gel preparation: 
Separating Gel Stacking Gel 
1 Gel 2 Gels   1 Gel 2 Gels 
2.3ml 4.6ml MilliQ 1.35ml 2.7ml 
1.25ml 2.5ml 30% Acrylamide 250µl 500µl 
1.35ml 2.7ml 80% Glycerol 335µl 670µl 
50µl 100µl (pH 8.8)  Tris Buffer  (pH6.8) 20µl 40µl 
50µl 100µl 10% APS 20µl 40µl 
50µl 100µl 10% SDS 20µl 40µl 
3µl 6µl TEMED 2µl 4µl 
 
 
SDS-PAGE gel sample preparation and SDS analysis: 1ml of overnight culture at an OD600 of 
0.5 was spun down at 13000 rpm for 5 minutes and the pellet was washed twice (by spinning 
and resuspending each time) with 1ml of 1X PBS. The resultant pellet was then resuspended 
in 150µl of SDS loading buffer and frozen at -20°C. Protein samples were heated in a 100°C 
water bath for 10 minutes and then spun down at 13000 rpm for 5 minutes before being 
loaded on the gel.  
 
The samples were run in a BIO-RAD mini-gel system assembled as per the manufacturer’s 
instructions. Before loading the samples, the empty wells were flushed with 1xSDS running 
buffer to remove any un-polymerised acrylamide that might have gotten stuck to the wells. 
15μl of each sample was then loaded into each well and the tank was filled with 1xSDS 
running buffer. The samples were run at 150V for 70-80 minutes. 
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2.6.2- Native gel 
Reagents required: 
 
- Resuspension buffer: 50 mM Tris-HCl (pH 7.5), 5 mM EDTA, 1 mM PMSF, 
100μg/ml DNase (from 10mg/ml stock), 500μg/ml lysozyme (from 10mg/ml stock) 
and 50μg/ml PIC. 
 
- 5X Native sample buffer: 15ml of 1M Tris-HCl (pH 6.8), 2.5ml of 1% solution of 
bromophenol blue, 7ml of distilled water and 25ml of glycerol. 
 
- 5X Native gel running buffer: 15.1g Tris base, 94g glycine. The components were 
dissolved and the volume made up to 1 litre. 
 
Gel preparation: 
Separating Gel Stacking Gel 
1 Gel 2 Gels   1 Gel 2 Gels 
1.4ml 2.8ml MilliQ 2.15ml 4.3ml 
1.25ml 2.5ml 30% Acrylamide 0.85ml 1.7ml 
1ml 2ml 80% Glycerol 1.25ml 2.5ml 
1.25ml 2.5ml (pH 8.8)  Tris Buffer  (pH6.8) 0.625ml 1.25ml 
50µl 100µl 10% APS 50µl 100µl 
4µl 8µl TEMED 5µl 10µl 
 
Native gel sample preparation: 1ml of overnight culture was spun down at 13000 rpm for 5 
minutes and the pellet resuspended in 120µl of resuspension buffer. The solution was then 
allowed to stand for 10 minutes at room temperature. It was then sonicated 3 times with 20 
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second bursts and allowed to stand at room temperature for a further 10 minutes. The solution 
was then spun at 13000 rpm for 10 minutes and the supernatant was transferred to a new 
Eppendorf tube with 30µl of sample buffer to obtain the native sample preparation. The gel 
was run in a tank filled with 1x native gel running buffer at 220V for a period of 4-5 hours.  
 
2.6.3- Western blot 
Reagents required: The following reagents were made prior to the blotting process: 
 
- Transfer Buffer (1L): 2.21g (10 mM) of CAPS in 10% methanol made up to 1 L with 
MilliQ. The pH was adjusted to 11 by using NaOH prior to the addition of methanol. 
The solution was stored in the fridge. 
 
- 10X PBS: 2g of KH2PO4 was added to 14.48g of Na2HPO4, 80g of NaCl and 2g of 
KCl before being dissolved in 1L of MilliQ water. The solution was then autoclaved 
and stored at room temperature. 
 
- 1X PBS: 100ml of 10X PBS was mixed with 900ml of MilliQ water and mixed 
thoroughly. 
 
- TPBS: 0.1% of Tween 20 was added to 1X PBS to make TPBS. 
 
- TBS: 10 mM Tris-HCl and 0.9% NaCl were made up to 1 L in MilliQ water and 
sterilised before storing it at room temperature. 
 
- Blocking solution: 5% non fat milk powder mixed with TPBS. 
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- Diluted primary antibody solution: A dilution of 1:1,000 of primary antibody in 
blocking solution was made and 0.05% sodium azide was added to prolong the life of 
the solution. This was then kept cool in a fridge until required.  
 
- Diluted secondary antibody: A dilution of 1:50,000 of secondary antibody (anti-
mouse HRP conjugate from Amersham ECL plus Western Blotting reagent pack, [GE 
Healthcare] was added to the blocking solution. 
 
Method:  
Four sheets of Whatman MM3 filter paper were cut to a size slightly larger than the gels. A 
PVDF membrane was also cut into 4 pieces of similar size and one corner was marked. The 
membrane was then placed in a Petri dish containing absolute methanol for 5 minutes before 
being moved to a container filled with transfer buffer. The four Whatman papers and two 
sheets of fibre pads were also placed into the container. Once the electrophoresis gel had run, 
the protein bands were transferred onto the membrane. This was achieved by first placing a 
fibre pad onto the negative side of the western blot apparatus, followed by two sheets of 
Whatman paper. The gel was then placed on top of the paper. On top of this was placed the 
PVDF membrane (facing the negative side, but placed on the positive side), followed by the 
remaining filter papers and then finally the last fibre pad. The gel holder (western blot 
apparatus) was placed in its tank facing the positive electrode with a cooling unit and pre-
chilled transfer buffer in the tank. Electrophoresis was then commenced at 200mA for 70 
minutes. This caused the proteins to move from the cathode to the anode, and as a result they 
get trapped in the membrane. 
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The next part of the process involved antibody binding and detection. The membrane was put 
in a tray with the protein containing side facing up. The membrane was then rinsed in TPBS 
for 30 minutes and then incubated in a blocking solution, made with 5% milk powder in 
TPBS, overnight. The membrane was then incubated in the diluted primary antibody for 1-2 
hrs and then washed 3 times for 15 minutes in TPBS. After this, the membrane was incubated 
in the secondary antibody for a further 1-2 hrs. It was then washed twice with TPBS (15 min) 
and once with TBS (5 min). It was then laid onto a foil   and layered with ECL developing 
solution and incubated for 5 minutes. The excess liquid was removed and the membrane was 
wrapped in cling film to be exposed on an x-ray film for 7-15 seconds. 
 
2.6.4- Protein Purification  
The purification of the JNL protein involved the use of ion exchange and size exclusion 
chromatography. In both cases the Bio-Rad biologic LP machine was used along with a 
fraction collector. Both of these processes are discussed after the lysate preparation below. 
After each process the protein sample was concentrated using the Vivaspin 20 5,000 MWCO 
columns (Sartorius sedim) in appropriate buffer and stored at -80°C.   
 
Cell lysate preparation:  
A single colony of E. coli MGM100 containing the pTrc plasmid was inoculated into 5 ml of 
LB broth and incubated at 37°C with shaking overnight (180rpm). 1ml of the overnight 
culture was added to 200ml of fresh LB broth in 3 x 500ml conical flasks with 0.2% glucose 
and incubated at 37°C with shaking. The growth of the culture was monitored at several time 
points until the OD600 reached 0.4-0.5. The culture was induced with 0.5 mM IPTG for 4 
hours. The cells were harvested by centrifuging at 6000rpm for 10 minutes at 4°C. The 
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supernatant was decanted and the cell pellet resuspended in 6ml of buffer 1. For cell lysate 
preparation, the resuspended pellet was sonicated (3x 1min, cooling intervals of 10sec). 
 
(a) DEAE sepharose ion exchange chromatography: DEAE sepharose (GE Healthcare) was 
used for this process. This has an ion capacity of 0.11-0.16 mmol (Cl-)/m, with a bed height 
of 15cm, and a max flow rate of 300-600cm/hour. 
 
Buffers used: 
- Buffer 1 (low salt buffer): 50 mM Tris (pH 6.5), 50 mM NaCl, and 1 mM EDTA 
- Buffer 2 (high salt buffer): 50 mM Tris (pH 6.5), 500 mM NaCl  
Chromatography: 
The DEAE sepharose column (GE Healthcare, 1cm x 20cm, 12ml) was connected to a Bio-
Rad Biologic LP HPLC system and equilibrated with 250ml buffer 1 before use. The crude 
cell extract was applied to the column followed by 125ml of buffer 1. The sample was run 
with a flow rate of 1ml/min. Proteins were eluted by using a linear gradient with increasing 
ionic concentration from buffer 1 to buffer 2 (0% - 100%). The column was then washed with 
~72ml buffer 2. The column was cleaned using 1M NaCl buffer. Protein samples were 
collected (approximately 10ml of fraction was collected in each tube) and checked on 12% 
SDS-PAGE. The purified products were concentrated using Vivaspin 5K cut concentrators 
(Vivascience). 
 
(b) Size exclusion chromatography (gel filtration): Superdex 200 (GE Healthcare) was used 
for this process. This has a bed dimension of 10 x 300 mm, bed volume of 24ml, a max flow 
rate of 1ml/min, and a separation range of 10,000600,000 globular protein. For this process 
250μl (approximately 1mg) of sample was used. 
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Buffer used: 
- Buffer 5: 50 Tris, 50 mM KCl, 10 mM MgCl2 at pH 7.4 
Chromatography: 
The size exclusion column (Superdex 200, 35ml, GE Healthcare) was connected to a Bio-Rad 
Biologic LP HPLC system and equilibrated with 250ml buffer 1 before use. Protein samples 
obtained from the previous step were applied to the column and eluted using buffer 5 at a 
flow rate of 1ml/min (approximately 10-15ml of fraction was collected in each tube). The 
collected sample was analyzed on 12% SDS-PAGE and concentrated using Vivaspin 5K cut 
concentrators (Vivascience). 
 
2.6.5- ATPase assay 
The ATPase assay was performed with the help of the PiColorLock gold ATPase kit (Innova 
Biosciences). The assay was performed on clear 96 well plates and the Abs was read at 620 
nm. For this assay 1μM protein was needed in a 100μl reaction (each well). A stock of 350μl 
buffer and protein was made and 100μl was transferred to 3 wells (triplicates). Into each of 
these wells ATP was added to the final concentration of 1mM in each well, and the plate was 
incubated at room temperature for 30 minutes. During this time, the required volume (25μl 
per well) of gold mix is prepared as per the manufacturer’s instructions (PiColorLock gold + 
1% accelerator). After the 30 minutes of incubation time are over, 25μl of gold mix is added 
to each well and left for 5 minutes. 10μl of stabiliser is then added into each well and the 
plate is incubated at room temperature for a further 30 minutes before the absorbance is read 
at 620nm.  
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2.6.6- Analytical ultracentrifugation (AUC) 
For this research, only sedimentation velocity experiments (chapter 5) were performed with 
the following parameters: 
 20 hours running time 
 40000 g 
 4°C 
In this project, Midi D-tube dialyzers (Novagen) were used to exchange the sample buffers. 
The sample is placed inside the tube and put into a beaker containing the buffer that is 
required (this must be at least 100 times the sample volume). This is then left overnight at 
4°C. The following morning, the sample is concentrated using the Vivaspin columns 
discussed above. 
 
2.6.7- Protein quantification 
In all cases the protein concentration is checked either with the Bradford assay (Bio-Rad 
protein assay reagent). 
 
The process involved the following steps: 
 20X dilution of protein sample was made in filtered water 
 20µl of this mix was added to 1ml Bradford reagent in a 1ml cuvette for 5min 
 Absorbance is read at 595nm (Bradford reagent on its own is the blank) 
 The absorbance was then converted to concentration using the formula: 
 [P] = (1.79 x Abs595nm + 0.0064) x 20 = mg/ml  
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Expression and complementation analysis of  
M. tuberculosis chaperonins in E. coli 
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Background 
As discussed above in section 1.5, most bacteria only have one GroEL homologue; however 
some bacteria have been shown to have 2 or more copies of the groEL gene, including most 
Mycobacteria. In Mycobacterium tuberculosis there are 2 distinct groEL homologues which 
encode the chaperonins Cpn60.1 and Cpn60.2 (Kong et al., 1993). cpn10 and cpn60.1 
constitute an operon, while cpn60.2 is arranged separately on the chromosome. In section 1.6 
the role played by these chaperonins in the pathogenicity of M. tuberculosis was discussed. In 
vitro studies have suggested that these chaperonins exist as lower oligomers (Qamra et al., 
2004). This finding was surprising, as in all other cases where this has been investigated, 
chaperonins are nearly always present as two or (occasionally) one single heptameric ring 
(Lin et al., 2009, Nielsen & Cowan, 1998). This cage like ring structure allows substrate 
proteins to fold in a secluded environment, away from interactions by other sources.  
 
It is known that the main house-keeping chaperonin in both M. tuberculosis and M. 
smegmatis is Cpn60.2, while Cpn60.1 seems to have evolved to perform alternate functions.  
Our current understanding of the functions of Cpn60.1 implicates its role in biofilm 
maturation for M. smegmatis while the M. tuberculosis homologue has been shown to play a 
role in granuloma formation during tuberculosis (Hu et al., 2008, Kim et al., 2003, Ojha et 
al., 2005). Recent published data reports that Cpn60.2 from M. tuberculosis is unable to 
complement for the loss of GroEL function in E. coli (Kumar et al., 2009). However, similar 
experiments conducted in our lab provided a different set of results (Han Liu, PhD thesis 
2006). Han Liu was able to show that Cpn60.2 from M. tuberculosis could complement in E. 
coli for the loss of endogenous GroEL. 
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In this chapter I have built on the observations made by Han Liu by first replicating his 
results, and then expanding it with different E. coli strains and conditions. Both the M. 
tuberculosis chaperonins were expressed and analysed for their ability to complement in E. 
coli. This was done along with the cochaperonins from both E. coli (GroES) and M. 
tuberculosis (Cpn10). Since Cpn60.2 is the main house-keeping chaperonin in M. 
tuberculosis, while Cpn60.1 is not, it was hypothesised that Cpn60.2 would be able to 
complement in E. coli while Cpn60.1 would not. It was predicted that Cpn60.2 would be able 
to function with both cochaperonins Cpn10 and GroES to rescue cell growth. 
  
Experimental design 
For the majority of these experiments the main E. coli strain used was MGM100. In this 
strain the groE promoter has been replaced with a PBAD promoter from the arabinose operon 
(Guzman et al., 1995). This enables the control of the expression of the E. coli endogenous 
GroEL by using glucose (to suppress expression) or arabinose (to increase expression). As a 
result, the ability of M. tuberculosis chaperonins to replace the endogenous E. coli chaperonin 
GroEL can be assessed on LB plates containing glucose or arabinose. During the process of 
analysing the complementation and expression of the chaperonins other E. coli strains were 
also used, namely, Tab21, which is a BL21 derivative (described in section 3.3) and a 
ΔgroEL strain called AI90 (described in section 3.6). 
 
To begin with I was provided with pTrc plasmids carrying various combinations of the 
chaperonin and cochaperonin homologues (groES+groEL, groES+cpn60.1, groES+cpn60.2, 
cpn10+cpn60.1, and cpn10+cpn60.2). These plasmids carry the trc promoter which contains 
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the -35 region of the trp promoter together with the -10 region of the lac promoter. This 
promoter is much more tightly regulated than either lac or trp, and can be over induced with 
IPTG (Amann et al., 1988). Since IPTG cannot be metabolised within the cell, its 
concentration remains constant, and this enables continuous over expression of the required 
chaperonins from the plasmids within the cells. The cloning process for these plasmids was 
done by a collaborator Dr. Yanmin Hu (Coates group, St. George’s University of London). 
These plasmids were first verified by restriction digests and sequencing to ensure the required 
genes were present without any unwanted mutations. After verification was completed, the 
plasmids were transformed into the required strains (MGM100, Tab21, and AI90) for the 
complementation assays. 
 
3.1 Induction of MetE in GroEL depleted cells 
Before work was carried out on the complementation assays, it was decided that the observed 
induction of a secondary protein, when GroEL levels were reduced in E. coli, should be 
investigated. These experiments were carried out in the MGM100 strain described above. 
Work conducted in the lab had shown that there was an increase in the expression of a protein 
called MetE when the groE operon was repressed in MGM100 (Darren Olden, Master’s 
thesis, University of Birmingham). In retrospect, this result was not surprising as it is known 
that the metE gene is repressed by MetF and MetK, both of which have been found to be 
obligate GroEL substrates (Kerner et al., 2005), so the lack of GroEL in the cell results in the 
over-expression of MetE (Chapman et al., 2006). If this observation of MetE induction was 
in fact being caused by the lack of functional chaperonin in E. coli, then it could prove to be a 
visual marker on SDS-PAGE gels. An experiment was conducted to confirm if the increased 
expression of MetE was occurring due to the absence of GroEL in the system. 
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MGM100 was grown overnight in LB with 0.2% arabinose and 100µg/ml kanamycin. The 
OD600 of the resulting culture was measured and a sample was transferred to a flask with 
40ml of LB + 0.2% arabinose, to give a starting OD600 of 0.01. The cells were grown and the 
OD600 was taken every 20 minutes for the first hour, and a final reading was taken at 130 
minutes. From this culture the volume required to get an OD600 of 0.1 was calculated and 
40ml was transferred into two 50ml Falcon tubes. Both the tubes were then centrifuged. One 
of the pellets was resuspended in 40ml of LB + 0.2% arabinose, while the second pellet was 
first washed with 20ml of 0.5% glucose, and then resuspended in 40ml LB + 0.5% glucose. 
Both cultures were then grown at 37°C and 1ml samples were collected every 20 minutes in 
1.5ml Eppendorfs. The samples were diluted with LB, such that the culture in each 
Eppendorf had an OD600 of 0.8. In all cases the growth rate of each culture was the same. 
Protein sample was then prepared from these cultures and run on a SDS-PAGE gel (Fig 3.1). 
 
The results showed that even after 1 hour of incubation, no MetE over-induction was 
distinguishable. However, after about 100 minutes the levels of a 100kDa protein started to 
increase in the cells grown on glucose but not in the cells grown on arabinose. This band was 
then cut out from the gel and analysed by trypsin digestion and mass spectrometry (service 
provided by the Functional Genomics laboratory in the School of Biosciences). The result of 
the mass spectrometry confirmed that the protein was the 92kDa protein, MetE. This result 
correlated with earlier results in the lab, and also with work done by Chapman et al. on the 
aggregation of certain proteins in the absence of GroEL (Chapman et al., 2006). 
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Fig 3.1: SDS-PAGE gel of protein extracts from MGM100 grown on arabinose or 
glucose at 20 minute intervals. Even numbered lanes are MGM100 in arabinose, while odd 
numbered lanes are MGM100 in glucose. Lane 1- Prestained protein marker (Fermentas). 
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Since a GroEL band wasn’t distinguishable on the Coomassie stained gel in either arabinose 
or glucose, its presence was determined with western blotting (Fig 3.2). The results of the 
western blot confirmed the presence of GroEL in the samples from cultures grown with 
arabinose as well as very low levels in the samples from cells grown with glucose. This was 
expected, and also confirms that the PBAD promoter can be used to express or repress GroEL 
in MGM100. This also demonstrated that even after 1.5 hours (approximately 4-5 
generations), although the levels of GroEL in the glucose culture was extremely low, there 
was still enough to sustain some growth. This result was again not surprising as it has been 
shown by previous work conducted in the lab that a very small concentration of GroEL is 
required to keep the cells viable (Ivic et al., 1997, Lorimer, 1996). It was however noted that 
after the initial 3 hour incubation period, cell growth in glucose drastically reduced when 
compared with those in arabinose. Cells grown on arabinose show a much more prominent 
GroEL band on the film. It was observed that the expression level of MetE started to rise at 
about 2 hours after incubation in the presence of glucose and not in the presence of arabinose. 
Taken together, these results confirmed the earlier findings that the reduction in the levels of 
GroEL within E. coli causes over-expression of the newly translated MetE protein. This 
result can also be used as a potential visual marker for a lack of functional chaperonin in a 
cell. 
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Fig 3.2: Western blot of GroEL from MGM100 grown in arabinose or glucose. (a) SDS-
PAGE protein gel of MGM100 grown in arabinose or glucose (arrows pointing at MetE). (b) 
Western blot using GroEL specific antibody. In both cases odd numbered lanes are MGM100 
in arabinose, while even numbered lanes are MGM100 in glucose. Lane 9- Prestained protein 
marker (Fermentas). 
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3.2 Expression and complementation of the M. tuberculosis GroEL homologues in E. 
coli MGM100 
Research conducted on Mycobacterium tuberculosis has shown that Cpn60.2, and not 
Cpn60.1, is the house-keeping chaperonin of this organism (Hu et al., 2008). Prior work 
conducted in the lab suggested that the Cpn60.2 chaperonin of Mycobacterium tuberculosis 
has the ability to complement for the loss of endogenous GroEL in E. coli. It was also noted 
that Cpn60.1 did not show any signs of complementation in such a system (Han Liu, PhD 
thesis 2006, University of Birmingham). However, the expression level of Cpn60.1 was also 
very low and could not be distinguished on SDS-PAGE gels. So it was possible that the lack 
of complementation by Cpn60.1 was caused by the lack of protein expression. In this section, 
the hypothesis that M. tuberculosis chaperonin 60.2 can function in E. coli MGM100 was put 
to the test. It was expected that the complementation data would confirm the original 
observations made by Han Liu that Cpn60.2 can function as a chaperonin in E. coli while 
Cpn60.1 cannot.  
 
As discussed in the experimental design, the reason behind the use of the MGM100 strain 
was that in this strain the chromosomal groE promoter has been replaced with a PBAD 
promoter from the arabinose operon. As a result, the expression of endogenous GroEL can be 
controlled with the use of either arabinose (to induce expression) or glucose (to suppress 
expression). This enables the assessment of the M. tuberculosis chaperonins to replace the 
endogenous E. coli GroEL and function as a chaperonin. 
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For this experiment, MGM100 was transformed with the pTrc plasmids carrying the 
chaperonin and cochaperonin genes. The resultant MGM100 + pTrc strains were grown 
overnight in arabinose, then sub-cultured and grown in LB + glucose the following morning 
for 2 hours, and then serially diluted (in ten-fold steps) to spot on to square petri dishes 
(Sterilin). 5µl of each dilution was spotted onto the plates with the final dilution factor being 
10
7. 
 The plates were then incubated at 37°C, 30°C, and 26°C. The remaining overnight 
culture was used to extract total cell proteins which were then run on SDS-PAGE gels. Four 
different plates were used for complementation under each temperature; LB + 0.2% 
arabinose, LB + 0.2% arabinose + 0.5 mM IPTG, LB + 0.2% glucose, and LB + 0.2% 
glucose + 0.5 mM IPTG. The pTrc plasmids in question are IPTG inducible.  
 
The complementation results showed that in the presence of arabinose all the cultures grew 
very well (figure 3.3). This was expected, as the arabinose induces the PBAD promoter and 
consequently the expression of the chromosomally encoded groEL and groES genes are 
sustained in all the cultures. In the presence of glucose, when PBAD is tightly repressed and 
hence levels of GroEL and GroES fall as the cells divide, only the GroEL homologues that 
have the ability to complement for the loss of the endogenous GroEL would be able to sustain 
cell growth. In this case it was seen that Cpn60.2, expressed either with GroES or Cpn10 as 
the cochaperonin, was able to maintain cell growth at all the temperatures tested. It was also 
noted that Cpn60.2 with GroES or Cpn10 gave improved growth relative to the endogenous 
GroES-GroEL form in the presence of 0.5 mM IPTG.  
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Fig 3.3: Mycobacterial Cpn60.2 can rescue growth of E. coli MGM100 under GroESL 
limiting conditions. (a) Plate grown at 37°C in the presence of arabinose. (b) Plate grown at 
37°C in the presence of glucose without IPTG. (c) Plate grown at 37°C in the presence of 
glucose with 0.5 mM IPTG. 
1- MGM100/ pTrc-GroES-Cpn60.1 
2- MGM100/ pTrc-GroES-Cpn60.2 
3- MGM100/ pTrc-Cpn10-Cpn60.1 
4- MGM100/ pTrc-Cpn10-Cpn60.2 
5- MGM100/ pTrc99a 
6- MGM100/ pTrc-GroES-GroEL 
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When IPTG was not included Cpn60.2 only showed complementation when co-expressed 
with GroES and not with Cpn10. Whether this is due to the efficiency of translation, which 
may be dependent on the exact sequence upstream of Cpn60.2, is unclear. The data suggests 
that even without IPTG the pTrc plasmids had leaky expression and that the levels of 
chaperonins within the cells were high enough to complement under certain conditions.  
 
However, the results also show that the addition of IPTG at a molarity of 0.5 mM was 
causing retarded growth of the strains carrying the pTrc-GroES-GroEL plasmid, suggesting 
that very high concentrations of chaperonin may be deleterious for the cells (as evidenced 
later – see Fig 3.4). The reason for this is unclear. These colonies were also usually smaller in 
size than those without IPTG. Only the images of plates grown at 37°C are shown as the 
results from the remaining temperatures were very similar. A summary of the results can be 
seen in table 3.1 below. 
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 30°C/26°C 37°C 
MGM100 
Arabinose – 
IPTG 
Arabinose + 
IPTG 
Glucose – 
IPTG 
Glucose + 
IPTG 
Arabinose 
– IPTG 
Arabinose + 
IPTG 
Glucose - 
IPTG 
Glucose + 
IPTG 
GroES + 
Cpn60.1 +++ +++ - - +++ +++ - - 
GroES + 
Cpn60.2 +++ ++ +++ ++ +++ ++ +++ ++ 
Cpn10 + 
Cpn60.1 +++ +++ - - +++ +++ - - 
Cpn10 + 
Cpn60.2 +++ +++ - +++ +++ +++ - +++ 
pTrc 
Vector +++ +++ - - +++ +++ - - 
GroES + 
GroEL +++ ++ +++ + +++ ++ +++ - 
 
Table 3.1: Summary of the complementation data in MGM100. This table summarises the 
complementation data of cells expressing different combination of chaperonins and 
cochaperonin from the pTrc plasmid at different temperatures, with or without 0.5 mM IPTG.  
+++   Denotes 10 – 100 % survival  - Complete complementation 
++     Denotes 1 – 10 % survival     - Partial complementation 
+       Denotes 0.1 – 1 % survival     - Partial complementation 
-        Denotes <0.1 % survival       - No complementation 
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The results from these complementation plates showed that Cpn60.2 can complement in 
MGM100 under appropriate conditions. However, Cpn60.1 failed to complement, 
irrespective of which cochaperonin it was co-expressed with. There are two possible reasons 
for this result. Either Cpn60.1 was incapable of recognising and/or folding the required 
GroEL substrates or the expression level of Cpn60.1 was too low. Therefore, the levels of 
Cpn60.1 expression were estimated from SDS-PAGE gels of whole cell lysates. It was 
expected that the expression of all the chaperonins and cochaperonins from the pTrc plasmid 
would increase in the presence of IPTG, and that this would be distinguishable on a SDS-
PAGE gel. A lower concentration of IPTG (0.1 mM) was used to reduce cell death in the 
over-night cultures. The results obtained from the SDS-PAGE gels showed that the 
expression of Cpn60.2 was distinguishable with both cochaperonins. The expression level of 
Cpn60.1 however, was much lower and could only be seen when co-expressed with GroES 
(fig 3.4a). MS confirmed that the band was Cpn60.1. As a result, it could be speculated that 
the level of expression of Cpn60.1 may not have been high enough to sustain cell growth. 
However a point to note here is that although the level of expression of Cpn60.1 was low, it 
was not nonexistent.  Interestingly, it was also observed that MetE was over-expressed in 
cells expressing Cpn60.1 both with and without IPTG, but only in cells expressing Cpn60.2 
when IPTG was not present (fig 3.4b). When Cpn60.2 is over-expressed with IPTG, the MetE 
band cannot be seen. This further supports the hypothesis that Cpn60.2 can function as a 
chaperonin in E. coli while Cpn60.1 cannot. 
 
Based on the results obtained in this experiment it can be concluded that Cpn60.2 from M. 
tuberculosis is capable of functioning as a chaperonin in E. coli. Cpn60.1 was unable to 
complement for the loss of endogenous GroEL, but this could be attributed to its low 
expression levels. To try and remedy this lack of expression various experiments were 
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designed which will be discussed shortly. First, the observation that excessive chaperonins 
can result in cell death was further analysed by altering their expression levels. 
 
 
 
 
 
Fig 3.4: SDS-PAGE gels. (a) Gel showing over-expression of Cpn60.2, and some over-expression of 
Cpn60.1 in MGM100. The samples were taken from cultures grown in 0.2% arabinose with 0.1 mM 
IPTG. (b) MetE induction seen with non functional chaperonins. Samples for 2b and 3b were taken from 
cells grown in 0.2% arabinose, while the remaining samples were taken from cells grown in 0.2% 
glucose with 0.5 mM IPTG. Black arrow indicates Cpn60.1, red arrow indicates Cpn60.2, yellow arrow 
indicates GroEL, and white arrows indicate MetE. 
Lane 1a and 1b- Prestained protein marker (Fermentas) 
Lane 2a- MGM100/ pTrc-GroES-Cpn60.1                  Lane 2b- MGM100/ pTrc99a  
Lane 3a- MGM100/ pTrc-GroES-Cpn60.2                  Lane 3b- MGM100/ pTrc99a 
Lane 4a- MGM100/ pTrc-Cpn10-Cpn60.1                  Lane 4b- MGM100/ pTrc-GroES-Cpn60.1 (-IPTG) 
Lane 5a- MGM100/ pTrc-Cpn10-Cpn60.2                  Lane 5b- MGM100/ pTrc-GroES-Cpn60.1 (+IPTG) 
Lane 6a- MGM100/ pTrc99a                                       Lane 6b- MGM100/ pTrc-GroES-Cpn60.2 (+IPTG) 
Lane 7a- MGM100/ pTrc-GroES-GroEL                    Lane 7b- MGM100/ pTrc-GroES-Cpn60.2 (-IPTG) 
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3.2.1 The effect of changing IPTG concentration on complementation  
In section 3.2 the ability of Mycobacterial chaperonins to complement for the loss of 
endogenous GroEL in E. coli MGM100 was tested. It was observed that the use of IPTG at a 
concentration of 0.5 mM resulted in a drastic reduction is the number of viable colonies with 
the strain carrying the pTrc-GroES-GroEL plasmid. It was hypothesised that excessively high 
levels of GroEL were deleterious for the cells. Since the plasmids in question are induces 
with IPTG, its concentration was altered before reattempting the complementation assay. It 
was decided that 3 different IPTG concentrations 0.5 mM, 0.25 mM, and 0.1 mM would be 
tested. It was predicted that the colonies grown on the lowest IPTG concentration would be 
able to complement better than those on higher IPTG concentrations. The complementation 
assay remained unaltered from that used in section 3.2. 
 
The results that were obtained were as predicted. The plates showed a reduction in the 
number of viable colonies when the IPTG concentration was increased (Fig 3.5). This 
confirmed the original hypothesis that high levels of expression of GroEL, and to a lesser 
extent Cpn60.2, is lethal for the cells. As a result, in all further complementation assays that 
required IPTG induction, a concentration of 0.1 mM was used. 
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Fig 3.5: Complementation at varying concentrations of IPTG at 37°C. (a) Plate grown at 
37°C with 0.2% glucose and 0.1 mM IPTG. (b) Plate grown at 37°C with 0.2% glucose and 
0.25 mM IPTG. (c) Plate grown at 37°C with 0.2% glucose and 0.5 mM IPTG. 
1- MGM100/ pTrc-GroES-Cpn60.1 
2- MGM100/ pTrc-GroES-Cpn60.2 
3- MGM100/ pTrc-Cpn10-Cpn60.1 
4- MGM100/ pTrc-Cpn10-Cpn60.2 
5- MGM100/ pTrc99a 
6- MGM100/ pTrc-GroES-GroEL 
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3.2.2 Using pRARE plasmids with MGM100 to reduce codon bias 
Codon bias is a phenomenon that involves different organisms preferring one of the several 
codons that encode the same given amino acid. The exact reason behind this is under constant 
debate. One theory is that it may occur due to natural selection, so as to optimise gene 
translation depending on the GC content of the DNA (Sharp et al., 2005). Since M. 
tuberculosis has a higher GC content than E. coli, it was expected that M. tuberculosis would 
prefer a different combination of codons as compared with E. coli. This was confirmed by 
statistical analysis done on their codon usage (Pan et al., 1998). To ensure that the 
Mycobacterial homologues were not being subjected to codon bias in E. coli, a second 
plasmid was transformed into MGM100 along with the pTrc plasmid combinations. This 
plasmid, pRARE, encodes tRNAs for codons that rarely occur in E. coli, and therefore 
enhances the expression levels of proteins otherwise limited by codon usage. 
 
The transformation, complementation, and protein expression protocols remained primarily 
unaltered from section 3.2. The only difference in this complementation assay was the use of 
0.1 mM IPTG to induce the expression of the chaperonins. The results showed that the use of 
pRARE had no prominent affect on the complementation data (Table 3.2). Images of the 
plates have not been shown as there was no significant difference between these results and 
the complementation results in section 3.2.1. As was previously seen, Cpn60.2 showed 
complementation with GroES in the presence and absence of IPTG, and with Cpn10 only in 
the presence of IPTG. Cpn60.1 did not show any signs of complementation again with either 
cochaperonin. The levels of protein expression also remained unaltered. 
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 30°C/26°C 37°C 
MGM100 
Arabinose - 
IPTG 
Arabinose + 
IPTG 
Glucose – 
IPTG 
Glucose + 
IPTG 
Arabinose – 
IPTG 
Arabinose 
+ IPTG 
Glucose – 
IPTG 
Glucose + 
IPTG 
GroES + 
Cpn60.1 + 
pRARE +++ +++ - - +++ +++ - - 
GroES + 
Cpn60.2 + 
pRARE +++ ++ +++ +++ +++ + +++ +++ 
Cpn10 + 
Cpn60.1 + 
pRARE +++ +++ - - +++ +++ - - 
Cpn10 + 
Cpn60.2 + 
pRARE +++ +++ - +++ +++ +++ - +++ 
pTrc 
vector + 
pRARE +++ +++ - - +++ +++ - - 
GroES + 
GroEL + 
pRARE +++ ++ +++ +++ +++ + +++ +++ 
 
Table 3.2: A summary of the complementation data in MGM100 with pRARE. This 
table summarises the complementation data of cells expressing different combination of 
chaperonins and cochaperonin from the pTrc plasmid along with pRARE at different 
temperatures, with or without 0.1 mM IPTG.  
+++   Denotes 10 – 100 % survival  - Complete complementation 
++     Denotes 1 – 10 % survival     - Partial complementation 
+       Denotes 0.1 – 1 % survival     - Partial complementation 
-        Denotes <0.1 % survival       - No complementation 
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3.3     Complementation and expression of M. tuberculosis GroEL homologues in Tab21  
Based on the observations made in section 3.2, it was speculated that the lack of viability of 
the Cpn60.1 strains in the complementation experiments could be due to the lower expression 
levels of the Cpn60.1 protein compared with GroEL and Cpn60.2.  As a result a number of 
strategies were tested for their ability to improve the expression of the Cpn60.1 protein. One 
of these methods was to use the strain Tab21, a BL21 (DE3) derivative.  
 
BL21 is derived from the E. coli B strain and is a very good protein expression strain. It has 
been modified to carry the T7 RNA polymerase gene under the control of an IPTG inducible 
lac promoter. This polymerase is extremely active and can synthesise RNA at a rate several 
times that of E. coli RNA polymerase. As a result this strain can be used to induce protein 
expression from plasmids that make use of the T7 transcription and translation mechanism 
(e.g. pET vectors).   
 
Before BL21 could be used in the complementation assays it was necessary to be able to 
control the expression of endogenous GroEL and GroES. This was necessary so that the 
complementing ability of Cpn60.1 and Cpn60.2 could be tested without the interference of 
endogenous chaperonins. For this reason it was decided that the pBAD expression system 
used in MGM100 would also be used with BL21. To achieve this, the groE promoter in BL21 
would need to be replaced with the PBAD promoter. However, since GroEL is vital for cell 
survival, gene deletion was not an option. Instead, the groESL operon under control of the 
PBAD promoter, which was available on the MGM100 chromosome, had to be inserted into 
the BL21 strains. This was achieved by using P1 bacteriophage transduction. 
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P1 phage was grown with MGM100 and then used to infect the BL21 strain as per the 
protocols described in section 2.4.5. This results in bacteriophage P1 injecting the donor 
bacterial DNA into the BL21 strain. The resultant recipient cell can then recombine the donor 
bacterial DNA into its own DNA. For the purpose of the complementation experiments, the 
pBAD-ESL operon had to replace the endogenous groESL operon. BL21 is not resistant to 
any antibiotics, but the pBAD-ESL operon has a Kanamycin resistance gene just downstream 
of the GroEL sequence which was also used in the screening process. So to test if the 
resultant BL21 strains had incorporated the pBAD-ESL operon into their genome, the cells 
were grown on LB plates with 0.2% arabinose and 50µg/ml kanamycin. Any colonies that 
were obtained were then re-streaked onto plates with 0.2% glucose and 50µg/ml kanamycin. 
BL21 cells that were able to grow in the presence of arabinose but not in the presence of 
glucose were then selected for the complementation assays. 
 
This new BL21 pBAD-groESL strain was named Tab21. The original pTrc plasmids 
containing the Mycobacterial homologues were transformed into Tab21 using the protocol 
described in section 2.4.16. This was done to test the complementation and expression of the 
chaperonins from the pTrc plasmid in Tab21 before attempts were made using pET vectors 
(section 3.3.1). It was hypothesised that Cpn60.2 would be able to complement in Tab21 but 
Cpn60.1 would not. Since the same pTrc plasmids were being used, an increase in protein 
expression compared with those seen in MGM100 was not expected. 
 
The results that were obtained showed that there was no variation in the complementation 
data at any of the temperatures tested (see Fig. 3.3). In the presence of arabinose all the 
strains grew as the PBAD promoter was inducing the expression of endogenous GroES and 
GroEL. In the presence of glucose, the complementation results obtained were similar to that 
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of MGM100. The use of Tab21 did not have any affects on the overall complementation data 
and similar levels of protein expression were obtained. It was concluded that, as was the case 
with MGM100, the Cpn60.2 chaperonin complements for the loss of endogenous GroEL in 
Tab21, while Cpn60.1 does not. A summary of the complementation and expression results 
can be seen in table 3.2 and figure 3.6.  
 
As discussed above, since Tab21 is a protein expression strain that makes use of the T7 RNA 
polymerase expression system, the next step in trying to achieve higher levels of protein 
expression of Cpn60.1 involved the transfer of the groES-cpn60.1 operon and the cpn10-
cpn60.1 operon onto a pET plasmid (section 3.3.1). 
 
Fig 3.6: SDS-PAGE gel showing over-expression of Cpn60.1 and Cpn60.2 in Tab21. All 
the samples were taken from cultures after 5 hours incubation with 0.1 mM IPTG and 0.2% 
arabinose.  
Lane 1- Prestained protein marker (Fermentas) Lane 3- Tab21/ pTrc-GroES-Cpn60.2 
Lane 2- Tab21/ pTrc-GroES-Cpn60.1 
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 30°C/26°C 37°C 
Tab21 
Arabinose - 
IPTG 
Arabinose + 
IPTG 
Glucose – 
IPTG 
Glucose + 
IPTG 
Arabinose - 
IPTG 
Arabinose + 
IPTG 
Glucose - 
IPTG 
Glucose + 
IPTG 
GroES + 
Cpn60.1 +++ +++ - - +++ +++ - - 
GroES + 
Cpn60.2 +++ ++ +++ +++ +++ ++ +++ +++ 
Cpn10 + 
Cpn60.1 +++ +++ - - +++ +++ - - 
Cpn10 + 
Cpn60.2 +++ +++ - +++ +++ +++ - +++ 
pTrc 
Vector +++ +++ - - +++ +++ - - 
GroES + 
GroEL +++ ++ +++ +++ +++ ++ +++ +++ 
 
Table 3.3: Summary of the complementation data in Tab21. The table shows the growth 
of cells expressing different combination of chaperonins and cochaperonin from the pTrc 
plasmid in Tab21 at different temperatures, with or without 0.1 mM IPTG.  
+++   Denotes 10 – 100 % survival  - Complete complementation 
++     Denotes 1 – 10 % survival     - Partial complementation 
+       Denotes 0.1 – 1 % survival     - Partial complementation 
-        Denotes <0.1 % survival       - No complementation 
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3.3.1 Using pET plasmid in Tab21 
To try and obtain a higher level of protein expression for Cpn60.1, its gene was cloned into a 
pET vector to be used with Tab21. It was expected that this would allow the required gene 
products to be expressed in greater quantity as compared with the pTrc plasmid by making 
use of the T7 transcription and translation mechanism.  
 
A pET vector with the ampicillin resistance gene was chosen, as Tab21 is kanamycin 
resistant. It was decided that pET23a+ would be used as the cloning vector as it had the 
required ampicillin resistance gene, and also had the appropriate restriction sites to allow a 
direct swap of genes from the pTrc plasmids. A schematic representation of the swaps is 
show in figure 3.7. As the level of protein expression of Cpn60.2 was high with the pTrc 
plasmid, it was decided that only the Cpn60.1 gene along with both the cochaperonins would 
be cloned into the pET vector. Once the required pET plasmid combinations were obtained 
and confirmed by sequencing, they were transformed into Tab21 as per the protocol 
described in section 2.4.16 and their expression levels were analysed. 
 
Unfortunately expression of Cpn60.1 could not be distinguished on the gel (fig 3.8). Only the 
over-expression of GroEL was seen from the cells containing pET-GroES-GroEL. It was also 
observed that the strains carrying the pET-GroES-Cpn60.1 and pET-Cpn10-Cpn60.1 
plasmids showed slower growth in both liquid and solid media compared with cells carrying 
the pTrc versions. An accurate complementation analysis could not be done as cell growth 
was extremely slow on solid media with glucose and arabinose. The reason for this 
observation is unclear. It is possible that the loss of the cells ability to regulate its endogenous 
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GroEL in both cases could have resulted in cell death. However this does not explain why 
cell growth was not affected by the pTrc plasmids as the cells are unable to regulate their 
expression either. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                          
 
Fig 3.7: Schematic illustration of the steps involved in cloning GroES-Cpn60.1 and 
Cpn10-Cpn60.1 into pET23a+. 
pTrc-groES-cpn60.1          
6.3 kb 
pET23a                 
3.6 kb 
pTrc-cpn10-cpn60.1               
6.3 kb 
groES 
cpn60.1(1.6kb) cpn60.1(1.6kb) 
Cpn10 
EcoRI 
ScaI EcoRI 
EcoRI 
T7 pro T7 ter 
EcoRI HincII 
EcoRI-ScaI digest 
(3.0 kb); Ligate 
EcoRI-HincII   
digest 
EcoRI digest EcoRI double 
digest (2.3 kb); 
Ligate 
pET23a-groES-cpn60.1               
6.6 kb 
T7 pro 
Transformed into 
Tab21 
pET23a-cpn10-cpn60.1               
5.9 kb 
T7 pro cpn10 
cpn60.1 
T7 terminator 
groES 
cpn60.1 
T7 terminator 
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Fig 3.8: SDS-PAGE of protein extracts from cells containing the pET vectors. The 
method used for protein extraction was the same as that use for the pTrc plasmids in 
MGM100. In all cases protein samples were made from cells grown in 0.2% arabinose for 5 
hours.  
Lane 1- Prestained protein marker (Fermentas) 
Lane 2- Tab21/ pET-GroES-Cpn60.1 (0.1 mM IPTG) 
Lane 3- Tab21/ pET-GroES-Cpn60.1 (no IPTG) 
Lane 4- Tab21/ pET-Cpn10-Cpn60.1 (0.1 mM IPTG) 
Lane 5- Tab21/ pET-Cpn10-Cpn60.1 (no IPTG) 
Lane 6- Tab21/ pET23a+ vector  
Lane 7- Tab21/ pET GroES-GroEL (0.1 mM IPTG) 
Lane 8- Tab21/ pET GroES-GroEL (no IPTG) 
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3.4 Cpn10 site directed mutagenesis 
As was discussed in section 3.2, during the initial experiments to test protein expression, 
some expression of Cpn60.1 was also observed. However, its expression was only 
distinguishable when the chaperonin was expressed with GroES and not with Cpn10. Since 
over induction of Cpn60.1 using pET vectors was unsuccessful, an alternate approach was 
looked into.  
 
SDS-PAGE gels showed the presence of both GroES and Cpn10 (figure 3.9 and 3.10). 
Sequence data showed that the start codon of Cpn10 was GTG (encoding valine), rather than 
the more widely used start codon of ATG (encoding methionine). It was hypothesised that 
perhaps this was the reason why Cpn60.1 was visible on Coomassie stained SDS-PAGE gels 
when co-expressed with GroES, but not with Cpn10. It may be that the starting codon of 
Cpn10, which is valine, does not allow the ribosome to form a strong enough initiation 
complex (Sussman et al., 1996). Instead the complex may be transient and as a result the 
expression of Cpn60.1, which is just downstream from Cpn10, may be affected.  To address 
this, the starting codon of Cpn10 was changed from a GTG (valine) to ATG (methionine) 
using site directed mutagenesis for both the pTrc-Cpn10-Cpn60.2 and pTrc-Cpn10-Cpn60.1 
plasmids.  
 
The primer design and PCR protocol used for this purpose has been described in the materials 
and methods section. The resulting PRC products were digested with DpnI before being 
transformed into MGM100. DpnI digestion is a necessary part of site directed mutagenesis as 
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it only digests the parental plasmid and not the PCR products. This drastically reduces the 
chances of transformed cells to carry the parental plasmid. DNA sequencing was done to 
confirm the presence of an ATG start codon for the cpn10 gene and to ensure no other 
mutations were present.  
 
After confirming the presence of the ATG forms of Cpn10-60.1 and Cpn10-60.2 (referred to 
as ATG-Cpn10-60.1 and ATG-Cpn10-60.2), the MGM100 strains expressing them were 
subjected to the same complementation and protein expression analysis as the original 
plasmids. The ATG-Cpn10-60.2 pTrc plasmid results showed a slight increase in the 
expression of Cpn10 but not in Cpn60.2. It was also noticed that there was a slight 
improvement in the complementing ability of ATG-Cpn10-Cpn60.2 in the presence of 
glucose and absence of IPTG as compared with the original Cpn10-60.2. Unfortunately no 
difference in the expression of Cpn60.1 was seen with ATG-Cpn10-60.1 (fig 3.11). The 
complementation data of ATG-Cpn10-Cpn60.1 also remained unchanged and no viable cells 
were seen on any of the complementation plates. A summary of the complementation data 
can be seen in table 3.4 below.  
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Fig 3.9: 15% SDS-PAGE gel of GroES in MGM100 with 0.2% arabinose and 0.1 mM 
IPTG using the pTrc plasmids. All protein samples were taken from 2ml of OD600 1 
culture. Arrows are pointing at the GroES protein band. Arrows are pointing at GroES while 
Cpn60.1 is circled.  
Lane 1- Prestained protein marker (Fermentas) 
Lane 2- MGM100/ pTrc-GroES-Cpn60.1 
Lane 3- MGM100/ pTrc-GroES-Cpn60.2 
Lane 4- MGM100/ pTrc-GroES-GroEL 
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Fig 3.10: SDS-PAGE gel showing the slight increase in expression of the ATG from of 
Cpn10 from the plasmid ATG-Cpn10-60.2 as compared with the original Cpn10-60.2 
plasmid. All the samples were taken from 2ml of OD600 1 MGM100 culture with 0.2% 
arabinose and 0.1 mM IPTG. Black arrows are pointing at Cpn10 band, red arrows are 
pointing at Cpn60.2, the green arrow is pointing at GroES, and the yellow arrow is pointing 
at GroEL. 
Lane 1- Prestained protein marker (Fermentas) 
Lane 2- MGM100/ Original pTrc-Cpn10-60.2  
Lane 3- MGM100/ pTrc-ATG-Cpn10-60.2  
Lane 4- MGM100/ pTrc99a vector (negative control) 
Lane 5- MGM100/ pTrc-GroES-GroEL  
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Fig 3.11: SDS-PAGE gel of ATG-Cpn10-60.1 showing no increase in expression in 
MGM100 with 0.2% arabinose and 0.1 mM IPTG. The protein samples were taken from 
1ml of OD600 0.5 cultures.  
Lane 1- Prestained protein marker (Fermentas) 
Lane 2- Original pTrc-Cpn10-60.1 
Lane 3- pTrc-ATG-Cpn10-60.1 
Lane 4- pTrc99a vector  
Lane 5- pTrc-GroES-GroEL 
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 30°C/26°C 37°C 
MGM100 
Arabinose 
– IPTG 
Arabinose + 
IPTG 
Glucose – 
IPTG 
Glucose + 
IPTG 
Arabinose - 
IPTG 
Arabinose 
+ IPTG 
Glucose – 
IPTG 
Glucose + 
IPTG 
         
Original 
Cpn10 + 
Cpn60.1 +++ +++ - - +++ +++ - - 
ATG      
Cpn10 + 
Cpn60.1 +++ +++ - - +++ +++ - - 
Original  
Cpn10 + 
Cpn60.2 +++ ++ - +++ +++ +++ - +++ 
ATG      
Cpn10 + 
Cpn60.2 +++ ++ + +++ +++ +++ + +++ 
pTrc 
Vector +++ +++ - - +++ +++ - - 
GroES + 
GroEL +++ + +++ + +++ + +++ + 
 
Table 3.4: A summary of the complementation data of ATG-Cpn10 when expressed 
with Cpn60.1 and Cpn60.2 in MGM100. 
+++   Denotes 10 – 100 % survival  - Complete complementation 
++     Denotes 1 – 10 % survival     - Partial complementation 
+       Denotes 0.1 – 1 % survival     - Partial complementation 
-        Denotes <0.1 % survival       - No complementation 
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3.5 Random mutagenesis of Cpn60.1 
It is already know that in E. coli a relatively small concentration of GroEL is needed to 
sustain cell growth at 37°C (Herendeen et al., 1979, VanBogelen et al., 1987, Lorimer, 
1996).  It was discussed in section 3.1 that even after 3 hours of being induced with 
arabinose, GroEL bands could not be distinguished on the SDS-PAGE gel without using 
western blots. Although attempts to improve the overall level of expression of Cpn60.1 in the 
last few experiments were unsuccessful, it can still be speculated that, if Cpn60.1 could 
function as a replacement for GroEL in E. coli then the level of expression seen in MGM100 
with GroES should have been sufficient to do so. However, it is unknown how active 
Cpn60.1 is compared with GroEL, so it is possible that if its activity is much lower than 
GroEL then a higher concentration of Cpn60.1 would be needed to complement. 
 
All the experiments done so far on Cpn60.1 have shown that it cannot complement in E. coli 
in the absence of endogenous GroEL, while Cpn60.2 is very capable of sustaining cell growth 
up to 37°C. Cpn60.1 and Cpn60.2 share 61% sequence identity and 76% sequence similarity 
(Fig 3.12). It was hypothesised that it may be possible to obtain a functional form of Cpn60.1 
that could complement for the loss of endogenous GroEL in E. coli MGM100 with random 
mutagenesis. For this reason, the XL1-Red E. coli strain provided by Agilent technologies 
(formerly Stratagene) was used to mutagenise cpn60.1. This E. coli strain is deficient in three 
of the primary DNA repair pathways and according to its manufacturer, has a mutation rate 
~5000 fold higher than that of wild-type. Unfortunately, after several attempts, no such 
mutants were found. 
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Fig 3.12: Comparison of the amino acid sequence of M. tuberculosis chaperonins. The 
asterisk indicates identical residues, a colon indicates a conserved substitution, and a full stop 
indicates a semi conserved substitution. The sequence was aligned with the help of 
ClustalW2 on the European Bioinformatics Institute website. 
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3.6 Complementation of M. tuberculosis and M. smegmatis Cpn60.2 in ΔgroEL AI90 
All the results so far have supported the understanding that Cpn60.2 is the main house-
keeping chaperonin of Mycobacteria. In this chapter it has been shown that Cpn60.2 can 
function very well in E. coli MGM100 and Tab21. However, in all these experiments it was 
possible that the PBAD promoter was a little leaky and that there was just enough GroEL 
present within the cell, when grown on glucose, that it was capable of functioning along with 
Cpn60.2 and sustaining cell growth.  A lab colleague, Andrew Large, was able to show that 
MGM100 cells grown on glucose did have very small amounts of residual GroEL by heavily 
overloading SDS-PAGE gels and western blotting. So, to better test the hypothesis that 
Cpn60.2 can fully complement in E. coli in the absence of endogenous GroEL, the 
chromosomally encoded groEL gene would need to be removed from E. coli.  
 
For this experiment the ΔgroEL strain, AI90, was used (Ivic et al., 1997). In this strain the 
groES and groEL genes are present on the pACYC plasmid (pACYC-Ptrc-GroESL-SacB), as 
it is not possible to delete the groEL gene without providing a complementing copy. It has 
been shown that the sacB gene expression in gram negative bacteria like E. coli confers 
sucrose sensitivity (Gay et al., 1985). When AI90 is grown on sucrose, it allows for the 
selection of cells that no longer posses the sacB gene. In a lot of these cases, it is achieved 
with the removal of the pACYC plasmid from the cells prior to the selection process. In such 
a case, the AI90 strain would only grow if pACYC was displaced with a plasmid carrying 
chaperonins capable of functioning in the complete absence of GroEL (plasmid shuffling). It 
was expected that both M. tuberculosis and M. smegmatis Cpn60.2 would be able to rescue 
cell growth in the complete absence of GroEL, as it had also been shown (T. Rao, PhD thesis) 
that Cpn60.2 from M. smegmatis could complement in MGM100. 
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AI90/pACYC-Ptrc-GroESL-SacB was transformed with the pTrc-GroES-Cpn60.2 constructs, 
the pTr99a vector, the pTrc-GroES-GroEL construct, and also pOFESL (constitutively 
expresses GroES and GroEL) using the protocol described in section 2.4.16. The cells were 
then grown over night in LB with 100µg/ml ampicillin, 50µg/ml chloramphenicol, and 0.1 
mM IPTG. The following day the cultures were serially diluted and plated out on selectable 
plates with and without sucrose at 30°C and 37°C (fig 3.13).  
 
The results showed that in the presence of sucrose and chloramphenicol none of the strains 
grew (fig 3.13a). This was expected, as the presence of sucrose causes the pACYC plasmid to 
be removed from the cell, and since this plasmid confers chloramphenicol resistance, its 
absence results in cell death. On plate (b) where there is no sucrose present, all the cells grew 
as the pACYC plasmid expressing the endogenous groES and groEL gene was still present. 
Finally on plate (c) in presence of sucrose and ampicillin, but in the absence of 
chloramphenicol, the positive controls along with the Cpn60.2 constructs were able to grow.  
 
To confirm the absence of GroEL from the colonies that were present on the plates, colony 
PCR was done using primers that were specific to the N-terminal region of GroEL (fig 3.14). 
The PCR yields a ~570bp fragment if GroEL is present in the cells, as can been seen in lane 2 
of figure 3.14, which is a colony PCR of a DH5α strain. The negative control for this PCR 
involved the use of a plasmid expressing Methanococcus maripaludis CCT, which is capable 
of complementing in E. coli (Andrew Large, personal communication). The results confirm 
that there was no GroEL present within the complemented strains. These results proved that 
both M. tuberculosis and M. smegmatis Cpn60.2 are capable of complementing in the 
complete absence of endogenous GroEL.  
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Fig 3.13: Images showing complementation of Cpn60.2 from M. smegmatis and M. 
tuberculosis in AI90 at 37 deg Celsius. A) Cells plated on LB with 10% sucrose, 100µg/ml 
ampicillin, 50µg/ml chloramphenicol, and 0.1 mM IPTG. B) Cells plated on LB with 
100µg/ml ampicillin, 50µg/ml chloramphenicol, and 0.1 mM IPTG. C) Cells plated on LB 
with 10% sucrose, 100µg/ml ampicillin, and 0.1 mM IPTG. 
1- AI90/ pOFESL  
2- AI90/ pTrc99a vector 
3- AI90/ pTrc-GroES-GroEL 
4- AI90/ pTrc-GroEs-Cpn60.2 (M. smegmatis) 
5- AI90/ pTrc-GroES-Cpn60.2 (M. tuberculosis) 
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Fig 3.14: PCR using groEL-specific primers. The protocol used for colony PCR is 
described in section 2.4.13. 
Lane 1- Kilobase ladder – Hyper ladder I (Bioline) 
Lane 2- DH5α (positive control) 
Lane 3- CCT (negative control) 
Lane 4- Cpn60.2 (M. smegmatis) 
Lane 5- Cpn60.2 (M. tuberculosis) 
Lane 6- Cpn60.2 (M. smegmatis) 
Lane 7- Cpn60.2 (M. tuberculosis) 
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3.7        Complementation by M. tuberculosis Cpn60.2 without a cochaperonin 
Throughout this chapter it was assumed that Cpn60.2 functions along with GroES and Cpn10 
to complement in E. coli. However, the ability of Cpn60.2 to function on its own has never 
been tested, even though it is known that in M. tuberculosis Cpn60.1 and Cpn10 constitute an 
operon while Cpn60.2 is arranged separately on the genome. It is unclear why the main 
house-keeping chaperonin is not present on the same operon as its cochaperonin. In this 
section, the ability of Cpn60.2 to complement in the absence of any cochaperonin was 
analysed. It was hypothesised that Cpn60.2 needs a cochaperonin to function.  
  
For the purpose of this experiment the groES gene from the pTrc-GroES-Cpn60.2 plasmid 
was removed. Sequence analysis reviled that there was an NcoI site just upstream from the 
groES gene and an XbaI site just downstream. Restriction digest was done with both these 
enzymes as per the protocol described in section 2.4.8. The digested sample was then run on 
a 1% agarose gel and the backbone vector, excluding the GroES fragment, was gel extracted. 
This fragment was blunt ended with Klenow and then religated. The resultant pTrc-Cpn60.2 
plasmid was transformed into MGM100 for the complementation and expression analysis. It 
was predicted that in the absence of any cochaperonin, Cpn60.2 would not be able to 
complement for the loss of endogenous GroEL in E. coli. 
 
The results that were obtained showed that in the presence of arabinose the strain grew well, 
but in the presence of glucose only the strain carrying both the chaperonin and cochaperonin 
was able to complement. To ensure the lack of complementation was not caused by the lack 
of expression, SDS-PAGE gels were run.  The gel showed that Cpn60.2 was being over-
expressed without GroES. This confirmed the hypothesis that Cpn60.2 cannot function 
without a cochaperonin. 
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Fig 3.15: Complementation and expression of pTrc-60.2.  
(a) Lack of complementation of pTrc-Cpn60.2 in MGM100 at 30°C in the presence of 
0.2% glucose and 0.1 mM IPTG. 1- MGM100 pTrc-GroES-Cpn60.2; 2- MGM100 
pTrc-Cpn60.2; 3- MGM100 pTrc-GroES-GroEL; 4- MGM100 pTrc99a. 
(b) & (c) SDS-PAGE showing over-expression of Cpn60.2, and lack of expression of 
GroES. Samples were taken from MGM100 cultures after 5 hours incubation in 0.2% 
arabinose. Every even numbered lane has no IPTG and every odd numbered lane has 
0.1 mM IPTG. Lane 1- Prestained protein marker (Fermentas); Lane 2 & 3- pTrc-
GroES-Cpn60.2; Lane 4 & 5- pTrc-Cpn60.2; Lane 6 & 7- pTrc99a. 
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Discussion 
It has been estimated that approximately 10% of the cellular proteins in E. coli interact with 
GroEL under normal conditions (Houry et al., 1999, Kerner et al., 2005). MetF and MetK are 
two of those proteins. It is known that the metE gene is repressed by MetF and MetK both of 
which have been found to be obligate GroEL substrates (Kerner et al., 2005), so the lack of 
GroEL in the cell would result in the over-expression of MetE (Chapman et al., 2006). This 
observation was confirmed in earlier experiments conducted in the lab, where the levels of 
MetE started to increase during the reduction of endogenous GroEL. In the results obtained 
here, MetE was distinguishable on the gels when the endogenous GroEL was suppressed. 
This result is interesting as it proved to be a very useful marker for the reduction or loss of 
function of GroEL in the cells. The main reason why no MetE induction was observed on the 
majority of protein gels shown in this chapter was because all the samples were taken from 
cells grown in arabinose, which does not repress the expression of GroEL. As such, these 
samples had enough GroEL present within them to stop the aggregation of MetE. However, 
MetE induction could be seen from cells containing Cpn60.1 (both with GroES and Cpn10) 
when the protein samples were made from cultures grown on glucose (fig 3.4b).  
When the multiple groEL genes were found in Mycobacterium tuberculosis it was unknown 
why such a system would be needed. It was initially thought that since cpn60.1 gene was in 
the same operon as the cochaperonin cpn10, it would be the house-keeping chaperonin. 
However, it was found that this is not the case, and that Cpn60.1 is not required by M. 
tuberculosis for its survival (Hu et al., 2008). Earlier work conducted in the lab suggested 
that when M. tuberculosis Cpn60.1 and Cpn60.2 were introduced into E. coli and the 
endogenous GroEL expression was suppressed, only the cells with Cpn60.2 were able to 
survive. The results that have been obtained from the experiments in this chapter agree with 
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this observation. The results show that only Cpn60.2 and not Cpn60.1 is able to complement 
for the loss of endogenous GroEL in E. coli. It also shows that the cochaperonin Cpn10 is 
capable of functioning together with Cpn60.2 in E. coli. This result agrees with the 
understanding that Cpn60.2 is the main house-keeping chaperonin in Mycobacterium 
tuberculosis, while Cpn60.1 seems to have been adapted to play a role in other cellular 
functions. It is already known that Cpn60.1 has very potent cytokine properties as compared 
with Cpn60.2 (Lewthwaite et al., 2001). So it is very probable that, with regards to M. 
tuberculosis, the Cpn60.1 is in fact a very important factor in the causation of infection. 
Further experiments will need to be done to determine the reasons behind the differences in 
the overall function of these chaperonins. One of these experiments involves domain swaps 
between the M. tuberculosis chaperonins and E. coli chaperonins and has been discussed in 
chapter 4. 
While there may be an issue of low levels of protein expression for Cpn60.1, the use of IPTG 
at higher concentrations showed that sustained high levels of chaperonins can be lethal for 
cell survival. The addition of IPTG at a concentration of 0.5 mM showed a loss in the number 
of viable cells with the combinations which otherwise would have complemented without 
IPTG. The use of the pBAD system while providing a good solution to suppress any 
background expression of endogenous GroEL, has resulted in the loss of MGM100 being 
able to control the expression of the homologues according to its requirements. As a result, it 
may have proved deleterious when expressed at very high levels. Since chaperonins like 
GroEL use hydrophobic residues to interact with substrates, it can be speculated that when 
GroEL is expressed at higher than needed levels they may interact with substrates other than 
their own, some of which could be vital for cell survival. In such a case if GroEL is unable to 
properly fold these proteins and instead just traps them, then over a period of time the lack of 
these essential proteins would lead to cell death. Reducing the concentration of IPTG, and in 
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doing so, reducing the over-expression of the chaperonins resulted in better cell growth and 
better complementation.  
It is known that E. coli codon usage differs from Mycobacterial codon usage (Pan et al., 
1998, Sharp et al., 2005). As a result, the GroEL homologues may not be expressing as well 
in E. coli as they would have been in Mycobacterium tuberculosis. To ensure no codon bias 
was involved in the expression of the chaperonins, the plasmid pRARE was used in section 
3.2.2. This pRARE plasmid encodes tRNAs for codons that rarely occur in E. coli. The 
results that were obtained, however, showed no difference to the original complementation 
data. Under appropriate conditions Cpn60.2 complemented well for the loss of endogenous 
GroEL, while Cpn60.1 showed no signs of increased expression or any signs of 
complementation. This result was not surprising as it was shown that Cpn60.2 could 
complement in E. coli without the pRARE plasmid in section 3.2. So the lack of 
complementation by Cpn60.1 was assumed to be its inability to function in E. coli rather than 
its reduced expression. However, low expression as the cause of lack of complementation 
was not formally ruled out.  
Results in Tab21 were the same as those in MGM100. The lack of complementation by 
Cpn60.1 could still be speculated to be due to low levels of protein expression within the 
cells. However, a key point to note here is that, while the expression of the Mycobacterial 
chaperonin 60.1 may have been too low to allow complementation, it was still higher than 
that of GroEL under normal cellular conditions. One method of trying to increase the protein 
expression further was by transferring the genes onto a pET vector. This vector has a T7 
RNA polymerase promoter and will increase the expression levels of any gene located 
downstream when induced with T7 RNA polymerase.  Since Tab21 has a T7 RNA 
polymerase gene, it should have, at least theoretically, resulted in higher levels of protein 
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expression. However, from the results obtained it was observed that the protein expression 
levels were lower than that achieved by the pTrc plasmids in MGM100. As has already been 
discussed, an accurate complementation analysis could not be done as cell growth was 
extremely slow on solid media with glucose and arabinose. A possible reason could be that in 
the presence of glucose, Cpn60.1 is not capable of complementing for the loss of GroEL and 
the loss of the cells ability to express its endogenous GroEL resulted in cell death. In the 
presence of arabinose however, the reason is unclear. As discussed in sections 3.2 and 3.3, it 
was only the Cpn10-60.1 combination that did not show any prominent increase in 
expression. Further work will need to be done to understand why it is that this particular 
combination of chaperonin/cochaperonin fails to express at higher levels and if possible to try 
and achieve levels of expression matching those seen in the other chaperonin/cochaperonin 
combinations. 
In this chapter the cochaperonins were also analysed. The experiments tested the ability of 
GroES to function with the Mycobacterial homologues, while also testing the ability of 
Cpn10 to function in E. coli. It was shown that that GroES can function as a cochaperonin for 
Mycobacterial chaperonins and also that Cpn10 can function as a cochaperonin in E. coli. 
However, from sequencing data it was noted that the starting codon for Cpn10 was valine 
rather than methionine, which is less prominent as a start codon. It was hypothesised that the 
starting codon of Cpn10 may not allow the ribosome to form a strong enough initiation 
complex resulting in lower expression of Cpn60.1, which is just downstream from Cpn10 
(Sussman et al., 1996). However, this does not explain why Cpn60.2 when co-expressed with 
Cpn10 had much higher expression levels. Even so, it could be speculated that Cpn60.1 needs 
the Mycobacterial cochaperonin to function. In such a case, over-expression of Cpn60.1 in 
the presence of GroES may not yield a fully functional chaperonin. Since it was only possible 
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to distinguish over-expression of Cpn60.1 in the presence of GroES, attempts were made to 
try and increase the expression of Cpn60.1 along with Cpn10. The results showed that the 
complementation data with the ATG form of Cpn10 was unaltered. It also showed that 
changing the start codon of Cpn10 only slightly increased the expression of cochaperonin but 
had no affects on the expression levels of the chaperonins downstream from it.  
Even attempts made at muteganising Cpn60.1 using XL1-Red did not yield any desirable 
products. There is however some issues with this experiment, including the fact that the pTrc-
GroES-Cpn60.1 plasmid was only passaged once through the XL1-Red strain. Although it’s a 
highly mutagenic strain, the difference between Cpn60.1 and Cpn60.2 may be large enough 
to require more than a few mutations, and as such may need to be mutagenised multiple 
times. In the end, no desired Cpn60.1 mutant could be found. Future work in this regard 
could also make use of other mutagenic chemicals such as hydroxylamine or error prone 
PCR. 
The aim of this study was to characterize the functional properties of Cpn60.1 and Cpn60.2. 
From all the results obtained here it has become evident that even though Cpn60.1 can be 
expressed at a higher than basal levels of GroEL, it still fails to complement. Cpn60.2 on the 
other hand complements extremely well both with Cpn10 and GroES, suggesting it is the 
main house-keeping chaperonin in Mycobacteria. This was confirmed with the 
complementation tests done in the ΔgroEL strain AI90. It proved that Cpn60.2 from both M. 
tuberculosis and M. smegmatis can function along with GroES in E. coli in the complete 
absence of GroEL.  
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This laminated page contains the table listing all the chimeras that were attempted in 
this chapter. Please detach the page and use it as a reference while reading through the 
results, as only the names of the constructs will be used. 
 
The white, orange, and black bars above the chimeric bars represent the approximate location 
of the equatorial, intermediate, and apical domains respectively.  
Name Construct 
GroEL amino 
acid seqs. 
Cpn60.1 amino 
acid seqs. 
Cpn60.2 amino 
acid seqs. 
  
Blue –Cpn60.2; Red -  Cpn60.1;  
Green – GroEL        
          
 
AHC 
 
 
144-403 
 
1-143; 404-542 
 
GBI 
 
 
1-144; 405-548 
 
145-504 
 
JNL 
 
 
192-375 
 
1-191; 376-541 
 
MKO 
 
 
1-191; 376-541 
 
192-375 
  
   
 
DHF 
 
 
144-403 1-143; 404-541 
 
 
     GEI 
 
 
1-144; 405-548 145-404 
 
 
PNR 
 
 
192-375 1-191; 376-540 
 
 
MQO 
 
 
1-191; 376-549 192-375 
 
  
   
 
AEC 
 
  
144-403 1-143; 404-541 
 
PKR 
 
  
1-191; 376-549 192-375 
 
DBF 
 
  
1-143; 404-541 144-402 
 
JQL 
 
  
192-375 1-191; 376-541 
Chapter 4 
144 
 
Background                                                                                                         
In the last chapter I showed that Cpn60.2 from M. tuberculosis can function in E. coli in the 
absence of endogenous GroEL. It was also demonstrated that Cpn60.1 was unable to do the 
same. As a result, it was concluded that there was a possibility of the chaperonins being 
specialised to fulfil specific functions within M. tuberculosis, such that only Cpn60.2 could 
function as the main house-keeping chaperone. There are a number of references that support 
this idea in Actinobacteria (Hu et al., 2008, Kim et al., 2003, Ojha et al., 2005, Qamra et al., 
2005, Cehovin et al., 2010). 
In most cases, chaperonins are large oligomeric complexes with a cage like structure. This 
allows substrate proteins to fold within the cavity without being subjected to interference by 
other complexes (Horwich et al., 2006). Although it has already been shown that Cpn60.2 
can complement in E. coli, one of the aspects of chaperonin function that we did not look at 
in the last chapter was structural stability, as in, the ability of the chaperonins to maintain 
higher oligomeric structures. It has been reported that that the Mycobacterial chaperonins 
have a tendency to exist as lower oligomers (Qamra et al., 2004). However, since Cpn60.2 
can function in E. coli in the absence of GroEL, it can be predicted that Cpn60.2 should be 
forming some higher oligomeric structure during its reaction cycle, even if it is very unstable. 
This was shown to be the case in some recent experiments done in our lab where Cpn60.2 
was analysed using AUC in various buffer conditions. It was noted that under high salt 
conditions and in the presence of either ATP or ADP Cpn60.2 does form larger oligomeric 
structures and this was confirmed to be tetradecameric by MS (Elsa Zacco, University of 
Birmingham; Dr. J Freeke and Dr. J Benesch, University of Oxford). This was also supported 
by the fact that Cpn60.2 can function with both Cpn10 and GroES, both of which are known 
to oligomerise as heptamers (Roberts et al., 2003, Hunt et al., 1996). Another aspect that 
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could determine the complementation ability of chaperonins is substrate specificity. As both 
chaperonins have evolved at different rates (Hughes, 1993), and have been shown to perform 
different functions in M. tuberculosis (Hu et al., 2008), there is a possibility that they can 
recognise a different set of substrates.  
This chapter will be focusing on two primary objectives. Firstly, to attempt to change the 
substrate specificity of Cpn60.1 such that it is then able to function in E. coli. Secondly, to 
see if it is possible to improve the unstable oligomeric nature of the M. tuberculosis 
chaperonins and to see how this affects their function in E. coli. To try and achieve these 
objectives, I decided to make chimeric proteins using domain swap techniques. The plan was 
to swap the apical domains of the three chaperonins between each other. In the process of 
doing so, I would also in effect be making chimeras where the equatorial and intermediate 
domains were being swapped. It was hypothesised that the apical domain of GroEL or 
Cpn60.2, if swapped with the apical domain of Cpn60.1 would allow the chimeric Cpn60.1 to 
recognise and fold GroEL substrates. It was also hypothesised that the domain swaps between 
GroEL and Cpn60.2 would improve the oligomeric stability of the Cpn60.2 chaperonin when 
the equatorial domain of GroEL is present in the chimera. 
As such it was predicted that apical domain swap between the chaperonins would confer the 
ability to complement in cases where they normally wouldn’t, and also that the swapped 
equatorial regions would result in higher stability in the oligomeric forms of the chaperonins.  
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Experimental design 
To make the various chimeric proteins, a modified PCR extension technique was used 
(Warrens et al., 1997)(Fig 4.1). The general protocol involved the use of specifically designed 
primers that had overlapping sequences, which allows the amplification of the different 
domains from the chaperonin sequence.  
 
Using GroEL as an example, the equatorial domain is present at the two extremities of the 
chaperonin polypeptide and consists of amino acid residues 6 to 133 and 409 to 523. The 
intermediate domain that links the equatorial and apical domains of GroEL also spans two 
regions of the polypeptide and includes residues 134 to 190 and 377 to 408. The apical 
domain is present in the centre of the polypeptide chain and constitutes residues 191 to 376. 
The different sections would then be annealed together in the required order and amplified 
further. The details of primers, numbered 1 to 54, used in this chapter are listed in the 
material and methods section.  
 
Using Cpn60.2 (referred to as ABC) and Cpn60.1 (referred to as DEF) as examples, the 
process has been outlined in the figure below (fig 4.1). The first PCR amplifies the three 
sections of the chaperonin while leaving 12bp overhangs that were designed to overlap the 
equivalent regions on the other chaperonin. Sections B and E constitutes the apical domain of 
Cpn60.2 and Cpn60.1 respectively, while sections A, C, and D, F constitute the equatorial and 
intermediate domains. For the 2
nd
 PCR stage, the required sections from the 1
st
 PCR stage 
were mixed and used as templates. This template was then amplified further with appropriate 
primers. In the 3
rd
 and final PCR step the products from the 2
nd
 PCR step and the final 
remaining section from the 1
st
 PCR step were combined to complete the sequence and 
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introduce the apical domain of one chaperonin into the sequence of the other. The resulting 
chimera was then amplified using the original flanking primers and purified for the cloning 
process.  
 
Since I already had plasmids with the original chaperonins and cochaperonins under the 
control of the IPTG inducible promoter, it was decided that rather than trying to clone the 
entire PCR product into a new plasmid, the chimeras would be swapped with the chaperonins 
using specific restriction enzymes. The restriction enzymes used were picked based on the 
protein sequences to find sites that would only be cut once at either side of the apical domain, 
but also ensured that the digested fragment contained the swapped domains (fig 4.2). For 
Cpn60.2 the restriction enzymes were BamHI and BsmI, for Cpn60.1 they were Bsu36I and 
BmgBI, and for GroEL they were BstBI and DraIII. The plasmids used for the cloning 
process were pTrc-GroES-Cpn60.1, pTrc-GroES-Cpn60.2, and pTrc-GroES-GroEL. Once 
cloned, the plasmids were sequenced to ensure there were no errors present in the genetic 
sequence and that the required swaps had been made. 
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Fig 4.1: Schematic representation of the steps involved in constructing chimeric proteins 
using a modified PCR extension technique (not to scale). The red bar represents the 
sequence for Cpn60.1, while the blue bar represents Cpn60.2. The central segment of each 
bar is the location of the apical domain sequence, represented by B and E for Cpn60.2 and 
Cpn60.1 respectively. The segments on either side of the apical domain include both the 
intermediate domain and the equatorial domain. 
 
Cpn60.2 Cpn60.1 
1 2 3 
4 5 6 
7 8 9 
10 11 12 
7 
5 
1 
11 
7 
12 6 
1 
Cpn60.2 with the apical domain 
of Cpn60.1 
Cpn60.1 with the apical domain 
of Cpn60.2 
Apical domain Apical domain 
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Fig 4.2: Schematic representation of the cloning process of the chaperonin chimeras. In 
all cases the chimeras were cloned into pTrc plasmids with GroES as the cochaperone. The 
restriction enzymes used for Cpn60.1 as mentioned were Bsu36I and BmgBI, while for 
Cpn60.2 they were BamHI and BsmI. For GroEL, the sites used were BstBI and DraIII. The 
backbone and insert were then ligated to obtain the required plasmids and transformed into 
DH5α. 
pTrc-groES-cpn60.1          
6.5 kb 
groES 
cpn60.1(1.6kb) 
pTrc-groES-cpn60.1          
6.5 kb 
groES 
cpn60.2(1.6kb) 
A E C D B F 
Bsu36I BmgBI 
Bsu36I BmgBI 
BamHI BsmI 
BamHI BsmI 
Digest plasmid and 
PCR product with 
Bsu36I and BmgBI, 
then ligate. 
Digest plasmid and 
PCR product with 
BamHI and BsmI, 
then ligate. 
pTrc-groES-DBF          
6.5 kb 
groES 
DBF (1.6kb) 
pTrc-groES-AEC          
6.5 kb 
groES 
AEC (1.6kb) 
Transformed into DH5α 
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The full list of all the chimeras that were attempted for this chapter have been shown below 
in table 4.1. In these experiments, two different groups of chimeras were attempted. Initially, 
I constructed chimeras where the apical domains and segments of the intermediate domains 
were swapped. These swaps were attempted as a result of similar work done on 
mitochondrial chaperonin by Nielsen and Cowan (Nielsen & Cowan, 1998). In these 
chimeras the junction points of the fusions were at I144 and A405 for GroEL and I143 and 
A403 for Cpn60.1 and Cpn60.2. For the purpose of this chapter, this group of chimeras will 
be referred to as imprecise chimeras (due to the imprecise nature of the apical domain swap). 
The complementation and expression results obtained from these chimeras can be seen in 
section 4.1. After the construction of these chimeras it was noted that the inclusion of partial 
segments of the intermediate domain, rather than the entire domain, was causing issues 
during the chaperonin cycle. In some cases this would result in cell death, while in others the 
complete loss of ability to function where they would not be expected to. To ensure that the 
results of these experiments were not being influenced by the inclusion of a partial segment 
of the intermediate domain, it was decided that a second group of chimeras, where only the 
apical domain was precisely swapped, would be made. The junction points for the fusions of 
the precise domain swaps were at E191 and V377 for GroEL and G190 and V376 for 
Cpn60.1 and Cpn60.2. For the remainder of this chapter, these chimeras will be referred to as 
precise chimeras (due to the precise nature of the apical domain swaps). The 
complementation and expression results of these chimeras can be seen in section 4.2.  
 
Using these chimeric proteins, attempts were made to ascertain the roles played by the apical 
and equatorial domains in the functional and structural properties of chaperonins. The table 
below lists all the chimeras attempted, and a simple hypothesis associated with each one. 
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Name Construct 
GroEL amino 
acid seqs. 
Cpn60.1 
amino acid 
seqs. 
Cpn60.2 
amino acid 
seqs. 
Expected to 
complement? 
Expected to 
oligomerise? 
  
Blue –Cpn60.2; Red -  Cpn60.1;  
Green – GroEL            
              
 
AHC 
 
 
144-403 
 
1-143; 404-542 Yes No 
 
GBI 
 
 
1-144; 405-548 
 
145-504 Yes Yes 
 
JNL 
 
 
192-375 
 
1-191; 376-541 Yes No 
 
MKO 
 
 
1-191; 376-541 
 
192-375 Yes Yes 
  
     
 
DHF 
 
 
144-403 1-143; 404-541 
 
Yes No 
 
GEI 
 
 
1-144; 405-548 145-404 
 
No Yes 
 
PNR 
 
 
192-375 1-191; 376-540 
 
Yes No 
 
MQO 
 
 
1-191; 376-549 192-375 
 
No Yes 
        
AEC 
 
  
144-403 1-143; 404-541 No No 
 
JQL 
 
  
192-375 1-191; 376-541 No No 
 
PKR 
 
  
1-191; 376-549 192-375 Yes No 
 
DBF 
 
  
1-143; 404-541 144-402 Yes No 
Table 4.1: The list of chimeric chaperonins made. The white, orange, and black bars above the chimeric bars represent the approximate 
location of the equatorial, intermediate, and apical domains, respectively. The table also includes some predictions on the functional and structural 
properties. 
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4.1 Imprecise domain swaps 
As discussed above, the first group of domain swaps were imprecise. The segments that were 
swapped included not only the apical domain but also a large part of the intermediate domain. 
These chimeras were constructed so that the junctions between the different genes were in the 
same relative positions as those described in a study which used chimeras between GroEL 
and the mitochondrial protein Hsp60 (Nielsen & Cowan, 1998). Since the PCR protocol used 
in the construction of all the imprecise chimeras was the same, a representative example of 
this approach is shown in figure 4.3, using Cpn60.2 (ABC) and GroEL (GHI) as examples. A 
schematic representation of this process has been shown in figure 4.1. 
 
The first PCR resulted in 3 segments being amplified from each chaperonin (fig 4.3a). The 
first band constituted the N-terminal equatorial domain sequence and a small section of the 
intermediate domain sequence. The second band included the remainder of the N-terminal 
intermediate domain sequence, the entire apical domain sequence, and a large section of the 
C-terminal intermediate domain sequence. The third band included the remaining sequence of 
the C-terminal intermediate and equatorial domains. The bands were then gel extracted using 
the protocol described in section 2.4 and used in the next reaction. For the second PCR the 
products of the first reaction were used as the templates, and then amplified further for the 
third and final reaction (fig 4.3b). The final reaction combines the product of the second PCR 
with the remaining C-terminal product of the first reaction and resulted in the completed 
chimera (fig4.3c). This was then cloned into the pTrc plasmids using restriction digests, as 
described above, and then transformed into DH5α using the protocol described in section 
2.4.16. Every construct was then sequenced to ensure the swaps were made at the right 
points, and did not have any undesired mutations.  
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Fig 4.3: Agarose gel for each of the 3 PCRs for Cpn60.2 (ABC) and GroEL (GHI). (a) 
The three bands obtained from the first PCR for each chaperonin. (b) Single band obtained 
after the second PCR. (c) The third PCR yields the final combination of chimera. 
 
 
 
 
(a) 
(b) (c) 
800bp 
400bp 
800bp 
400bp 
1500bp 
1000bp 
1500bp 
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4.1.1  Chimera AEC  
This is a chimera where an imprecise domain swap has been made between Cpn60.2 and 
Cpn60.1. In this chimera the equatorial domain sequence and a partial segment of the 
intermediate domain sequence are from Cpn60.2 while the apical domain sequence and the 
remainder of the intermediate domain sequence come from Cpn60.1.  
 
This chimera was cloned into pTrc99A, to give the plasmid pTrc-GroES-AEC, and was 
sequenced to confirm the junctions between cpn60.1 and cpn60.2, and that no other mutations 
were present. This pTrc plasmid was then transformed into MGM100 to test its ability to 
complement in E. coli. It was hypothesised that the introduction of the apical domain from 
Cpn60.1 into Cpn60.2 would result in this chimera failing to complement for the loss of 
endogenous GroEL because the apical domain from Cpn60.1 is unable to recognise the same 
substrates as Cpn60.2.  
 
The complementation protocol was the same as that used in the last chapter. The resultant 
MGM100 + pTrc strain was grown overnight in arabinose, then sub-cultured and grown in 
200 ml LB + 0.2% glucose the following morning for 2 hours, and then serially diluted (in 
ten-fold steps) to spot on to square petri dishes. 5µl of each dilution was spotted onto the 
plates with the final dilution factor being 10
7. 
 The plates were then incubated at 37°C, 30°C, 
and 26°C. Proteins samples were prepared from the same cultures and run on SDS-PAGE 
gels to check expression.  
 
 The results obtained from the complementation plates were as expected. While the cells were 
viable in the presence of arabinose (endogenous GroEL is expressed), they were unable to 
rescue E. coli MGM100 growth in the presence of glucose (fig 4.4a). SDS-PAGE gels 
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confirmed that AEC was being expressed in the cells, so the loss of ability to function in E. 
coli was not due to lack of expression (fig 4.4b). This result supported the original hypothesis 
that the apical domain from Cpn60.1 would not be able to recognise the same substrates as 
Cpn60.2 and as such it would fail to rescue E. coli MGM100 growth. To try and confirm this 
hypothesis we made a chimera where the apical domain of Cpn60.1 was replaced with that of 
Cpn60.2. The results and discussion of this can be seen below in section 4.1.2 below. 
 
4.1.2  Chimera DBF  
In this chimera the equatorial domain sequence and a partial segment of the intermediate 
domain sequence is from Cpn60.1, while the apical domain sequence and the remainder of 
the intermediate domain sequence comes from Cpn60.2. 
 
Attempts at cloning this product into the pTrc plasmid were unsuccessful. After the digestion 
and ligation process, the pTrc plasmids were transformed into DH5α. Of the 42 clones 
screened using colony PCRs, restriction digests, and plasmid sequencing, a larger number 
had truncated sequences where approximately 200-300bp were missing from the C-terminus. 
In cases where positive colony PCR results were obtained, sequencing results showed that 
frameshift mutations had occurred. All the attempts to correct the frameshift mutations by 
using site directed mutagenesis were unsuccessful. Attempts to better control the over 
expression of this chimera using the pBAD24 plasmid was also unsuccessful. The reason for 
this is unclear. To ensure this wasn’t an issue in the protocol, the same process was used with 
the plasmid pTrc-GroES-Cpn60.1 (without any chimeric sequence) successfully. It can only 
be speculated that this chimera was lethal for the cells and as such only cells that contained 
non-functional variants were able to survive. Due to the results obtained here, the original 
hypothesis could neither be accepted, nor rejected.  
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Fig 4.4: Complementation and expression of AEC.  
(a) Lack of complementation of AEC in MGM100 at 30°C in the presence of 0.2% 
glucose and 0.1 mM IPTG. 1- MGM100 pTrc-GroES-AEC, 2- MGM100 pTrc99a,    
3- MGM100 pTrc-GroES-GroEL, 4- MGM100 pTrc-GroES-Cpn60.2. 
(b) SDS-PAGE showing over expression of AEC (circled). Samples were taken from 
cultures after 5 hours incubation with 0.1 mM IPTG and 0.2% arabinose. Lane 1- 
Prestained protein marker (Fermentas), Lane 2- MGM100 pTrc-GroES-AEC; Lane 3: 
MGM100 pTrc99a. 
Dilutions 
      10-1           10-2            10-3          10-4           10-5             10-6            10-7 
   1                  2                     3                                  
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4.1.3  Chimera AHC 
In this chimera the equatorial domain sequence and a partial segment of the intermediate 
domain sequence is from Cpn60.2, while the apical domain sequence and the remainder of 
the intermediate domain sequence comes from GroEL. 
 
This chimera was cloned into the pTrc plasmid and sequenced to ensure the appropriate swap 
has been made before being transformed into MGM100 to tests its ability to complement in 
E. coli. The protocol used for the complementation assay is the same as that used in section 
4.1.1. According to the original hypothesis, the introduction of the apical domain from GroEL 
into Cpn60.2 should not affect its ability to complement in E. coli, as it has already been 
shown that both GroEL and Cpn60.2 can function in E. coli. As such it was expected that a 
domain swap between Cpn60.2 and GroEL would also work.  
 
The results that were obtained however were unexpected. MGM100 cells containing the AHC 
chimera failed to complement in the absence of endogenous GroEL. To ensure this result was 
not due to lack of expression an SDS-PAGE gel was run. The protein samples were taken 
from cultures grown in LB with 0.2% arabinose and 0.1 mM IPTG for 5 hours. The SDS-
PAGE gels showed that AHC was being over expressed at levels that were comparable to 
those of GroEL and Cpn60.2. This indicates the lack of complementation was not being 
caused by lack of expression. It was reasoned that the imprecise nature of the domain swap 
could be resulting in the lack of complementation. As the intermediate domain of this 
chimera consisted of partial sequences from both GroEL and Cpn60.2, there is a possibility 
that it may have affected the chaperonin cycle, as the intermediate domain is vital for the 
transfer of the allosteric signal between the apical and equatorial domains. A very interesting 
point to note is that the native gel of the chimera showed a band with comparable size to that 
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of GroEL (fig 4.7). This is surprising, as it is known that the equatorial domain that is mainly 
responsible for the stability of the chaperonin structure and not the apical domain (Braig et 
al., 1994). The results obtained here suggest that a very stable oligomeric structure may not 
be necessary for function.  
 
 
 
 
 
 
Fig 4.5: Complementation and expression of AHC.  
(a) Lack of complementation of AHC in MGM100 at 30°C in the presence of 0.2% 
glucose and 0.1 mM IPTG. 1- MGM100 pTrc99a, 2- MGM100 pTrc-GroES-GroEL,    
3- MGM100 pTrc-GroES-Cpn60.2, 4- MGM100 pTrc-GroES-AHC. 
(b) SDS-PAGE gel showing over expression of AEC. Samples were taken from cultures 
after 5 hours incubation with 0.1 mM IPTG and 0.2% arabinose. Lane 1- Prestained 
protein marker (Fermentas), Lane 2- MGM100 pTrc99a; Lane 3: MGM100 pTrc-
GroES-GroEL with 0.1 mM IPTG, Lane 4: MGM100 pTrc-GroES-Cpn60.2 with 
0.1mM IPTG, Lane 5: MGM100 pTrc-GroES-AHC with 0.1 mM IPTG, Lane 6: 
MGM100 pTrc-GroES-AHC without IPTG. 
Dilutions 
      10-1           10-2            10-3           10-4           10-5             10-6            10-7 
  1                             2              3             4               5              6                      
95 kDa 
 72 kDa 
 55 kDa 
1 
2 
3 
4 
(a) 
(b) 
Chapter 4 
159 
 
 
 
4.1.4  Chimera GBI 
This chimera also consists of an imprecise domain swap between Cpn60.2 and GroEL. In this 
chimera however, the equatorial domain sequence and a partial segment of the intermediate 
domain sequence are from GroEL, while the apical domain sequence and the remainder of 
the intermediate domain sequence comes from Cpn60.2.  
 
As with AHC, it was expected that this chimera would function in E. coli MGM100. 
However, even this chimera was unable to rescue cell growth in glucose (fig 4.6a). Another 
strange result was that, on SDS-PAGE gels the protein band showed some over expression, 
but it always showed a band with a lower molecular weight (fig 4.6b). Sequence analysis 
however, showed that there were no errors in the genetic sequence. The reason for this 
unclear, but it is possible that these bands were proteolytic fragments. Also, since the 
chimera’s equatorial domain is from GroEL, it was expected that the native gel would show a 
band at around 840kDa, representing a double ring structure.  What was observed however 
was that, along with the band at around 800kDa, there were also bands present closer to 
400kDa (single ring) and a very faint band around 60-70kDa (monomer) (fig 4.7). However, 
since the chimera had partial sequences of the intermediate domain, it couldn’t be claimed 
that it was entirely due to the apical domain that the oligomeric stability of the chaperonin 
was being affected.  
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Fig 4.6: Complementation and expression of GBI.  
(a) Lack of complementation of GBI in MGM100 at 30°C in the presence of 0.2% 
glucose and 0.1 mM IPTG. 1- MGM100 pTrc-GroES-GroEL, 2- MGM100 pTrc-
GroES-Cpn60.2, 3- MGM100 pTrc99a, 4- MGM100 pTrc-GroES-GBI. 
(b) SDS-PAGE gel showing over expression of AEC. Samples were taken from cultures 
after 3 hours incubation in LB with 0.2% arabinose (with or without 0.1 mM IPTG). 
Lane 1- Prestained protein marker (Fermentas), Lane 2- MGM100 pTrc99a; Lane 3: 
MGM100 pTrc-GroES-AHC without IPTG, Lane 4: MGM100 pTrc-GroES-GBI with 
0.1 mM IPTG. 
GBI 
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Fig 4.7: Native gel of AHC and GBI. Native samples of AHC and GBI were taken from 
cells grown in LB with 0.2% glucose and induced with 0.1 mM IPTG for 4 hours. The GroEL 
native sample was from a purified stock. Lanes are described below: 
Lane 1: GroES + GBI  
Lane 2: GroES + AHC  
Lane 3: GroES + GroEL 
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4.1.5  Chimeras DHF & GEI  
For these chimeras, attempts were made to make imprecise apical domain swaps between 
GroEL and Cpn60.1. DHF is the chimera where the equatorial domain sequence and a partial 
segment of the intermediate domain sequence are from Cpn60.1, while the apical domain 
sequence and the remainder of the intermediate domain sequence come from GroEL. In GEI, 
the equatorial domain sequence and a partial segment of the intermediate domain sequence 
are from GroEL, while the apical domain sequence and the remainder of the intermediate 
domain sequence come from Cpn60.1. 
 
 Unfortunately, as was the case with DBF in section 4.1.2, it was not possible to analyse the 
functional and structural properties of DHF, as the final PCR product could not be cloned into 
the pTrc plasmid. Attempts at transforming the ligated product into DH5α predominantly 
caused cell death, while any colonies that were viable after the transformation process usually 
had frameshift mutations in their chimera sequences. To try and resolve the frameshift issue, 
site directed mutagenesis was performed using the Quickchange kit (Stratagene), as per the 
manufacturer’s instructions, to reintroduce the missing nucleotide. However, no desirable 
products were obtained. Again, it can only be speculated that the imprecise nature of the 
domain swaps may have resulted in this chimera being lethal for the cells. As a result only the 
clones with non functional chimera were viable. 
 
Chimera GEI could not be analysed as no products were obtained after the final PCR. The 
reasoning behind this is unclear, as the PCR process was largely successful up to this point. 
Altering the protocol of the reaction by using a temperature gradient, increasing and reducing 
extension times, altering the concentration of dNPTs used, and changing the ramping speed 
had no effect. New primers were also used with no effect. As such, it was decided that the 
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construction of these chimeras would be reattempted with different junction points, so that 
only the apical domain was being swapped between them. 
 
Summary of the complementation data of the imprecise domain swaps 
A summary of all the complementation data from the imprecise domain swaps has been listed 
in the table 4.2 below. 
 
 37°C 30°C/26°C 
MGM100 Arabinose Glucose – 
IPTG 
Glucose + 
IPTG 
Arabinose Glucose - 
IPTG 
Glucose+ 
IPTG 
GroES + 
AEC 
+ - - ++ - - 
GroES + 
DBF 
N/A N/A N/A N/A N/A N/A 
GroES + 
AHC 
+ - - ++ - - 
GroES + 
GBI 
++ - - +++ - - 
GroES + 
DHF 
N/A N/A N/A N/A N/A N/A 
GroES + 
GEI 
N/A N/A N/A N/A N/A N/A 
pTrc99a 
vector only 
+++ - - +++ - - 
GroES + 
GroEL 
+++ +++ +++ +++ +++ +++ 
GroES + 
Cpn60.2 
+++ +++ +++ +++ +++ +++ 
 
Table 4.2: Complementation data of imprecise domain swapped chimeric proteins in E. 
coli MGM100. The table shows the growth of cells expressing different chimeras with the 
cochaperonin GroES at different temperatures, with or without 0.1 mM IPTG.  
+++   Denotes 10 – 100 % survival  - Complete complementation 
++     Denotes 1 – 10 % survival     - Partial complementation 
+       Denotes 0.1 – 1 % survival     - Partial complementation 
-        Denotes <0.1 % survival       - No complementation 
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4.2 Precise domain swaps 
As has been discussed throughout section 4.1, the use of imprecise domain swaps could have 
caused issues in the chaperonin cycle and affected the results of the complementation assays. 
To ensure that only the apical domain from each chaperonin was swapped and that the 
intermediate domains remained unaltered, precise domain swapped chimeras were made.  
 
All the primers were redesigned for this section, but the PCR process that was used remained 
mainly unaltered from the original protocol (section 4.1). In all cases, the PCR products were 
first run on a 1% agarose gel to confirm fragment sizes and then purified before cloning (not 
shown). The restriction enzymes remained unaltered from the original protocol. 
 
 
4.2.1  Chimeras MQO and PNR 
In the chimera MQO, the equatorial and intermediate domain is from GroEL while the apical 
domain is from Cpn60.1. In PNR, the apical domain was from GroEL, while the equatorial 
and intermediate domains were from Cpn60.1.  
 
Unlike GEI, there were no issues in the PCR process or in the cloning process of MQO. The 
plasmid was also sequenced to ensure the domain swaps were made at the right junction 
points before transforming it into MGM100 for the complementation assay. The resultant 
MGM100 + pTrc strain was grown overnight in arabinose, then sub-cultured and grown in 
200 ml LB + 0.2% glucose the following morning for 2 hours. This culture was then serially 
diluted (in ten-fold steps) to spot on to square petri dishes. 5µl of each dilution was spotted 
onto the plates with the final dilution factor being 10
7. 
 The plates were then incubated at 
37°C, 30°C, and 26°C. Proteins samples were prepared from the same cultures and run on 
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SDS-PAGE gels to check expression.  
 
As was the case with the original imprecise domain swaps, it was hypothesised that the apical 
domain is responsible for substrate recognition, and that the introduction of the apical domain 
from Cpn60.1 into GroEL would result in this chimera failing to complement for the loss of 
endogenous GroEL as it is unable to recognise the same substrates as GroEL.  
 
The results obtained from the complementation plates of MQO were as expected. In the 
presence of arabinose all the cultures grew, but in the presence of glucose when endogenous 
GroEL expression is suppressed, MQO was unable to complement (fig 4.8a). The expression 
levels of MQO were examined to ensure that the lack of complementation was not due to a 
lack in expression. It was observed, on the SDS-PAGE gel, that the expression level of MQO 
was low but still present (fig 4.8b), and this was further confirmed with MS. Although its 
expression level was low, it is known that very low numbers of functional chaperonins are 
needed for normal growth (Lorimer, 1996). On the native gel, a band of approximately 
400kDa was observed, which is normally associated with a chaperonin that assembles as a 
single ring (fig 4.9). This result suggests that the apical domain may also play some role in 
the oligomeric stability of the chaperonins, as was observed with other chimeric constructs 
(section 4.1.3 and 4.1.4). However, further experiments would be needed to confirm this 
observation.  
 
From the results obtained, it was reasoned that if the lack of function was in fact due to the 
lack of ability to recognise appropriate substrates, then a reciprocal swap between GroEL and 
Cpn60.1 should yield a fully functional chimeric chaperonin. For this purpose, another 
chimera was constructed where the apical domain was from GroEL, while the equatorial and 
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intermediate domains were from Cpn60.1 (referred to as PNR). However, as was the case 
with DHF, the PCR product could not be cloned into the pTrc plasmid. No viable cells were 
obtained after transformation into DH5α.  It is known, from the experiments done with 
Cpn60.2 in chapter 3, that the chaperonin constructs on the pTrc plasmid are induced at low 
levels, even in the absence of IPTG. Since there was a possibility of this chimera being lethal 
to the cells, even low levels of expression may have been causing cell death. As such, 
attempts were made to better control its expression using the pBAD24 plasmid. The 
expression of the chimera from this plasmid can be suppressed by growing the cells on 
glucose media. Unfortunately, this method was also unsuccessful.  
 
4.2.2  Chimeras JQL and PKR  
Chimera JQL is the precise domain swap that has the equatorial and intermediate domain of 
Cpn60.2 while the apical domain is from Cpn60.1. Chimera PKR has the reciprocal swap 
with the equatorial and intermediate domains from Cpn60.1, while the apical domain is from 
Cpn60.2. Both chimeras were made without any issues, and sequenced to ensure no 
mutations were present. They were then transformed into MGM100 using the protocol 
described in 2.4.16 to test their functional properties. The complementation method used was 
unaltered from the previous experiments. 
 
These swaps were made to see if incorporating the apical domain from Cpn60.2 into Cpn60.1 
would allow it to function in E. coli, and if the reciprocal swap would prevent Cpn60.2 from 
functioning. It was hypothesised that the apical domain of Cpn60.2 would allow Cpn60.1 to 
recognise and bind to substrates that would rescue MGM100 growth, while the apical domain 
of Cpn60.1 would prevent Cpn60.2 from functioning in its regular manner. 
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Fig 4.8: Complementation and expression of MQO.  
(a) Lack of complementation of MQO in MGM100 at 30°C in the presence of 0.2% 
glucose and 0.1 mM IPTG. 1- MGM100 pTrc-GroES-MQO, 2- MGM100 pTrc-
GroES-GroEL, 3- MGM100 pTrc-GroES-Cpn60.2, 4- MGM100 pTrc99a. 
(b) SDS-PAGE gel showing minimal over expression of MQO. Samples were taken from 
cultures after 4 hours incubation with 0.1 mM IPTG and 0.2% arabinose. Lane 1- 
Prestained protein marker (Fermentas), Lane 2- MGM100 pTrc-GroES-MQO; Lane 
3: MGM100 pTrc99a, Lane 4: MGM100 pTrc-GroES-GroEL. 
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Fig 4.9: Native gel of MQO. Native samples of MQO were taken from cells grown in LB 
with 0.2% glucose and induced with 0.1 mM IPTG for 4 hours. The Cpn60.2 native sample 
was from a purified stock. Lanes are described below: 
Lane 1: GroES + Cpn60.2  
Lane 2: GroES + MQO 
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The results that were obtained showed that in the presence of arabinose and 0.1 mM IPTG, all 
MGM100 cultures except those carrying JQL were viable (fig 4.10a). In the presence of 
glucose when the endogenous GroEL is suppressed, neither of the chimeras was able to 
complement (fig 4.10b). An SDS-PAGE gel was run to ensure that the lack of 
complementation was not being caused due to the lack of expression. It is unclear why JQL 
was causing cell death in the presence of arabinose. A possibility is that JQL may be 
interacting with GroEL to form oligomers that are unable to function. Due to the results 
obtained here, it was not possible to either confirm or reject the hypothesis. A native gel of 
these chimeras was not done.  
 
4.2.3  Chimeras MKO and JNL  
One of the original objectives of this chapter was to investigate if it was possible to construct 
a chaperonin that was not only functional, but also more stable than Cpn60.2 as an oligomer. 
It is already known that GroEL functions as a stable oligomer. It was also shown in the last 
chapter that Cpn60.2 can function, but is known to be unstable. So the best choice to obtain a 
stable and functional chimera was to make domain swaps between GroEL and Cpn60.2.  The 
original attempts that had imprecise domain swaps proved unsuccessful, so precise domain 
swaps were made. It was predicted that both combinations of chimeras would be able to 
function in E. coli to rescue cell growth, when endogenous GroEL expression is suppressed. 
It was also predicted that these chimeras would be able to form more stable oligomeric 
structures owing to the presence of domains from GroEL.  
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Fig 4.10: Complementation and expression of JQL and PKR.  
Complementation results of JQL and PKR in MGM100 at 30°C in the presence of 0.2% 
arabinose with 0.1 mM IPTG (a) or in 0.2% glucose with 0.1 mM IPTG (b). a1 and b2- 
MGM100 pTrc-GroES-PKR, a2 and b1- MGM100 pTrc-GroES-JQL, a3 and b3- MGM100 
pTrc-GroES-Cpn60.2, a4 and b4- MGM100 pTrc-GroES-GroEL, b5- MGM100 pTrc99a. 
SDS-PAGE showing levels of over expression of JQL and PKR (c). Samples were taken from 
cultures after 4 hours incubation with 0.1 mM IPTG and 0.2% arabinose. Lane 1- Prestained 
protein marker (Fermentas), Lane 2- MGM100 pTrc-GroES-JQL; Lane 3: MGM100 
pTrc99a, Lane 4: MGM100 pTrc-GroES-PKR, Lane 5: MGM100 pTrc-GroES-GroEL. 
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Chimera MKO is the precise domain swap that has the equatorial and intermediate domain of 
GroEL while the apical domain is from Cpn60.2. Chimera JNL has the reciprocal swap with 
the equatorial and intermediate domains from Cpn60.2, while the apical domain is from 
GroEL. Both chimeras were cloned into the pTrc99a plasmid and sequenced to ensure the 
domain swaps were made at the correct junction points, while also ensuring no mutations 
were present. These plasmids were then transformed into MGM100 to test their functional 
properties.  
 
The results obtained here show that both MKO and JNL can complement for the loss of 
endogenous GroEL in E. coli MGM100. While there were no growth issues on arabinose 
plates, it was noted that JNL was a little better at complementing than MKO in glucose. 
Interestingly, on SDS-PAGE gels the over expression of MKO was not visible (fig 4.12a). 
Again, this supports the idea that very small amounts of functional chaperonin are needed to 
maintain cell growth.  Attempts to try and increase the expression of MKO by cloning it into 
the pBad24 plasmid were unsuccessful. Due to the lack of expression of MKO, a native gel 
could not be run.  
 
The expression level of JNL was much higher, and as a result its oligomeric properties were 
analysed on a native gel (fig 4.12). The protein sample was prepared from cells grown in LB 
with 0.2% glucose and induced with 0.1 mM IPTG for 5 hours. Two distinct bands were 
visible on the native gel. The first band represented a size of approximately 100kDa, while 
the second band was approximately 200kDa. When these results are compared with that of 
Cpn60.2 it can be seen that the 100kDa band approximately correlates with the 
monomeric/dimeric band of Cpn60.2. The second visible band of JNL however is not seen 
with Cpn60.2 and could indicate the presence of a slightly more stable structure. However, it 
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is important to note that this band would only indicate a trimeric/tetrameric structure and not 
a heptamer. For comparison sake, the tetradecameric GroEL band can also be seen on the 
native gel in lane 4 (fig 4.12b). 
 
 
 
 
 
 
 
Fig 4.11: Complementation results of MKO and JNL. Complementation results of MKO 
and JNL in MGM100 at 30°C in the presence of 0.2% glucose and 0.1 mM IPTG.  
      1- MGM100 pTrc-GroES-MKO            5- MGM100 pTrc-GroES-JNL  
2- MGM100 pTrc-GroES-GroEL                   6- MGM100 pTrc99a 
3- MGM100 pTrc-GroES-Cpn60.2                    7- MGM100 pTrc-GroES-Cpn60.2 
      4- MGM100 pTrc99a    8- MGM100 pTrc-GroES-GroEL 
Dilutions 
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Fig 4.12: SDS-PAGE and native protein gels.  
(a) SDS-PAGE gel showing minimal over expression of MKO and JNL. Samples were 
taken from cultures after 4 hours incubation with 0.1 mM IPTG and 0.2% arabinose. 
Lane 1- Prestained protein marker (Fermentas), Lane 2- MGM100 pTrc-GroES-
Cpn60.2; Lane 3: MGM100 pTrc-GroES-MKO, Lane 4: MGM100 pTrc-GroES-
GroEL, Lane 5: MGM100 pTrc-GroES-JNL. 
(b) Native gel of JNL. Protein samples were taken from cells grown in LB with 0.2% 
glucose and induced with 0.1 mM IPTG for 5 hours. The GroEL native sample was 
from a purified stock. Lane 1: Native protein marker, Lane 2: GroES + Cpn60.2, Lane 
3: GroES + JNL, Lane 4: GroES + GroEL. 
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Summary the complementation data of the precise domain swaps 
A summary of the complementation data for the precise domain swaps can be seen below in 
table 4.3. 
 
 37°C 30°C/26°C 
MGM100 Arabinose 
Glucose - 
IPTG 
Glucose + 
IPTG 
Arabinose 
Glucose - 
IPTG 
Glucose+ 
IPTG 
GroES + 
MQO 
+++ - - +++ - - 
GroES + 
PNR 
N/A N/A N/A N/A N/A N/A 
GroES + 
JQL 
- - - - - - 
GroES + 
PKR 
+++ - - +++ - - 
GroES + 
MKO 
+++ ++ ++ +++ ++ ++ 
GroES + 
JNL 
+++ +++ +++ +++ +++ +++ 
pTrc99a 
Vector only 
+++ - - +++ - - 
GroES + 
GroEL 
+++ +++ +++ +++ +++ +++ 
GroES + 
Cpn60.2 
+++ +++ +++ +++ +++ +++ 
 
Table 4.3: Complementation data of precise domain swapped chimeric proteins in E. 
coli MGM100. The table shows the growth of cells expressing different chimeras with the 
cochaperonin GroES at different temperatures, with or without 0.1 mM IPTG.  
+++   Denotes 10 – 100 % survival  - Complete complementation 
++     Denotes 1 – 10 % survival     - Partial complementation 
+       Denotes 0.1 – 1 % survival     - Partial complementation 
-        Denotes <0.1 % survival       - No complementation 
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Discussion 
The objective of this chapter was to try to expand on the knowledge of the functional and 
oligomeric properties of M. tuberculosis chaperonins. In the last chapter the two chaperonins, 
Cpn60.1 and Cpn60.2, were tested for their ability to function in E. coli in the absence of 
endogenous GroEL. It was shown that while Cpn60.2 can complement for the loss of GroEL, 
Cpn60.1 could not. As a result, and based on the data obtained from literature, it was accepted 
that while Cpn60.2 may function as the main house-keeping chaperonin, it can be predicted 
that Cpn60.1 has evolved to perform other functions (Hu et al., 2008, Kim et al., 2003, Ojha 
et al., 2005, Qamra et al., 2005, Cehovin et al., 2010).  
 
There could be various reasons as to how both these chaperonins are able to assist in different 
cellular functions. One of these reasons could be that both of these M. tuberculosis 
chaperonins are able to recognise and fold different groups of substrates. Since Cpn60.2 can 
also function in E. coli, it suggested that Cpn60.2 can also recognise a large number of the 
GroEL substrates, or at the very least the substrates that are vital for cell survival. A point to 
note is that, GroEL has very broad substrate specificity as it interacts with a large number of 
substrates in E. coli (Chapman et al., 2006).  
 
It is already known that the apical domain of the chaperonins is where a potential substrate 
first interacts with the chaperonins. It was reasoned that swapping the apical domain from 
Cpn60.2 or GroEL into Cpn60.1 might allow it to recognise the same set of substrates as the 
house-keeping chaperonins. This could then potentially lead to Cpn60.1 functioning in E. 
coli. However, this assumed that Cpn60.1 would be able to fold these new substrates and 
release them at the rate required by the cell.  
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The other aspect of this chapter was to see how the oligomeric properties of the M. 
tuberculosis chaperonins are affected by such domain swaps. It is known that both Cpn60.1 
and Cpn60.2 do not form very stable oligomeric structures, and that Cpn60.2 crystallises as a 
dimer (Qamra et al., 2004, Qamra & Mande, 2004). GroEL however, forms much more stable 
oligomeric structures. As such it was reasoned that making domain swaps between Cpn60.2 
and GroEL may yield a functional yet stable oligomeric Cpn60.2 chimera. However, as will 
be discussed shortly, a lot of the results that were obtained proved to be a little difficult to 
explain. 
 
Out of the six potential imprecise domain swaps, only three could be cloned and transformed 
into MGM100, namely AEC, AHC, and GBI. These will be discussed after the chimeras that 
could not be cloned or made, namely DBF, DHF, and GEI. 
 
Chimeras DBF and DHF could not be cloned into the pTrc plasmid without affecting cell 
growth and all the attempts that were made to rectify this issue were unsuccessful. It can be 
speculated that these chimeras were lethal to the cells, and as a result only the strains carrying 
non functional variants were able to survive. This could have been due to various reasons. 
Firstly, since the apical domain of DBF and DHF are from Cpn60.2 and GroEL respectively, 
it is possible that these chimeras were able to recognise and bind to the GroEL substrates, but 
were unable to fold them. In such a case, the results could lead to cell death. Secondly, it is 
possible that the imprecise nature of the domain swaps, where parts of the intermediate 
domain were from one chaperonin while the remainder was from another, could have affected 
the chaperonin cycle. This is because the intermediate domain is known to be responsible for 
transmitting the allosteric signals between the apical and equatorial domains to ensure 
appropriate structural changes are made to fold and release the bound substrates. So if its 
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structure was altered to the extent where it was unable to fulfil its function, then any 
substrates that were present in the cavity of the chimeras would not be released. As such, if 
large numbers of substrates were being trapped within the chimera, it would affect cell 
growth and could also cause cell death.  
 
The issues encountered with GEI are much harder to explain as I was unable to obtain a final 
PCR product. A reason for this is unclear. Every aspect of the PCR reaction that could be 
altered was systematically changed without success, including using temperature gradients, 
altering the number of cycles, using new primers, altering the concentration of dNTPs, and 
changing the ramping speed between the temperature ranges.  
 
The imprecise chimeras, which could be constructed and transformed into MGM100 
generally showed unexpected results. While the results obtained with AEC were as predicted, 
those obtained with AHC and GBI (chimeric swaps between GroEL and Cpn60.2) were not. 
The complementation data of AEC showed that it was unable to complement for the loss of 
endogenous GroEL. This result was expected, as AEC had the apical domain of Cpn60.1, and 
it was predicted that, due to this apical domain Cpn60.2 would lose its ability to function in 
E. coli. However, based on the speculations made with DBF and DHF, the lack of function 
due to the imprecise nature of the swap could not be conclusively rejected.  
 
One of the reasons why the results of the AHC and GBI swaps were unexpected is because 
both GroEL and Cpn60.2 can function in E. coli when expressed along with cochaperonin 
GroES. As such, it was predicted that a domain swap between them would also function. 
However, neither of these chimeras was able to complement for the loss of GroEL in 
MGM100. An SDS-PAGE gel was run to ensure the lack of complementation was not being 
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caused due to lack of expression. The protein expression analysis of GBI displayed a band 
lower than that of AHC, although sequence analysis confirmed no mutations were present. It 
is possible that the band seen for GBI was a proteolytic fragment. Surprisingly, both AHC 
and GBI showed signs of forming higher oligomeric structures with bands on a native gel that 
were comparable to that of GroEL, which is known to be a tetradecameric structure. While 
this result was expected with GBI, as it has the equatorial domain of GroEL and it is known 
that the equatorial domain is responsible for the majority of the inter-ring and intra-ring 
interactions, it was not expected with AHC. This result suggests that the apical domain may 
also play some role in the oligomeric stability of a chaperonin. Even though both these 
chimeras displayed signs of forming higher oligomeric structures, neither was able to 
complement for the loss of endogenous GroEL. One possible reason could be that a stable 
double ringed oligomeric structure is not necessary for substrate folding. Alternatively, it may 
also simply be because the chimera is not able to properly fold the substrates in this chimeric 
form even though it assembles as a double ring. A point to note, however, is that purified 
proteins were not used while running the native gels, so conclusive sizes could not be 
confirmed. Due to the number of issues being caused by the imprecise nature of the domain 
swaps, precise apical domain swaps were made. 
 
The precise domain swaps proved to be easier to construct and transform into MGM100. The 
only cloning issue encountered, was with PNR (which is similar to DHF). Although with 
DHF, it was speculated that one of the possible reasons could be the imprecise nature of the 
swap, for PNR this could not be the case. Instead it can be speculated that PNR may be able 
to recognise and bind to GroEL substrates, since the apical domain is from GroEL, but may 
not be able to fold it properly in the chamber at a rate that is required by the cells. However 
this does not explain why no such issue was observed with PKR. Interestingly, a similar 
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mutant, where the equatorial domain was from Cpn60.1 while the intermediate and apical 
domains were from GroEL(referred to as GroELMER), was made by Kumar et al., and was 
shown to be non functional in E. coli (Kumar et al., 2009). They also made the reciprocal 
swap where the equatorial domain was from GroEL, while the intermediate and apical 
domains were from Cpn60.1 (referred to as GroELMEF), and showed that this chimera could 
function in E. coli and also forms tetradecameric structures. According to their results, 
Cpn60.1 is capable of recognising the substrates of GroEL, and the only reason it does not 
function in E. coli is because of its lack of oligomerisation. This was a surprising observation 
as it was shown in the last chapter, that Cpn60.1 cannot complement in E. coli at all, and it 
was suggested that this lack of function was because Cpn60.1 is unable to recognise the same 
substrates as GroEL or Cpn60.2. Also, based on the data obtained in this chapter, a similar 
chimera to GroELMEF, MQO, was shown to express but not complement in MGM100 which 
supports the hypothesis that Cpn60.1 lacks the ability to recognise GroEL substrates. It would 
also have been expected that if swapping just the equatorial domain from GroEL to Cpn60.1 
allows it to form tetradecameric structures like GroELMEF, then the MQO chimera should 
have also displayed similar results. However, this was not the case. On native gels, MQO 
only displayed bands corresponding with single rings and not double rings. A point to note is 
that the native gel sample of MQO was not purified protein, so it is possible the result may 
differ with purified MQO.  
 
Although the data obtained here with MQO supports the hypothesis that apical domain of 
Cpn60.1 cannot recognise the substrates of GroEL, this hypothesis cannot be accepted or 
rejected because the reciprocal swap of PNR could not be analysed. Similar swaps between 
Cpn60.1 and Cpn60.2 were done to see if the results obtained with MQO would be repeated. 
Since both these chaperonins are known to exist as lower oligomers, higher oligomeric 
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structures were not expected. The results that were obtained showed that neither JQL nor 
PKR could complement for the loss of endogenous GroEL, in the presence of glucose. It was 
also noticed that JQL would cause cell death in the presence of arabinose and IPTG, 
suggesting that when it is over expressed it may be interacting with GroEL to form a non 
functional GroEL. A possible reason why PKR failed to complement is less apparent. Since 
the apical domain is from Cpn60.2, it can speculated that it may have been able to recognise 
and bind to the appropriate substrates, but since the intermediate and equatorial domains are 
from Cpn60.1, it may not have been able to properly fold these substrates.  
 
The chimeras MKO and JNL were primarily constructed to see if it was possible to improve 
the oligomeric stability of Cpn60.2. It was also expected that these chimeras would be able to 
function in E. coli. When similar swaps were made with imprecise domains, the resulting 
chimeras were unable to function in MGM100. As a result, it was speculated that if more 
precise domain swaps were made where just the apical domain was being swapped, then 
those chimeras would be able to function. As expected, the complementation data of MKO 
and JNL showed that both could complement for the loss of endogenous GroEL in E. coli 
MGM100. It was interesting to see that the expression of MKO was extremely low compared 
with JNL, yet it was able to complement reasonably well, supporting the suggestion that very 
low amounts of functional chaperonin are needed for cell survival. However, due to the low 
levels of expression, a native gel of MKO could not be run. An attempt to try and increase its 
expression levels using an arabinose inducible plasmid, pBAD24, was also unsuccessful. The 
expression levels of JNL were much better and as a result samples were prepared for a native 
gel. Based on the original predictions, JNL was not expected to form higher oligomeric 
structures on the native gel as its equatorial and intermediate domains were from Cpn60.2. 
However, it was observed that along with a band matching that of Cpn60.2, another band, of 
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higher molecular weight, was visible on the gel. This second band, approximately 200kDa in 
size, would normally be associated with a trimeric or tetrameric structure. Although no single 
or double rings were observed, it was interesting to reconfirm an earlier observation with 
AHC, that the apical domain may also be playing a role in the oligomeric stability of a 
chaperonin.  
 
An important point to note here is that while AHC showed signs of forming larger double 
ringed structures, it was unable to complement in E. coli, whereas JNL could complement 
even though it showed the presence of much smaller structures. This result, along with others 
in this chapter suggests that forming stable oligomeric structures may not be necessary for 
substrate folding. However, this suggestion goes against our current understanding on 
chaperonin function. It is much more likely that JNL does form double ringed structures like 
AHC but is more unstable.  
 
The aim of this study was to broaden our understanding on the functional and oligomeric 
properties of the M. tuberculosis chaperonins. Results here show that the evolutionary 
difference between Cpn60.1 and the house-keeping chaperonins Cpn60.2/GroEL is large 
enough that apical domain swaps alone cannot confer the ability to function in E. coli. It also 
shows that the apical domains may be playing a larger role in stabilising the oligomeric 
structure of the chaperonins than previously thought. Since all the native gels were run with 
whole cell protein extracts it was difficult to suggest without a doubt that these chimeras were 
forming larger oligomers. As such, in the next chapter I went on to test the oligomeric 
properties of JNL by purifying it and running it in an AUC under different buffer conditions. 
A table summarising all the data from all our attempted chimeric constructs can be seen in the 
table 4.4 below. 
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Name Construct 
Expected to 
complement?  
Did it 
complement? 
Expected to 
oligomerise?  
Did it 
oligomerise? 
  
Blue –Cpn60.2; Red -  Cpn60.1;     
Green – GroEL    
 
    
 
  
      
 
    
 
  
 
AHC 
 
 
Yes 
 
No No 
 
Double Ring 
 
GBI 
 
 
Yes 
 
No Yes 
 
Double Ring and 
Single Ring 
 
JNL 
 
 
Yes 
 
Yes No 
 
Monomer/Dimer 
 
MKO 
 
 
Yes 
 
Yes Yes 
 
Possible Single 
Ring 
     
 
 
  
 
  
 
DHF 
 
 
Yes 
 
could not be 
cloned 
No 
 
could not be 
cloned 
 
GEI 
 
 
No 
 
could not be 
made 
Yes 
 
could not be 
made 
 
PNR 
 
 
Yes 
 
could not be 
cloned 
No 
 
could not be 
cloned 
 
MQO 
 
 
No 
 
No Yes 
 
Possible Single 
Ring 
     
 
 
  
 
  
 
AEC 
 
 
No 
 
No No 
 
Not done 
 
JQL 
 
 
No 
 
No, Lethal in 
arabinose 
No 
 
Not done 
 
PKR 
 
 
Yes 
 
No No 
 
Not done 
 
DBF 
 
 
Yes 
 
could not be 
cloned 
No 
 
could not be 
cloned 
Table 4.4: Summary of data obtained from apical domain swaps between GroEL, Cpn60.1, and Cpn60.2. The white, orange, 
and black bars above the chimeric bars represent the approximate location of the equatorial, intermediate, and apical domains 
respectively. 
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Background 
As discussed in section 1.5 it is already know from the literature that the accepted mechanism 
of chaperonin function, involves the formation of cage like structures to trap a non native 
protein within it. Exactly how the protein is then folded to its native state is still under debate 
(Lin et al., 2008, England et al., 2008, Horwich et al., 2007, Chakraborty et al., 2010). What 
is agreed upon however, is that the entrapment of the non native protein allows it to fold 
without influence from other cellular structures (Ellis, 1994). One of the most widely studied 
chaperonin is the E. coli GroEL. The mechanism by which this chaperonin functions has 
already been discussed in section 1.5, but briefly, involves the formation of a stable double 
ringed structure which can bind to and encapsulate its substrate proteins. Along with the help 
of its cochaperonin GroES, the GroEL chaperonin then goes through a repeating cycle of 
binding, folding and releasing the substrate in an ATP dependent manner (Horwich et al., 
2007).  
 
It was surprising then, that in 2004, Qamra et al. showed that the chaperonins of M. 
tuberculosis existed as lower oligomers and crystallised as dimers (Qamra et al., 2004, 
Qamra & Mande, 2004). Since ATP hydrolysis is an integral part of the chaperonin reaction 
cycle, it was also surprising to find that these chaperonins displayed very weak ATPase 
activity (Qamra et al., 2004). They also claimed that the Mycobacterial chaperonins are 
unable to complement in E. coli (Kumar et al., 2009). These findings were unusual, as it 
suggested the possibility of M. tuberculosis chaperonins using a different mechanism to that 
of GroEL to function. In chapter 3 however, it was shown that Cpn60.2 from M. tuberculosis 
can function in E. coli. Although this does not prove the formation of a multimeric structure, 
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it does support the idea that Cpn60.2 forms higher oligomeric structure in vivo, even if it is 
very unstable. Then in chapter 4 it was shown that the precise apical domain swaps between 
GroEL and Cpn60.2 resulted in functional proteins. This also supported the hypothesis that 
Cpn60.2 functions using a similar, if not the same, mechanism than that of GroEL. It was 
shown that both chimeras JNL and MKO were able to complement well in E. coli MGM100, 
while the chimera AHC failed to do the same. What was interesting however was the 
observation that, at least on native gels, JNL was a lower oligomer while AHC formed higher 
oligomeric structures. However, since this observation was based entirely on data from native 
gels, a better approach was needed.  
 
For this reason, it was decided that JNL (Precise domain swap between Cpn60.2 and GroEL) 
and AHC (imprecise domain swap between Cpn60.2 and GroEL) would be purified and the 
protein samples would be analysed using analytical ultracentrifugation (AUC).  
 
AUC is a technique that allows real time monitoring, during sedimentation, of the behaviours 
of macromolecules in solution in their native state. This method allows the characterisation of 
proteins by their hydrodynamic and thermodynamic properties in solution, without 
interaction with any matrix or surfaces. There are two types of experiments that can be 
performed with AUC, namely, sedimentation velocity and sedimentation equilibrium. 
Sedimentation velocity is a hydrodynamic technique that measures the rates at which 
molecules move in a centrifuge as a response to the centrifugal forces that are generated. This 
method measures the entire time course of sedimentation and provides information on both 
the shape and the molecular mass of the dissolved molecules. Sedimentation equilibrium on 
the other hand is a thermodynamic technique that measures concentration distribution of 
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macromolecules at equilibrium, when sedimentation is balanced by diffusion, and only 
provides information on the molecular mass of the molecule. In both cases data collection can 
be done with either absorbance optics or interference optics.  
 
Before analysis on the chimeric proteins was done, extensive work in the lab had shown that 
under high salt buffer conditions with ATP, M. tuberculosis Cpn60.2 displayed the presence 
of higher oligomeric structures in the AUC (Elsa Zacco, Master’s Thesis 2010). MS analysis 
on this sample by our collaborators, Dr. J Freeke and Dr. J Benesch from the University of 
Oxford, showed that these higher oligomers included tetradecameric forms of Cpn60.2. As 
such, it was decided that the chimeras would also be tested under similar conditions. This was 
done to see if AHC and JNL were also forming higher oligomeric structures, and what affect 
this had on their ATPase activity. Unfortunately, AHC proved to be very difficult to remake 
and express. The reason for this is unclear.  Due to time constraints it was decided that only 
JNL would be purified and analysed. It was hypothesised that the oligomeric properties of 
JNL would be similar to that of Cpn60.2 as its equatorial domain is unchanged. It was also 
expected that conditions that favour oligomerisation would result in higher ATPase activity 
by JNL. 
 
Experimental design 
JNL was first purified using ion exchange and size exclusion chromatography. The protein 
sample was then analysed using AUC in low salt buffer without ATP and then high salt 
buffer with ATP. As discussed above, high salt buffer with ATP results in Cpn60.2 forming 
higher oligomers. Hence, it was expected that high salt buffer would also result in JNL 
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forming higher oligomers. The second part of this chapter was to test the ATPase activity of 
JNL in both buffers. It was expected that the high salt buffer that allows oligomerisation, 
would also result in an increase in the ATPase activity of JNL. The ATPase activity was 
tested along with Cpn60.2 and compared against GroEL. 
 
In this chapter various buffers were used and have been listed below:  
Buffer 1 – Low salt buffer containing 50 mM Tris, 50 mM NaCl, 1 mM EDTA at pH 6.5 
Buffer 2 – High salt buffer containing 50 mM Tris, 500 mM NaCl, 1 mM EDTA at pH 6.5 
Buffer 5 – Gel filtration buffer containing 50 mM Tris, 50 mM KCl, 10 mM MgCl2 at pH 7.4 
Buffer A- Buffer 5 + 1M (NH4)2SO4 and 1 mM ATP 
 
The reason why the buffers are named as such is because buffer 1 to 5 is the usual order in 
which they are used to purify proteins. Buffers A to F were used for oligomerisation tests 
with buffer A containing the highest ATP concentration and buffer F containing the lowest. 
Only the buffers that were used in this chapter have been listed. 
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5.1   Purification of JNL  
5.1.1 Ion exchange purification: DEAE sepharose 
For the first purification step, an ion exchange column with DEAE sepharose fast flow 
chromatography media (GE healthcare) was used. This method separates proteins based on 
the differences in their net surface charge. The underlying basis of this process involves the 
interaction of charged particles from proteins of interest with the opposite charge on the 
column matrix.  Since proteins vary in their charge properties, their interaction with the 
charged chromatography media also varies. The net surface charge of proteins is highly pH 
dependent and different proteins have different relationship between the net surface charge 
and the pH. By controlling this property of proteins, it is possible to control the interaction of 
the proteins with the column matrix to either favour binding or elution. 
 
The protocol used to over-induce and prepare the sample has been described in section 2.6, 
but briefly, MGM100 cells containing pTrc plasmid encoding both GroES and JNL were 
over-expressed in 3 x 500ml conical flasks with 200 ml LB, 0.2% glucose, and 0.5 mM IPTG 
for 4 hours. The samples from each of the flasks was then collected and centrifuged at 
6000rpm for 10 minutes at 4°C. The resulting pellet was then resuspended in 6 ml of buffer 1 
and then sonicated for a total of 1 minute and 30 seconds with 10 second pulses to break open 
the cells. This sample was then used in the ion exchange column. 
 
The sample was first loaded into the column and left for approximately 1 hour. This allowed 
the buffer to flow through along with other unbound molecules into fraction tubes due to 
gravity. Once all the buffer had been removed, the programme was started with a flow rate of 
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1ml/min and the elute was collected in the fraction tubes. Each fraction tube collected the end 
product of the purification step for approximately 10-15 minutes. A sample from every 5
th
 
tube was analysed by SDS-PAGE to determine where JNL had eluted. As shown in figure 
5.1a, tube 20 contained a clear band corresponding to the size of JNL. As a result, samples 
from tubes 16-24 were then further analysed by SDS-PAGE (fig 5.1b), and the fractions from 
the tubes with the highest concentration of JNL (tubes 18-23) were pooled and concentrated. 
This sample was then used to further purify JNL in a gel filtration column. 
 
5.1.2 Gel filtration purification 
The next step in our purification protocol was to try and further purify JNL as the 
concentrated solution from the ion exchange column still contained a high concentration of 
smaller proteins. It was decided that the sample would be run through a gel filtration column. 
This filtration technique separates proteins based on their molecular size and shape. The gel 
consists of extremely small porous beads that allow smaller molecules to freely enter the 
internal space while preventing larger molecules from entering. As elution begins, the smaller 
molecules penetrate the beads, and as a consequence migrate slower than the larger 
molecules. As a result the larger molecules, which can pass through the column at the same 
rate as a buffer, are eluted first and collected as fractions. The smaller molecules elute later as 
they have to travel through a larger volume of solvent. As a result the largest molecules are 
collected in earlier fraction tubes and a gradual decrease in the size of proteins is observed in 
later fraction tubes.  
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Fig 5.1: SDS-PAGE analysis of JNL from ion exchange column.  
(a) Lane 1:  Unbound sample; Lane 2: Prestained marker (Fermentas);  Lane 3: Tube 1; Lane 
4: Tube 5; Lane 5: Tube 10; Lane 6: Tube 15; Lane 7: Tube 20; Lane 8: Tube 25; Lane 9: 
Tube 28; Lane 10: Tube 30. 
(b) Lane 1: Prestained marker (Fermentas);  Lane 2: Tube 16; Lane 3: Tube 17; Lane 4: Tube 
18; Lane 5: Tube 19; Lane 6: Tube 20; Lane 7: Tube 21; Lane 8: Tube 22; Lane 9: Tube 23; 
Lane 10: Tube 24. 
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The protocol used for gel filtration has been described in section 2.6. The concentrated 
sample from the ion exchange column was loaded into the gel filtration column and the 
filtration process was started with a flow rate of 1ml/min. Based on the results obtained from 
the UV detector (fig 5.2a), the samples between peaks A and D (columns 5-18) were 
analysed on a SDS-PAGE gel. The results showed that the fractions containing JNL still had 
a large concentration of smaller proteins present (fig 5.2b).  
 
5.1.3 Second Ion exchange purification: DEAE sepharose 
As better separation had been obtained with the ion exchange column, this method was 
repeated with a shallower buffer gradient. This was done as an attempt to improve the 
separation of JNL from the smaller proteins. As can be seen in figure 5.3a, this approach was 
largely successful. Samples from tubes 15 to 18 (lanes 2 to 5 in figure 5.3a) were then 
collected and pooled together. To ensure JNL had not eluted in fraction tubes prior to tube 15, 
another SDS-PAGE gel was run and included samples from tubes 10 to 14 (fig 5.3b). This 
SDS-PAGE gel also had the pooled product from tubes 15 to 18 (purified JNL) as well as 
running samples from the unbound collection to ensure no JNL was  present (5.3b).  
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Fig 5.2: UV graph and SDS-PAGE page analysis of JNL from gel filtration column. 
(a) UV graph showing regions of protein elution. 
(b) SDS-PAGE gel. Lane 1: Prestained marker (Fermentas); Lane 2: Tube 5; Lane 3: Tube 6; 
Lane 4: Tube 7; Lane 5: Tube 8; Lane 6: Tube 9; Lane 7: Tube 10; Lane 8: Tube 11; Lane 9: 
Tube 12; Lane 10: Tube 13; Lane 11: Tube 14; Lane 12: Tube 15; Lane 13: Tube 16; Lane 
14: Tube 17; Lane 15: Tube 18. 
 
A           B          C            D                          E     
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Fig 5.3: SDS-PAGE analysis of JNL from second ion exchange column, and purified 
JNL 
(a) Lane 1: Prestained marker (Fermentas);  Lane 2: Tube 15; Lane 3: Tube 16; Lane 4: Tube 
17; Lane 5: Tube 18; Lane 6: Tube 19; Lane 7: Tube 20; Lane 8: Tube 21; Lane 9: Tube 22; 
Lane 10: Tube 23 
(b) Lane 1: Prestained marker (Fermentas);  Lane 2: Unbound 1; Lane 3: Unbound 2; Lane 4: 
Unbound 3; Lane 5: Tube 10; Lane 6: Tube 11; Lane 7: Tube 12; Lane 8: Tube 13; Lane 9: 
Tube 14; Lane 10: Concentrated JNL 
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5.2 AUC analysis of JNL 
Using AUC (analytical ultracentrifugation), attempts were made to determine the oligomeric 
state of JNL. The JNL protein sample was run in buffer 5 and buffer A at 20°C and 40,000g 
for 20 hours. As discussed above, it was shown that under high salt buffer conditions with 
ATP, M. tuberculosis Cpn60.2 displays the presence of higher oligomeric structures in the 
AUC and this was confirmed to include the presence of tetradecameric structures by MS (fig 
5.4a and 5.4b). As such, it was expected that JNL would also oligomerise in buffer A. 
 
On the graphs obtained from the AUC data, the increase in sedimentation coefficient (S) 
value denotes an increase in oligomeric structures. For Cpn60.2 a sedimentation coefficient 
of around 13 represents the tetradecameric structure. With that in mind it can be seen from 
the results obtained here that there is evidence of some large oligomers in buffer A but not in 
buffer 5 (fig 5.5a and 5.5b). However, since sedimentation velocity experiments depend not 
only on the molecular mass but also on the shape of a molecule, it becomes difficult to obtain 
the precise molecular mass measurements from the S value. Although we were unable to 
analyse the structure further with MS, by analogy with Cpn60.2 we expect this to include 
tetradecamers. This result was as expected and is consistent with what has been observed 
with Cpn60.2. 
 
Since it is possible to obtain JNL at higher oligomeric forms, it was decided that ATPase 
assays would be done to see if its ability to hydrolyse ATP is dependent on its ability to 
oligomerise. For this reason, ATPase assays were done in buffer A and buffer 5 for JNL, 
Cpn60.2, GroEL (positive control), and BSA (negative control).  
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Fig 5.4: Oligomeric states of Cpn60.2. Using AUC and MS the oligomeric states of 
Cpn60.2 were determined (Adapted from Elsa Zacco, Master’s Thesis 2010). (a) AUC 
analysis showing sedimentation coefficient of Cpn60.2 in buffer A and buffer 5. (b) MS 
analysis showing the various oligomeric states of Cpn60.2 present in high salt buffer with 
ATP (result obtained by Dr. J Freeke and Dr. J Benesch from the University of Oxford). 
 
 
13.06
2.45
0
1
2
3
4
5
6
7
8
9
0 2 4 6 8 10 12 14 16 18 20
c
(S
)
s
Cpn60.2 TB - buffer 5 and A comparison
bufferA+ATP buffer5
 
Monomer 
 
 
Dimer 
 
 
Trimer 
 
 
Tetramer 
 
 
Pentamer 
 
 
Heptamer 
 
 
Tetradecamer 
 
 
(a) 
(b) 
Chapter 5 
196 
 
 
 
 
 
Fig 5.5: AUC data analysis showing sedimentation coefficient of JNL in buffer 5 (a) and 
buffer A (b). 
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5.3 ATPase assay of purified JNL 
It is known from the literature, and has been confirmed in our lab, that Cpn60.2 has a very 
weak ATPase activity in standard resuspension buffer (Qamra et al., 2004). However, it was 
also shown that in buffer A the activity of Cpn60.2 would rise by 3 to 4 folds of normal level 
(Elsa Zacco, Master’s thesis 2010). As the current model of chaperonin function relies on 
their ability to oligomerise and fold substrates in an ATP dependent manner, it was reasoned 
that the rise in ATPase activity of Cpn60.2 was due to the presence of higher oligomeric 
forms of Cpn60.2 in the solution. The aim of this part of the study was to test the hypothesis 
that oligomerisation plays a role on the ATPase activity of JNL. As it is was shown that 
higher oligomeric forms of JNL could be obtained in buffer A, it was expected that the 
ATPase activity in that buffer would also be higher than in buffer 5.  
 
For this experiment, I made use of the PiColorLock gold ATPase kit (Innova Biosciences), 
using the protocol described in section 2.6. This enables the use of a simple colorimetric 
assay on 96 well plates to determine the ATPase activity of a molecule. The assay measures 
Pi based on the change in absorbance of malachite green in the presence of molybdate (fig 
5.6a). The intensity of the colour is directly proportional to the release of Pi in the solution 
after ATP hydrolysis. An example of this colour change can be seen in figure 5.6b below. 
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Fig 5.6: (a) Principle of the Picolorlock assay. (b) Example of colour change caused by 
an increase in free Pi in solution. 
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Before the ATPase activity of JNL could be assessed, it was necessary to ensure that the 
assay being used for detecting free phosphate was linear. For this reason a standard curve 
with different Pi concentrations (0μM, 25μM, 50μM, 75μM, and 100μM) was set up (fig 5.7). 
The absorbance (620nm) reading after the addition of the gold mix was also tested at 
different time points, from 0 minutes to 150 minutes, to ensure the stability of the assay (fig 
5.7).  
 
 
Fig 5.7: Image showing Pi Standard curve at varying Pi concentrations and incubation 
time. 
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In this experiment GroEL was the positive control, while bovine serum albumin (BSA) was 
used to measure the background reading. Cpn60.2 was also included as a comparison for the 
JNL ATPase activity. The background activity obtained from BSA would be used to correct 
the observed activity of the chaperonins. In each case, the OD620 reading was taken after 30 
minutes of incubation with the gold mix. 
 
The results that were obtained showed that the ATPase activity of JNL and Cpn60.2 changed 
considerably depending on the buffer used. When compared with the activity of GroEL it 
becomes apparent that the activity of JNL and Cpn60.2 is much lower in buffer 5 than it is in 
buffer A. Once corrected for the background activity, if GroEL activity is taken as 100%, 
then the activity of JNL in buffer 5 is almost nonexistent at just 0.49 ± 2.49% of GroEL (fig 
5.8). As expected the ATPase activity of Cpn60.2 in buffer 5 is also extremely low at just 
8.27 ± 3.82% of GroEL. In buffer A however, both JNL and Cpn60.2 have higher ATPase 
activity, although still not as high as GroEL. Both Cpn60.2 and JNL are at approximately 
32.19 ± 1.66% and 25.86 ± 9.42% of GroEL respectively (fig 5.9). The results of these 
experiments support the original hypothesis that in conditions where oligomerisation can 
occur, the ATPase activity of Cpn60.2 and JNL increases. 
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  1 2 3 Corrected values Average  % Pi release Average % Pi release SD 
GroEL 1.984 1.819 1.915 1.684 1.258 1.409 1.450 100.00 100.00 100.00 100.00 0 
Cpn60.2 0.512 0.628 0.603 0.212 0.067 0.097 0.125 12.59 5.33 6.88 8.27 3.82 
JNL 0.356 0.544 0.499 0.056 -0.017 -0.007 0.011 3.33 -1.35 -0.50 0.49 2.49 
BSA 0.300 0.561 0.506                   
 
 
 
Fig 5.8: ATPase activity of GroEL, Cpn60.2, JNL, and BSA in buffer 5. 
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  1 2 3 Corrected values Average  % Pi release Average % Pi release SD 
GroEL 1.637 1.972 1.960 0.276 0.733 0.671 0.560 100.00 100.00 100.00 100.00 0 
Cpn60.2 1.453 1.461 1.510 0.092 0.222 0.221 0.178 33.33 30.29 32.94 32.19 1.66 
JNL 1.403 1.482 1.485 0.042 0.243 0.196 0.160 15.22 33.15 29.21 25.86 9.42 
BSA 1.361 1.239 1.289                   
 
 
 
Fig 5.9: ATPase activity of GroEL, Cpn60.2, JNL, and BSA in buffer. 
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Discussion 
As discussed in the introduction, the accepted mechanism by which chaperonins function 
involves the assembly of stable ringed structures to provide a central cavity for protein 
folding. Substrate proteins can fold within this central cavity without being influenced by 
other cellular components (Ellis, 1994). Mycobacterial chaperonins however have been 
shown to be structurally very unstable and posses very weak ATPase activity (Qamra et al., 
2004, Kumar et al., 2009).  
 
The original aim of this section of the project was to analyse and compare the oligomeric and 
ATP hydrolysing properties of two the Mycobacterial chaperonin chimeras AHC and JNL. 
AHC however proved to be very difficult to remake and as such only JNL could be further 
analysed. Once JNL was purified using ion exchange chromatography, samples were run in 
the AUC using two different buffers. As discussed above, extensive work in the lab had 
shown that under high salt conditions and in the presence of ATP, Cpn60.2 formed large 
tetradecameric structures in vitro (Elsa Zacco, Master’s thesis, 2010). Since the equatorial 
domain of JNL was from Cpn60.2, it was expected that JNL would also structurally behave 
like Cpn60.2.  
 
The results that were obtained confirmed this hypothesis. In the presence of low salt and no 
ATP (buffer 5), JNL was shown to be primarily monomeric. A point to keep in mind is that 
none of the JNL samples were analysed using MS, and as such the results obtained from 
AUC can only be compared with those of Cpn60.2. Elsa Zacco had shown that in buffer 5, 
Cpn60.2 was also monomeric in nature. In the presence of high salt buffer and ATP, as 
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expected, evidence of larger oligomeric structures of JNL was seen. As MS could not be 
done, the AUC data was compared with that of Cpn60.2. Due to similar results being 
obtained with Cpn60.2, it is reasonable to infer that the presence of higher oligomeric 
structures of JNL also includes tetradecamers.  
 
Interestingly, when the AUC data in buffer 5 of JNL is compared with that of Cpn60.2, there 
are signs of slightly higher oligomeric structures, possibly trimers or tetramers, present in the 
JNL sample. This was consistent with what was observed on the native gel. As was 
speculated, this may be due to the presence of the apical domain of GroEL. Exactly how this 
interaction takes place is unclear. However it does suggest that the apical domain also plays a 
role in the structural stability of a chaperonin.  
  
As discussed above the ATPase activity of Mycobacterial chaperonins was shown to be very 
low when compared with that of GroEL (Kumar et al., 2009, Qamra et al., 2004). The second 
objective of this study was to analyse the ATPase activity of JNL. As it is known that the 
protein folding cycle of stable chaperonins such as GroEL is dependent on its ATPase 
activity, it was expected that in conditions that support oligomerisation, the ATPase activity 
of JNL would rise. The results that were obtained from the ATPase assays confirmed this 
hypothesis. It was shown that in buffer 5 when large oligomers are not being formed, the 
ATPase activity of JNL and Cpn60.2 is extremely low when compared to that of GroEL. 
However, in buffer A where both Cpn60.2 and JNL show the presence of larger oligomers, 
their ATPase activity rises considerably. However, even under these conditions the ATPase 
activity of both Cpn60.2 and JNL is only approximately 30% of that of GroEL.  
Chapter 5 
205 
 
 
Based on the results obtained here and from chapters 3 & 4, it becomes apparent that under 
appropriate conditions, Cpn60.2 and its chimera JNL can not only function in E. coli, but also 
form higher oligomeric structures and hydrolyse ATP. This is in contrast to the data obtained 
by Kumar et al., and Qamra et al.  It is however important to note that all the experiments 
done in this chapter were in vitro and used conditions that were in effect forcing the 
chaperonins to oligomerise. It still does not explain the chaperonin cycle that takes place in 
vivo. It is possible that M. tuberculosis chaperonins have evolved to be less energy 
dependent. This reduced dependency on energy could result in their unstable nature. 
However, since Cpn60.2 and JNL can both function in E. coli, even though they show bands 
corresponding to monomers on a native gel, it can be speculated that the disassembled and 
assembled states of the chaperonins are transient. It is possible that under conditions that do 
not require high concentrations of functional chaperonins, the Mycobacterial chaperonins are 
primarily in an unassembled monomeric/dimeric state. When the conditions within the cell 
change to the point where more functional chaperonins are needed, then higher 
concentrations of oligomeric chaperonins are present. How this is achieved within the cell is 
unclear. It is possible that the oligomerisation of Mycobacterial chaperonins may be substrate 
dependent. It can also be speculated that under stressful conditions, such as heat shock, the 
highly crowded nature of the cells and the over-expression of the heptameric Cpn10 (or 
GroES in E. coli) may provide the Mycobacterial chaperonins with the scaffolding needed to 
assemble into ringed structures. To prove the presence of large oligomeric structures in vivo, 
further experiments would need to be done. One possibility is cross-linking experiments. 
Cross-links are ionic or covalent bonds that link interacting polypeptide chains to each other 
and is used as a probe for protein-protein interaction. In context to Mycobacterial 
chaperonins, it could be used to see if they are forming tetradecameric structures in vivo.  
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In summary, based on the results obtained here and the results obtained from the previous 
result chapters, it is very probable that within the cell where there are various crowding 
agents and different salt concentrations, the Mycobacterial chaperonins form higher 
oligomeric structures and hydrolyse ATP in the substrate folding reactions.   
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In this chapter I will be looking to further characterise the chaperonins of Mycobacterium 
tuberculosis in three different sets of experiments. For this reason, the chapter will be split 
into 3 separate sections so that their background information and results can be discussed 
separately. The three sections that will be discussed here are as follows: 
6.1- Testing the ability of M. tuberculosis Cpn60.1 to function in M. smegmatis 
6.2- Testing the existence of double ring M. tuberculosis Cpn60.2 by attempting to make 
single ring mutants 
6.3- Testing the hypothesis that phosphorylation is needed for improved oligomerisation 
In section 6.1, since I will be referring to M. tuberculosis, M. smegmatis and E. coli 
chaperonins, the prefixes Mtb, Ms, or Ec will be used. So, MtbCpn60.1 denotes M. 
tuberculosis Cpn60.1, while MsCpn60.1 denotes M. smegmatis Cpn60.1, and EcGroEL 
denotes E. coli GroEL. In all cases, unless mentioned otherwise, the cochaperonin in the 
experiments was M. smegmatis Cpn10. To make it easier to follow, each strain will be 
denoted with a letter: 
Strain A- M. smegmatis mc
2
 155 
Strain B- M. smegmatis Δcpn60.1 
Strain C- Strain B with pMsGroEL1 plasmid (Mscpn10-Mscpn60.1) 
Strain D- Strain B with pMs10-MsCpn60.2 plasmid 
Strain E- Strain B with pMs10-MsCpn60.3 plasmid 
Strain F- Strain B with pMs10-EcGroEL plasmid 
Strain G- Strain B with pMs10-MtbCpn60.1plasmid 
Note: The constructs in strains D, E, and F were made by Tara Rao (PhD thesis, 2010, 
University of Birmingham). 
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Section 6.1: Testing the ability of M. tuberculosis Cpn60.1 to function in M. 
smegmatis 
 
Background 
As discussed in the introductory chapter and in chapter 3, it is known that the main house-
keeping chaperonin in both M. tuberculosis and M. smegmatis is Cpn60.2, while Cpn60.1 has 
evolved to perform alternate functions.  Our current understanding of the functions of 
MsCpn60.1 implicates its role in biofilm maturation for M. smegmatis while the MtbCpn60.1 
chaperonin has been shown to play a role in granuloma formation during tuberculosis (Hu et 
al., 2008, Kim et al., 2003, Ojha et al., 2005).  
 
Biofilm formation is an important aspect of many pathogenic bacteria, including E. coli, V. 
cholerae, H. influenze, and P. aeroginosa (Hall-Stoodley & Stoodley, 2009, Bjarnsholt et al., 
2010, Fux et al., 2005). These bacteria make use of the biofilms to provide them with 
protection from the diverse environmental and nutrient conditions, while also providing them 
with the means to protect themselves from the effects of antibiotics (Bjarnsholt et al., 2010, 
Hall-Stoodley et al., 2004, Cernohorska & Votava, 2010).   
 
In M. smegmatis, it has been shown that the loss of biofilm maturation can be caused by 
deleting the groEL1 (Mscpn60.1) gene which results in the lack of association between 
MsCpn60.1 and KasA (Ojha et al., 2005). KasA is a component of the fatty acid synthase 
(FAS)-II complex which is required for the elongation of mycolic acid chains. So the deletion 
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of Mscpn60.1 can indirectly lead to the non assembly of the FAS-II complex and as a result 
cause defective mycolic acid biosynthesis. In the same study, Ojha et al. also showed that 
they could reverse this phenotype in M. smegmatis by complementing the strain with a 
plasmid carrying the M. smegmatis cpn60.1 gene.  
 
As it is known that MtbCpn60.1 has a high degree of sequence similarity (≈90%) and is 
evolutionarily related to MsCpn60.1, and does not function as the main house-keeping 
chaperonin in M. tuberculosis, I wanted to test the link between sequence homology and 
functional property to see if it was possible to complement for the loss of MsCpn60.1 in M. 
smegmatis with MtbCpn60.1. It was hypothesised that MtbCpn60.1 should be able to 
function in M. smegmatis and hence be able to reverse the phenotype of the M. smegmatis 
Δcpn60.1 knockout strain (strain B). To do this the M. tuberculosis cpn60.1 gene was 
expressed in M smegmatis lacking Mscpn60.1, and the biofilm assay repeated. 
 
Experimental design 
Ojha et al. were kind enough to provide the original complementing plasmid pMsGroEL1, 
the original M. smegmatis strain (strain A), and the Mscpn60.1 knockout strain (strain B). To 
test the ability of MtbCpn60.1 to function in M. smegmatis, its gene was first cloned into the 
complementing plasmid. In doing so, the M. smegmatis cpn60.1 gene was replaced with the 
M. tuberculosis cpn60.1 gene. The plasmid was then sequenced before being transformed 
into strain B and analysed using the complementation assay used by Ojha et al.  
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Before the experiment was carried out, a colleague was already working on trying to replicate 
the original results obtained by Ojha et al., but was unable to do so in our lab (Tara Rao, PhD 
thesis 2010). Further attempts made by me to replicate the results using the same protocol 
also failed. Tara Rao then made various alterations to all the variables in the protocol 
including the use of a different growth media, using HPLC grade water, including tween80, 
changing the iron concentration, and even changing the glassware. Unfortunately none of 
these resulted in reproducible results. It was only when she went to the lab in Pittsburgh 
herself, that she was able to obtain the desired results. As such, it was decided that after the 
construction and transformation of the required plasmid was complete, it would be sent to 
Ojha et al. in Pittsburgh so that the complementation assays could be done by them. 
 
6.1.1    Construction and transformation of the plasmid 
 
To clone the Mtbcpn60.1 gene into the pMsGroEL1 plasmid a combination of restriction 
digests and PCRs were used. The original pMsGroEL1 plasmid had a HindIII site both 
upstream and downstream of the Mscpn60.1 gene. As such it was possible to remove the 
Mscpn60.1 sequence by digesting the plasmid with HindIII using the protocol in section 
2.4.8, running the resultant fragments on a 1% agarose gel, and then extracting the vector 
backbone as per the manufacturer protocol (Qiagen gel extraction kit). The vector was then 
made blunt ended by using Klenow (section 2.4.9). During this process, phusion polymerase 
(NEB) was used to PCR amplify the Mtbcpn60.1 gene from the Ptrc-GroES-MtbCpn60.1 
plasmid. This results in a blunt ended PCR product. The Vector backbone was then ligated 
with the PCR amplified Mtbcpn60.1 and transformed into DH5α. Since blunt ended ligations 
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can produce products with the wrong orientation, this was checked with restriction digests 
and PCR screening. The plasmid was then also sequenced to ensure no undesired mutations 
were present before being transformed into strain B to be sent to Pittsburgh. A schematic 
representation of the process can be seen in figure 6.1. 
 
6.1.2    Results obtained from America 
Since the original complementation assay results could not be replicated in our lab in 
Birmingham, the construct had to be sent to Pittsburgh for the complementation analysis. 
However, to check the reliability of the experiments the constructs were first sent blind, such 
that the collaborators in Pittsburgh were not aware of the identity of the strains. This was 
done to see if they could correctly identify the constructs based on their phenotypic results 
alone.  
 
Based on the results that were obtained, they were able to correctly identify all the control 
strains. Their results showed that both strain A (original strain) and C (complementing 
Mscpn60.1) produced mature biofilms (fig 6.2a and 6.2c), while strain B (ΔMscpn60.1) 
lacked any signs of biofilm maturation (fig 6.2b).  
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Fig 6.1: A schematic representation of the process used to clone Mtbcpn60.1 into the 
pMsGroEL1 plasmid. 
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As the group in Pittsburgh were able to correctly identify the control strains and obtained 
expected results, the data from the remaining constructs was analysed. The results that were 
obtained after 5 days incubation were as expected. According to their analysis, strain D 
(Mscpn60.2) did not show any major signs of biofilm formation (fig 6.2d); while strains E 
(Mscpn60.3) and F (EcgroEL) showed partial complementation, i.e. the phenotypic biofilm 
results were in between the positive and negative controls (fig 6.2e and fig 6.2f).  
 
Interestingly, and consistent with the hypothesis, they were also able to show that 
MtbCpn60.1 (in strain G), was able to complement in the knockout strain and produce a 
mature biofilm similar to that of Mscpn60.1 (in strain C) (fig 6.2g). This confirmed the 
original hypothesis that MtbCpn60.1 can substitute for the loss of endogenous MsCpn60.1 in 
M. smegmatis. It should be noted however that visually the complemented strains do not 
produce as much biofilm as the original strain (strain A). However, upon further inspection it 
was found that the mass of the biofilm was roughly the same for the complemented strains 
and the wild type while being lower for the non complemented strains (fig 6.3). Interestingly, 
the mass of the biofilm from the strain carrying the EcgroEL gene was also as good as that of 
WT. 
 
 
 
 
 
Chapter 6 
215 
 
 
 
 
 
 
Fig 6.2: Biofilm assay results after 5 days of incubation. The assay was done with strains 
A (a), B (b), C (c), D (d), E (e), F (f), and G (g).  
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Fig 6.3:  Masses of 4 day old biofilms. M. smegmatis mc
2
155 (1), M. smegmatis mc
2
155 
Δcpn60.1 (2), M. smegmatis mc2155 Δcpn60.1/pMs10-cpn60.1 (3), M. smegmatis mc2155 
Δcpn60.1/pMs10-cpn60.2 (4), M. smegmatis mc2155 Δcpn60.1/pMs10-cpn60.3 (5), M. 
smegmatis mc
2
155 Δcpn60.1/pMs10-EcgroEL (6), M. smegmatis mc2155 Δcpn60.1/pMs10-
tbcpn60.1 (7).  Assays were repeated at least in triplicate. Image obtained from Ojha et al. 
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Discussion 
As discussed in the introduction, our understanding of the properties of the chaperonins of 
Mycobacteria suggests they have different functions within the cell. In M. tuberculosis, 
Cpn60.1 has been shown to be unnecessary for cell viability, but its deletion causes a 
complete lack of granuloma formation in infected mice and guinea pigs (Hu et al., 2008). 
Similarly in M. smegmatis, Cpn60.1 is not needed for cell survival but plays a role in its 
biofilm maturation (Ojha et al., 2005). The results obtained in chapters 3 and 4 also support 
this view, as it was demonstrated that only Cpn60.2 (and chimeras between Cpn60.2 and 
GroEL) could function as house-keeping chaperonins and not Cpn60.1.  
 
As MtbCpn60.1 and MsCpn60.1 are more closely related to each other than Cpn60.2 (section 
1.5.5), it suggested that these chaperonins could be interchangeable between the two 
organisms. Although the ability of MsCpn60.1 to complement in M. tuberculosis has not 
been tested, the results obtained with M. smegmatis enable the prediction that it would be 
able to complement for the loss of the MtbCpn60.1 chaperonin. The results obtained here 
show that MtbCpn60.1 can complement for the loss of endogenous Cpn60.1 in M. smegmatis. 
The phenotype observed was also very similar to that seen when the knockout strain is 
complemented with its own Cpn60.1. A point to note however is that although these 
constructs could complement in M. smegmatis; neither of them seemed to produce biofilms at 
the same level as that seen in the WT strain. However when the mass of the biofilms was 
analysed, it was shown that the complemented strains had biofilms that weight roughly the 
same as that of the WT strain and higher than the un-complemented strains. Another point to 
remember is that the images that were shown here were taken after a period of 5 days rather 
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than 7 days, so there is a possibility the biofilms would have matured further, but this would 
not have affected the overall results.  
 
It would have been interesting to further analyse the properties of these chaperonins. One 
possibility would have been to make apical domain swaps between the Cpn60.1 and Cpn60.2 
chaperonins of M. smegmatis to test the hypothesis that the apical domain is responsible for 
substrate specificity. The resulting chimeric chaperonins would be tested in a similar manner 
as the complementation tests shown above and in E. coli (chapter 3). Another possible 
experiment could involve making specific mutations between the chaperonins to try and find 
the regions that are responsible for biofilm maturation. Other experiments, such as testing if 
MsCpn60.1 could allow M. tuberculosis ΔMtbcpn60.1 strains to cause granuloma in infected 
mice would also have further expanded our understanding of the specialisation of the 
Mycobacterial chaperonins.  
 
 In summary, the results obtained here support the original hypothesis and show that 
MtbCpn60.1 can complement for the loss of endogenous Cpn60.1 in M. smegmatis. These 
results are consistent with the phylogenetic data (Figure 1.20c), and with the hypothesis that 
cpn60 duplicated in the strain that was ancestral to all known existing Mycobacteria, and that 
separate functions evolved for one of the two copies that have been maintained subsequently 
(Hughes, 1993, Hu et al., 2008, Lewthwaite et al., 2001).  
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Section 6.2: Testing the existence of double ring M. tuberculosis Cpn60.2 by 
attempting to make single ring mutants 
 
Background 
It has been proposed that Cpn60.2 from M. tuberculosis tends to exist as a lower oligomer 
(Qamra et al., 2004). However, chaperonin function (as currently understood) relies on the 
ability of chaperonins to form larger oligomeric structures to fold proteins in the central 
cavity of one of the two rings. The release of this protein from the first ring is then 
orchestrated by the interaction of ATP and substrate on the second ring. As a result, the 
unstable nature of these chaperonins was initially surprising, and suggests either that these 
chaperonins function by a non-canonical mechanism or that oligomers do in fact form under 
certain defined conditions. The results obtained in the previous chapters and by Elsa Zacco 
(Master’s thesis 2010) have shown that Cpn60.2 can function as a chaperonin in E. coli, and 
supports the hypothesis that it forms higher oligomeric structures under appropriate 
conditions.  These results, along with the fact that Cpn60.2 can function with both Cpn10 and 
GroES in E. coli, both of which form heptameric rings (Hunt et al., 1996, Roberts et al., 
2003), further supported the hypothesis that Cpn60.2 forms ringed structures in vivo. 
 
The structural stability of GroEL is vital for its function. It has been shown that making 
specific mutations in the equatorial domain of GroEL causes it to form single ringed 
structures, referred to as SR1 (Weissman et al., 1995). This single ringed structure, although 
able to interact with and even provide a chamber for substrate folding, is unable to release the 
substrate. This occurs because the allosteric signals that are sent from the second ring, which 
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are required to facilitate the release of the substrate from the first ring, are absent. As a 
consequence of this, SR1 loses its ability to function as a chaperone (Weissman et al., 1996).  
A point to note here is that functionality of the SR1 GroEL variant can in fact be resorted by 
making further specific mutations (Sun et al., 2003). It was shown that the functionality of 
SRI was restored because GroES was bound very weakly in the presence of ATP, and 
effectively abolished in the presence of ADP. Also, it is known that there are chaperonins in 
nature like the mitochondrial chaperonin, Hsp60, that also function as single rings (Nielsen & 
Cowan, 1998). However, this still requires the formation of at least one ring within which a 
substrate can fold. The data on Cpn60.2 suggested that they are even more structurally 
unstable. So it was hypothesised that the in vivo oligomeric property of Cpn60.2 could be 
indirectly analysed by making single ring mutations. If these mutations resulted in Cpn60.2 
losing its ability to function, then it would in essence support the idea that Cpn60.2 forms 
double ringed structures during its substrate folding cycle.  
 
Experimental design  
To obtain the single ring variant of GroEL, mutations were made to the residues R452, E461, 
S463, and V464. Residue 452 was replaced with Glu, while residues 461, 463, and 464 were 
replaced with Ala (Weissman et al., 1995). To try and replicate these results in Cpn60.2, the 
Cpn60.2 and GroEL sequences were first aligned (fig 6.4) and then appropriate primers were 
designed to make the required mutations using site directed mutagenesis (listed in section 
2.3.2).  
For these experiments the original pTrc-GroES-Cpn60.2 and pTrc-GroES-GroEL plasmids 
were used. Since it was not known if all four mutations were necessary to obtain a single ring 
variant (A. Horwich, personal communication), each of the four mutations were initially 
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made separately. A figure showing the sequence alignment and the residues that were 
mutated has been shown below in figure 6.4. The next step in these experiments was to 
analyse the complementation and expression data of the Cpn60.2 single mutants in MGM100. 
After these mutations were analysed, similar mutations were made in GroEL to see if it can 
replicate the results obtained with Cpn60.2 and if any one of these mutations result in the 
formation of SR1. GroEL was used in this experiment because native gels of the Cpn60.2 
mutants would not provide any useful information, since WT Cpn60.2 shows up as a 
monomer/dimer on the gel. 
 
6.2.1      Construction of the plasmids 
Site directed mutagenesis was used as per the protocol in section 2.4.13, to change the amino 
acid sequence of cpn60.2 to match that of groEL. Since four different mutations will be 
referred to in this section, they will be referred to as Cpn60-K449G (first mutation only), 
Cpn60-E458A (second mutation only), Cpn60-G460A (third mutation only), and Cpn60-
V461A (fourth mutation only). The four sites that were altered including the mutations that 
were made have been listed in the table below: 
Mutation Old Residue Old Sequence  New Residue New sequence 
Cpn60-
K449G 
K449 ccgctgaagcagatc  G449 ccgctggggcagatc 
Cpn60- 
E458A 
E458 gggctggagccgggc  A458 gggctggcgccgggc 
Cpn60-
G460A 
G460 gagccgggcgtggtg  A460 gagccggccgtggtg 
Cpn60-
V461A 
V461 ccgggcgtggtggcc  A461 ccgggcgcggtggcc 
 
Table 6.1: List of residues and mutations that were made to obtain the four required 
Cpn60.2 mutants 
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Fig 6.4: Sequence alignment between GroEL and Cpn60.2.  The blue regions represent the 
residues that were selected for mutation. 
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6.2.2         Complementation and expression results of Cpn60.2 mutants 
After all the four plasmids were obtained, they were sequenced to ensure the required 
mutations were present and that there were no undesired mutations. The constructs were then 
transformed into MGM100 using the protocol described in section 2.4.16. These strains were 
then analysed to test their complementation abilities using the protocol described in section 
2.5, but briefly, the resultant MGM100 + pTrc strains were grown overnight in arabinose, 
then sub-cultured and grown in 200 ml LB + 0.2% glucose the following morning for 2 
hours, and then serially diluted (in ten-fold steps) to spot on to square petri dishes. 5µl of 
each dilution was spotted onto the plates with the final dilution factor being 10
7
.  
 
The complementation analysis showed that out of the four mutants, only Cpn60-E458A was 
unable to complement for the loss of endogenous GroEL in MGM100 in the presence of 
glucose (fig 6.5a). Another point to note is that, while Cpn60-K449G, Cpn60-G460A, and 
Cpn60-V461A all grew very well in glucose and arabinose (with IPTG), strains with Cpn60-
E458A struggled to grow even in arabinose (fig 6.5b). This is not a surprising result, as it was 
expected that if any of the four mutations were in fact affecting the oligomerisation of 
Cpn60.2, then that mutant would also lose the ability to function. It was also expected that if 
this chaperonin was then over-expressed in the presence of IPTG (on glucose or arabinose) 
then it could be lethal for the MGM100 strain. The reason being, that this mutant chaperonin 
would interact with and trap its substrates and not be able to release them. Since some of 
these substrates are essential for cell survival, the lack of ability to fold and release them 
would result in cell death. 
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To ensure that the lack of complementation was not due to the lack of expression of Cpn60-
E458A, an SDS-PAGE gel was run (fig 6.6). Since Cpn60-E458A was causing cell death in 
the presence of arabinose as well, it was difficult to induce the cells for long durations of 
time. As a result, this plasmid could only be induced for 2-3 hours. It was observed that the 
expression level of Cpn60-E458A was lower than that of Cpn60-K449G, Cpn60-G460A, and 
Cpn60-V461A. However, even this level of expression should have been enough to allow 
Cpn60-E458A to complement in MGM100 if it was functional.  
 
 
                                         
 
 
Fig 6.5: Complementation assay of Cpn60.2 mutants in glucose or arabinose. (a) Cells 
grown on LB plates at 30°C with 0.2% arabinose and 0.1 mM IPTG. (b) Cells grown on LB 
plates at 37°C with 0.2% glucose and 0.1 mM IPTG. 
1- MGM100/ pTrc-GroES-Cpn60-K449G 
2- MGM100/ pTrc-GroES-Cpn60-E458A 
3- MGM100/ pTrc-GroES-Cpn60-G460A 
4- MGM100/ pTrc-GroES-Cpn60-V461A 
5- MGM100/ pTrc-GroES-GroEL 
6- MGM100/ pTrc99a 
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Fig 6.6: SDS-PAGE gel of Cpn60.2 mutants showing over-expression of all four 
mutants. All the samples, except Cpn60-E458A, were taken from cultures after 5 hours 
incubation at 37°C with 0.1 mM IPTG and 0.2% arabinose. Cpn60-E458A sample was taken 
from a culture after 2.5 hours of incubation at 37°C with 0.1 mM IPTG and 0.2% arabinose. 
1- Prestained protein marker (Fermentas) 
2- MGM100/ pTrc-GroES-MKO 
3- MGM100/ pTrc-GroES-JNL 
4- MGM100/ pTrc-GroES-Cpn60-K449G 
5- MGM100/ pTrc-GroES-Cpn60-E458A 
6- MGM100/ pTrc-GroES-Cpn60-G460A 
7- MGM100/ pTrc-GroES-Cpn60-V461A 
8- MGM100/ pTrc-GroES-GroEL 
9- MGM100/ pTrc99a 
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6.2.3     Complementation analysis of the GroEL mutant 
Since the 2
nd
 mutation in Cpn60.2 was enough to render it non functional, attempts were 
made to see if the same mutation could be made in GroEL, and if it could, then to see if it 
produced a non functional single ring oligomer on a native gel. The same site directed 
mutagenesis approach was used for GroEL as was done to make the Cpn60.2 mutants. 
Primers were designed so that E461 could be changed to A461, the details of which can be 
seen in the primers list in section 2.3.2. After mutagenesis, the resulting plasmid was 
sequenced to ensure that the required mutation was present before being transformed into 
MGM100 to test its functional ability. For the purpose of this thesis, the GroEL mutant will 
be referred to as GroEL-E461A.  
 
The complementation assay protocol was the same as that used for the Cpn60.2 mutants. The 
results that were obtained showed that GroEL-E461A does in fact work in E. coli MGM100 
and complements well for the loss of endogenous GroEL (fig 6.7). No growth issues were 
encountered in either arabinose or glucose in the presence or absence of IPTG. Since a fully 
functional chaperonin was obtained, a protein expression gel was not done. Instead, the 
remaining three possible mutations were attempted to see if they yielded similar results, and 
if all four mutations were in fact necessary to form SR1. Unfortunately, these mutations could 
not be made. Although colonies were being obtained after mutagenesis, the only method of 
screening them was by sequencing. Between 10 and 15 colonies were screened for each of 
the three mutants without success. Although this is a very small number of colonies, lack of 
time and financial resources prevented further screening.   
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Fig 6.7: Complementation assay of GroEL-E461A mutant in glucose. Cells were grown 
on LB plates at 30°C with 0.2% glucose and 0.1 mM IPTG.  
1- MGM100/ pTrc-GroES-GroEL-E461A 
2- MGM100/ pTrc-GroES-GroEL 
3- MGM100/ pTrc-GroES-Cpn60.2 
4- MGM100/ pTrc99a 
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Discussion 
The double ring structure of chaperonins like GroEL play a major functional role, although 
single ringed chaperonins are also known to occur in nature that are functional (Nielsen & 
Cowan, 1998). In either case, a ringed structure (either double or single) is needed to allow 
substrates to fold within a central cavity. Work done in our lab has already proven the 
existence of Cpn60.2 tetradecameric structures under certain conditions in vitro (Elsa Zacco, 
Master’s thesis 2010, University of Birmingham). It was also shown in the last chapter that 
JNL forms large tetradecameric structures under the same conditions in vitro. However, it 
becomes a lot more difficult to prove the existence of tetradecameric Cpn60.2 structures in 
vivo due to its unstable nature. The main reason why it is believed Cpn60.2 does form ringed 
structures in vivo is because it can function in E. coli MGM100, both with Cpn10 and GroES. 
As has been stated before, both these cochaperonins are known to exist as heptameric 
structures (Hunt et al., 1996, Roberts et al., 2003). In section 3.7 this was confirmed by 
deleting the cochaperonin GroES from the plasmid and showing that Cpn60.2 cannot 
function in E. coli MGM100 without it. 
 
The results that have been obtained here are a little difficult to interpret. It cannot be claimed 
that Cpn60-E458A proves that the Cpn60.2 forms a double ringed structure, since the same 
result could not be obtained with GroEL with the same mutation. The GroEL-E461A 
complementation data was a little surprising. This mutation had no affect on the functional 
ability of the chaperonin, although similar work done on GroEL where a E461K mutation 
was made resulted in the cells being heat sensitive (Sewell et al., 2004). However a point to 
note here is that this mutation alone did not result in the formation of SR1 either. The results 
obtained here can however support the possibility that the second mutation was able to 
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destabilise the oligomeric properties of Cpn60.2 further, to the point where it lost its ability to 
function. It can be suggest that since a single mutation was needed for Cpn60.2 to lose its 
functional abilities in E. coli, a combination of all 4 would also be expected to be non 
functional. Since we know that GroEL can be made into a single ring with those 4 mutants, 
which also renders it non functional, it indirectly supports the possibility of Cpn60.2 forming 
ringed structures in vivo.  
 
In summary, the data presented here supports but does not confirm the hypothesis that 
Cpn60.2 forms large tetradecameric structures in vivo. Further work to improve the results 
obtained here could involve making all 4 mutations in Cpn60.2, rather than assuming what its 
functional properties would be based on one negative result, and then comparing it with SR1. 
The Cpn60-E458A mutant could also have been put through the MS under the same 
conditions that showed Cpn60.2 forms tetradecamers to see if only heptamers were obtained. 
Other experimental techniques could also include the use of negative stain EM to visually 
observe if any single rings were present, however the unstable nature of Cpn60.2 may make it 
difficult to obtain the required results. 
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Section 6.3: Testing the hypothesis that phosphorylation is needed for 
improved oligomerisation 
 
Background 
Protein phosphorylation is a very important part of many cellular functions. It is involved in 
changing the properties of many proteins and hence used as a major method of regulating the 
activity of these proteins.  
 
It is expected that phosphorylation also plays a major role in the cellular processes of M. 
tuberculosis as it has been shown that the M. tuberculosis genome encodes 11 Ser/Thr protein 
kinases (STPKs) (Av-Gay & Everett, 2000, Wehenkel et al., 2008). It has also been shown 
that phosphorylation promotes the pathogenicity of Mycobacteria (Wehenkel et al., 2008, 
Walburger et al., 2004). Research on these kinases along with the M. tuberculosis Cpn60.1 
has revealed that Cpn60.1 is in fact a substrates of these kinases (Canova et al., 2009).  
 
Interestingly, there are potential phosphorylation sites present in the equatorial region of M. 
tuberculosis chaperonins and as a result Kumar et al. recently suggested that the 
oligomerisation of these chaperonins was dependent on the phosphorylation of these sites 
(Kumar et al., 2009). They showed that they could obtain tetradecameric structures for 
Cpn60.1, and that only these tetradecameric forms were phosphorylated on Serine 393, and 
not any of the lower oligomers. They suggested that this should also be true for Cpn60.2.  
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I found these results and the suggestions that were put forward a little odd. Firstly, M. J. 
Canova, L. Kremer, and V. Molle, who have done a lot of work on protein phosphorylation, 
have recently shown that although there are phosphorylation sites in the equatorial domain of 
Cpn60.1, they are mapped to Thr25 and Thr54 rather than Ser393 (Canova et al., 2009). 
Secondly, Kumar et al., have also stated that the lack of function of Cpn60.2 in E. coli, based 
on their results, may be due to the lack of oligomerisation as a result of the lack of 
phosphorylation in E. coli. While it can be agreed that Cpn60.2 may not be phosphorylated in 
E. coli, as it does not express the kinases required from M. tuberculosis; my results however 
differ in that it has been shown Cpn60.2 can in fact function in E. coli. 
 
Recent information with regards to Cpn60.2 suggests that it has three phosphorylation sites 
present in the equatorial domain, Thr90, Thr92, and Thr127 (V. Molle, personal 
communication). If phosphorylation was indeed necessary for oligomerisation, then it should 
be possible to stop or mimic phosphorylation in Cpn60.2 by mutating the phosphorylation 
sites to either alanine or glutamic acid respectively. These mutants could then be tested to see 
if phosphorylation does in fact improve oligomerisation. It was hypothesised that changing 
Thr to Ala or Thr to Glu would not have any effect on the functional properties of the 
chaperonin but it may improve its oligomeric stability.  
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Experimental design 
For these experiments, Cpn60.2 mutants had their phosphorylation sites either mutated to 
alanine (referred to as T/A60.2) which would stop phosphorylation, or to glutamic acid 
(referred to as T/E60.2) which has been known to mimic the affects of phosphorylation.  For 
this purpose I was kindly provided with three pET plasmids by Virginie Molle carrying the 
WT Cpn60.2, T/A60.2 triple mutant, and T/E60.2 triple mutant. These were first sequenced 
to ensure no unwanted mutations were present before analysing their complementation 
properties. 
 
Since the plasmids being used were pET plasmids that make use of the T7 RNA polymerase 
system to over-express proteins, it was decided that Tab21 should be used to test their 
complementation abilities. As discussed in chapter 3, Tab21 is a BL21 derivative that 
expresses T7 RNA polymerase and can be used to over-express proteins from pET plasmids. 
The chaperonins present on the plasmids provided by V. Molle had N-terminal His-tags, but 
no cochaperonin genes. Because of this, a plasmid carrying the groES gene was transformed 
into Tab21. This plasmid, pSUEH, which has a chloramphenicol resistance marker, carried 
both the groES and groEL genes. As such, restriction digest was used to remove the groEL 
gene before transforming it into Tab21 along with the pET plasmids. Furthermore, the 
presence of the N-terminal His-tags were causing issues during the complementation assay 
(section 6.3.2), and as such were also removed by restriction digests. 
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6.3.1       Modification of GroES inducing plasmid 
The plasmid that was picked to over-express GroES was pSUEH. Since it already had both 
the groES and the groEL genes it could not be used in the complementation experiments 
without modification. The plasmid was sequenced to see what restriction sites were available 
upstream and downstream of GroEL. Unfortunately, this plasmid lacked any appropriate sites 
that could be used to completely remove GroEL. However, the plasmid did have a HindIII 
site just downstream of GroEL and an EcoRV site present approximately halfway into the 
groEL gene. So a restriction digest was done with HindIII and EcoRV to remove a large 
segment of the groEL gene, which would render the encoded protein non functional. After the 
digest, the sample was run on a 1% agarose gel, and the vector backbone was extracted. It 
was then blunt ended using Klenow, and concentrated with ethanol precipitation before being 
religated. Using these restriction sites approximately 800bp of the groEL gene was removed 
without affecting the expression of GroES. The entire process has been represented with a 
schematic figure below (Fig 6.8).  
 
The resulting plasmid, referred to as pSUES, only expresses GroES. This was confirmed by 
transforming pSUES and pSUEH into Tab21 and then over-expressing them by growing the 
cell at 30°C in 0.2% arabinose with 0.1 mM IPTG for 3 hours. The SDS-PAGE gel shows 
clearly that in pSUEH both GroES and GroEL are induced, whereas in pSUES only GroES 
over-expression can be seen (fig 6.9).  
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Fig 6.8: A schematic representation of the process used to modify the pSUEH plasmid to 
obtain pSUES. 
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Fig 6.9: SDS-PAGE gel of pSUEH and pSUES. All the samples were taken from Tab21 
cultures after 3 hours incubation at 30°C with 0.1 mM IPTG and 0.2% glucose. Red arrows 
are pointing at GroES. 
1- Tab21/ pSUES 
2- Prestained protein marker (Fermentas)  
3- Tab21/ pSUEH 
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6.3.2   Complementation results in Tab21 
 
After confirming that only GroES was being expressed from the pSUES plasmid, it was 
transformed into Tab21 along with the three pET plasmids to test complementation using the 
complementation protocol described in section 2.5. The resultant Tab21 + pET + pSUES 
strains were grown overnight in arabinose, then sub-cultured and grown in 200 ml LB + 0.2% 
glucose the following morning for 2 hours, and then serially diluted (in ten-fold steps) to spot 
on to square petri dishes. 5µl of each dilution was spotted onto the plates with the final 
dilution factor being 10
7
.
 
  
 
In was noticed that while the cells grew normally in the presence of arabinose (fig 6.10a), the 
addition of 0.1 mM IPTG saw a drastic reduction in viable colonies (fig 6.10b). On glucose 
plates no complementation was seen from any of the strains, including WT (fig 6.10c). This 
was unexpected as it is already known from experiments done in chapter 3 that WT Cpn60.2 
does complement in Tab21. To ensure the lack of complementation was not being caused by 
the lack of protein expression, SDS-PAGE gels were run. These confirmed that all the 
chaperonins were being expressed at high enough levels to be able to complement (fig 6.11). 
Native gel analysis by a lab colleague, MingQi Fan, showed that the oligomeric properties of 
the chaperonins had not changed (Data not shown). 
 
From these results, it was not possible to conclusively say that T/A60.2 and T/E60.2 do not 
complement, as the WT (positive control) also did not grow. It was reasoned that, since all 
the Cpn60.2 constructs had His-tags on the N-terminal region, this could be causing issues 
with the chaperonins ability to function. As a result of this, it was decided that the His-tag 
would be removed and the complementation experiments would be attempted again. 
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Fig 6.10: Complementation results of the T/A60.2 and T/E60.2 mutants. (a) Plate grown 
at 37°C in the presence of 0.2% arabinose. (b) Plate grown at 37°C in the presence of 0.2% 
arabinose and 0.1 mM IPTG. (c) Plate grown at 37°C in the presence of 0.2% glucose and 
0.1mM IPTG. 
1- Tab21 + pET-Cpn60.2 WT + pSUES 
2- Tab21 + pET-T/A60.2 + pSUES 
3- Tab21 + pET-T/E60.2 + pSUES 
4- Tab21 + pSUES  
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Fig 6.11: SDS-PAGE gel of Cpn60.2 WT, T/A, and T/E mutants showing over-
expression. All the samples were taken from Tab21 cultures after 3 hours incubation at 37°C 
with 0.1mM IPTG. 
1- Prestained protein marker (Fermentas) 
2- Tab21 + pET-T/A60.2 + pSUES 
3- Tab21 + pET-T/E60.2 + pSUES 
4- Tab21 + pET-Cpn60.2 WT + pSUES 
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6.3.3     Complementation results in Tab21 without His-tagged chaperonins 
Since His-tags can potentially affect the function of a protein, it was decided that the tags 
would be removed from all three pET plasmids before re-attempting the complementation 
assay. To do this restriction digests were used again. From the sequence data, sites that would 
allow the complete removal of the His-tags without affecting the ribosome binding site (RBS) 
or the protein sequence were picked. It was noticed that there was an NcoI site upstream from 
the His-tag but downstream from the RBS and an NdeI site downstream from the His-tag but 
upstream from the starting codon of the chaperonins. A double digest using the respective 
restriction enzymes was done to remove the His-tags. The vector backbone was then gel 
extracted and made blunt ended using Klenow before being religated. These religated 
plasmids were then re-sequenced to ensure the His-tags had been removed without altering 
any of the other sequences. 
 
The resulting plasmids were transformed back into Tab21 and their complementation abilities 
were checked. Unfortunately, the results obtained here were also unexpected. The 
complementation data remained primarily unaltered with just a small improvement in 
complementation (fig 6.12). Although an improvement in growth on arabinose + IPTG plates 
with the WT construct was observed, it clearly showed that cells were still struggling to grow 
with the T/A60.2 and T/E60.2 triple mutants. On glucose plates there was a slight 
improvement in growth, but not enough to be regarded as good complementation. A 
reduction in the levels of over-expression of these chaperonins was also observed (fig 6.13), 
so there is a possibility that the lack of complementation was caused by the reduction in over-
expression.  
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Fig 6.12: Complementation results of the WT Cpn60.2, T/A60.2, and T/E60.2 mutants 
without His-tag. (a) Plate grown at 37°C in the presence of 0.2% arabinose and 0.1 mM 
IPTG. (b) Plate grown at 37°C in the presence of 0.2% glucose and 0.1 mM IPTG.  
1- Tab21 + pET-Cpn60.2 WT + pSUES (no His-tag) 
2- Tab21 + pET-T/A60.2 + pSUES (no His-tag) 
3- Tab21 + pET-T/E60.2 + pSUES (no His-tag) 
4- Tab21 + pSUES  
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Fig 6.13: SDS-PAGE gel of Cpn60.2 WT, T/A, and T/E mutants without His-tags 
showing a reduction in expression levels. All the samples were taken from Tab21 cultures 
after 3 hours incubation in 0.2% arabinose at 37°C with 0.1 mM IPTG. 
1- Prestained protein marker (Fermentas) 
2- Tab21 + pET-Cpn60.2 WT + pSUES (no His-tag) 
3- Tab21 + pET-T/A60.2 + pSUES (no His-tag) 
4- Tab21 + pET-T/E60.2 + pSUES (no His-tag) 
5- Tab21 + pSUES 
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Discussion 
The results that have been obtained here are quite difficult to interpret. The original objective 
of these experiments was to see if mimicking phosphorylation resulted in Cpn60.2 
oligomerising more readily. Unfortunately these mutants failed to even function in Tab21 
although they seemed to be expressing well. While the cells grew fine in the presence of just 
arabinose, the addition of 0.1 mM IPTG resulted in a drastic reduction in the number of 
viable cells. This was interesting, as this affect was seen with the WT Cpn60.2 as well, which 
has already been shown to be able to complement in Tab21 without any issues. In the 
presence of glucose (with or without IPTG), none of the 3 constructs showed any signs of 
growth. Since even the WT Cpn60.2 on the pET plasmid failed to complement, it could not 
be claimed that the mutations on the T/A60.2 and T/E60.2 constructs were responsible for the 
lack of functionality.  
 
It was initially reasoned that the lack of functionality may have been caused by the presence 
of the His-tag. However, even after removing the tag from the sequence and ensuring that 
none of the protein sequence was affected, the levels of complementation were only 
marginally better. In the presence of arabinose and 0.1 mM IPTG the WT construct grew 
quite well, but the T/A and T/E triple mutants had the same complementation data as was 
seen prior to the removal of the His-tag. In the presence of glucose however, there was only a 
slight improvement in complementation. However, it was observed that the levels of protein 
expression had fallen. So it is possible that this lack of function could have been due to the 
lack of protein expression.  However, since both the T/A60.2 and the T/E60.2 triple mutants 
struggled to grow on arabinose plates with IPTG, even after the His-tag was removed it 
suggests that these mutants are lethal to the cells when their expression levels are raised. It 
could be speculated that the mutants are in some way hampering the normal function of 
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endogenous GroEL. The exact mechanism by which this is being done is unclear, but it is 
possible that the over-expression of these mutants is resulting in the formation of non 
functional Cpn60.2 which traps the substrates required for cell survival and is unable to 
release them.  
 
In summary, these results have not provided enough information to come to an appropriate 
conclusion. Further experiments would need to be done to first try and resolve the 
complementation issues and then the expression issues before trying to test the oligomeric 
properties of these mutants. It may be worth trying to re-do the experiments with single or 
double mutants, as well as attempting the experiments by cloning the mutants into the pTrc 
vectors such that the cochaperonin is co-expressed.  
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Summary 
 
The main aim of this study was to better understand the properties of the multiple 
chaperonins of Mycobacterium tuberculosis. There are many reasons why Mycobacterial 
chaperonins are very interesting and unusual.  
 
One of the reasons why these chaperonins are interesting is that they occur in multiples, while 
most other bacteria only have a single copy (referred to as GroEL or Cpn60). In 
Mycobacterium tuberculosis there are 2 distinct homologues which encode the chaperonins 
Cpn60.1 and Cpn60.2. It was initially thought that since cpn60.1 gene was in the same 
operon as the cochaperonin cpn10, it would be the house-keeping chaperonin. However, it 
was found that this is not the case, and that Cpn60.1 is not required by Mycobacteria for its 
survival.  Phylogenetic analysis of the Mycobacterial chaperonins has shown that the genes 
for the duplicated chaperonins diverged a long time ago, such that one of the groEL 
homologues in M. tuberculosis is more closely related to one in M. smegmatis than it is to the 
other one in M. tuberculosis. This suggested that the two chaperonins in M. tuberculosis have 
evolved to fulfil different functions within the cell.  
 
Although studies have supported the idea that Cpn60.2 is the main housekeeping chaperonin 
in M. tuberculosis (Hu et al., 2008), other studies suggested that it did not function as a 
regular chaperonin and could not function at all in E. coli (Kumar et al., 2009). In this study I 
have shown that Cpn60.2 both from M. tuberculosis and from M. smegmatis can complement 
for loss of GroEL in E. coli.  Cpn60.1, however, was unable to complement in E. coli, but 
biofilm complementation experiments have shown that Cpn60.1 from M. tuberculosis can 
245 
 
complement for loss of the homologue in M. smegmatis. These results support the view that 
both the chaperonins have evolved to fulfil different cellular functions. As the apical domain 
is responsible for substrate protein binding in GroEL, it was predicted that the difference in 
function between M. tuberculosis Cpn60.2 and Cpn60.1 could be due to a difference in 
substrate recognition by the apical domain. Unfortunately, attempts to test this by making 
apical domain swaps did not give unambiguous results.  
 
These chaperonins are also unusual in that they have been shown not to form oligomers under 
standard conditions, to have very low ATPase activity, and in one case to crystallise as a 
dimer (Qamra et al., 2004, Kumar et al., 2009, Qamra & Mande, 2004). Most GroEL proteins 
occur as stable, large complexes with a characteristic double ring structure of 14 subunits. 
Given that the large structure formed by GroEL and its ATPase activity is vital for its 
mechanism, it is unclear why the oligomers of Mycobacteria are less stable and less active. It 
has been proposed that Cpn60.2 does not function in a similar fashion to GroEL and is unable 
to form oligomers with a central cavity. However, I have shown that Cpn60.2 most probably 
does function as an oligomer in the cell as it is able to function in E. coli with GroES. 
Although attempts to stabilise the oligomeric nature of Cpn60.2 by making domain swaps 
were not successful, making apical domain swaps between Cpn60.2 and GroEL resulted in 
fully functional chimeric chaperonins. This suggests that both chaperonins probably function 
in a similar manner.  The existence of higher oligomeric species of Cpn60.2 and its functional 
chimera has been studied using analytical ultracentrifugation in this and another project, and 
in the case of Cpn60.2, mass spectrometry under high salt conditions with ATP. These 
studies provided evidence of oligomerisation and increased ATPase activity from Cpn60.2 
and a chimera derived from it under specific conditions (high salt plus nucleotide). Taken 
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together, these results strongly suggest that Cpn60.2 from M. tuberculosis functions by 
forming multimeric complexes.  
 
The results that have been obtained in this project have extended and enhanced our 
understanding of the functional and oligomeric properties of the chaperonins of M. 
tuberculosis and support the hypothesis that Cpn60.2 of Mycobacterium tuberculosis 
functions in a similar manner to GroEL. Cpn60.1, on the other hand, has probably evolved to 
perform different cellular functions.  
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